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The Role of Eukaryotic Recombinase Loop L1 During Homologous Recombination
Justin Benjamin Steinfeld
Within the life of an organism, its deoxyribonucleic acid (DNA) is constantly bom-
barded with damaging agents from exogenous and endogenous sources. One of the most
deleterious types of damage is the double-stranded break (DSB) in which a continuous
strand of DNA is broken in two. As a result, the information stored in their connection
is lost. If improperly repaired, a cell will either not survive or transform into a neoplasm.
Homologous recombination (HR) is a mechanism by which the cell processes these broken
ends and uses proteins called recombinases to search for an undamaged homologous DNA
template for repairing the break, the homology search. Generally for eukaryotes, the recom-
binase, Rad51, performs the homology search. Without it, cells cannot repair spontaneous
DSBs by recombination and instead, must use alternative, less efficacious pathways. This
type of reparative homologous recombination generally occurs during mitosis and is thus
called mitotic recombination.
In addition to its role in repair, HR is employed by eukaryotes during the first stage
of meiosis to create crossover events, or chiasmata, between DNA homologs. The formation
of these chiasmata is necessary for proper segregation of the chromosomes, preventing ane-
uploidy in the haploid cells destined for sexual reproduction. These crossover events have
an added evolutionary benefit of mixing genes between the parental chromosomes, creat-
ing allelic diversity in the haploid cells. Eukaryotes have evolved a subset of meiotically-
expressed proteins to mediate this process. Dmc1 is a meiosis-specific, second recombinase
that eukaryotes require to properly form these crossover events between homologs. It is not
entirely understood why most eukaryotes require a second recombinase specifically designed
for meiotic HR. A potential reason for this second recombinase may lie in the preferred
templates for recombination that Rad51 and Dmc1 seek. Rad51 is employed mitotically
to repair spontaneous DSBs and thus searches for the perfect undamaged copy, the sister
chromatid, to prevent the loss of genetic information. Conversely, Dmc1 is employ meiot-
ically to purposely form crossover events between homologs, which carry single-nucleotide
polymorphisms (SNPs) between parental chromosomes. Thus, Dmc1 must be able to anneal
DNA strands that aren’t perfectly the same.
This work uses the single-molecule technique of DNA curtains to understand the factors
that effect Rad51 and Dmc1 homologous DNA-capture stability. The first part of Chapter 1
is a historical exploration of homologous recombination research and a review of the current
understanding of the pathway. The second part of Chapter 1 discusses human diseases
that are associated with the failure to properly repair double-strand breaks. Chapter 2 will
explain the single-molecule DNA curtain technique used throughout this work. Chapter 3
will show that Dmc1 is more tolerant of mismatches in captured DNA than Rad51. Chapter
4 will test the limits of Dmc1’s tolerance to imperfect DNA and attempts understand how it
accomplishes this tolerance. Chapter 5 will demonstrate that this tolerance of mismatches
is mediated by a specific structural element in recombinases, loop L1, and a chimeric Rad51
with a Dmc1-like L1 can tolerate mismatches in vitro and in vivo. Chapter 6 will explore
how recombinase mediators such as BARD1 and BRCA1 enhance RAD51’s ability to capture
DNA during the homology search.
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As a museum that holds the great works of humanity, each living being holds the
magnum opus of evolution in the form of its DNA. For humans, this work represents an
almost four-billion year process of natural selection to produce over six billion base pairs of
sequence information stored in every cell in the body. Although variations in DNA account
for the diversity of life across species and the human population, alterations in certain genetic
regions can contribute to the morbidity and mortality that plague all life. Thus, there is
a balance between the preservation of these alterations and the restoration of the original
work to realize each organism’s Darwinian potential.
Deleterious alterations can come in many forms and from various sources. Each form
poses a formidable challenge to genomic integrity. Thus, organisms have evolved many
proteins designed specifically for each type of damage. One such form is a discontinuation
in the series of phosphodiester linkages that hold a strand of DNA together. Normally, this
single-stranded nick can be seamlessly repaired through ligation; however, when there is also
a second break on the opposite strand of DNA, the information stored in their connection
can be forever lost. This type of alteration is referred to as a double-strand break (DSB),
one of the most deleterious forms of DNA damage, making proper repair of DSBs critical
for longterm survival.
1
1.1 Double-Strand Break Repair
1.1.1 Formation of Double-Strand Breaks
The causes of double-strand breaks (DSBs) can be categorized into spontaneous and
programmed events. Spontaneous DSBs can originate from exogenous sources, such as ioniz-
ing radiation (IR) or chemotherapeutic agents, and endogenous sources, such as free radicals
from metabolism or DNA stress during replication [1, 2]. The frequency of DSBs has been
estimated to be about one per 108 bp per day—a rate consistent across E. coli [3], yeast
[1], chicken DT40 cells [4], and normal humans cells [3]. For humans, this represents about
50 DSBs per cell per day or more than 50 quintillion breaks in the entire body over an
average human lifetime. DSBs during DNA replication, either by ssDNA breaks or stalled
replication forks, appear to represent a majority of spontaneous events [1, 5]. However, at
certain times, cells intentionally create DSBs, such as during mating-type switching in yeast,
during meiosis, or for adaptive immunity (e.g. V(D)J recombination, class switching, and
somatic hypermutation); and recent studies have even suggested DSBs contribute to normal
physiological neural function [1, 2, 6]. These programmed events are highly regulated and
involve additional proteins outside the canonical double-strand break repair (DSBR) path-
way [1]. Since most of this work is related to Saccharomyces cerevisiae proteins, this model
organism will be the primary focus of this part of the introduction and often referred to as
just yeast. E. coli, archaea, and human homologs will be noted when appropriate.
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1.1.2 Recognition of the Double-Strand Break
As with finding any solution, recognition of the problem is often the most important
step. In yeast, the sentinel of DSBs is the MRX (MRN in humans) complex composed of
Mre11, Rad50, and Xrs2 (Nbs1 in humans) and appears to be one of the first complexes to
recognize DSB damage [7, 8]. The MRX complex appears to be at least partially responsible
for physically tethering the two DSB ends through the Rad50 Zn-hook structure, preventing
the broken ends from diffusing away from one another [8–10]. Mre11 and Rad50 are conserved
in bacteria and archaea, but Xrs2 appears to be unique to eukaryotes, ensuring Mre11
nuclear localization [11]. MRX complex bound to DSB ends recruits the serine/threonine
kinase, Tel1 (ATM in humans), through direct interaction with Xrs2, activating Tel1 for
phosphorylation of histone H2A (H2AX in humans) at serine 129 and cell-cycle arrest [8,
12, 13]. Once the DSB is recognized, the cell must now act to repair the damage. There
are two primary DSBR pathways: non-homologous end joining (NHEJ) and homologous
recombination (HR) and the predominant pathway choice is dependent on where in the cell
cycle the DSB has occurred and whether initial DNA processing has occurred (Fig. 1.1) [5,
14, 15].
1.1.3 Non-homologous End Joining (NHEJ)
Although NHEJ occurs throughout the cell cycle, it is the predominant mode of repair
during the G1 phase of haploid yeast cells [8, 15]. The pathway choice between HR and NHEJ
is determined by whether initial resection of the dsDNA ends has occurred, as inhibition of
the resection pathway is necessary for NHEJ to proceed [8, 15]. This inhibition is achieved
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Figure 1.1: Main pathways of DNA repair. Non-homologous end-joining (NHEJ) and ho-
mologous recombination (HR) pathways act competitively to repair DNA double-strand breaks
(DSBs). Key players of NHEJ and HR are depicted. The MRE11/RAD50/XRS2 (MRX) com-
plex is recruited very early at DNA ends and appears to play important roles for both NHEJ and
HR. Ku70/Ku80 heterodimer is required for NHEJ and, through inhibition of DNA end resection
(5’→3’exo), acts as a repressor of HR. Fidelity of NHEJ-dependent DSB repair is low and, most of
the time, associated with nucleotide deletions and/or insertions at repair junctions. The common
early step of HR-dependent mechanisms is the formation of ssDNA which is then coated by repli-
cation protein A (RPA). Single-strand annealing (SSA) mechanism requires the presence of direct
repeats (shown in orange) on both sides of the break. SSA does not imply any strand invasion
process and is therefore not dependent on RAD51 protein. Strand invasion and D-loop formation
are however common steps of synthesis-dependent strand annealing (SDSA) and double Holliday
junction (HJ) dissolution mechanisms. In the latter case, double Holliday junctions are resolved
with or without crossing-over. This figure was reproduced with permission from Decottignies, A.
Alternative end-joining mechanisms: a historical perspective. Front Genet (2013).
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Figure 1.2: Current model of the Saccharomyces cerevisiae NHEJ. (A) Simple religa-
tion. In a similar manner to the process of mammalian NHEJ, Yku70/80 heterodimer is the
first NHEJ factor to bind to broken DNA ends. Subsequently, DNA-bound Yku70/80 recruits
the Mre11/Rad50/Xrs2 complex and facilitates its end-bridging activity. This activity enables
Lig4/Lif1/Nej1 complex to join Yku70/80-bound DNA ends. (B) DNA-ends-processing-dependent
NHEJ. If broken DNA ends are non-complementary, DNA end-processing reactions, generating
ligatable structure and occurring prior simple ligation, are required. These reactions include nu-
cleolytic end-processing and gap-filling mediated by Rad27 and Pol4, respectively. This figure was
reproduced with permission from Dudasova, Z., A. Dudas, and M. Chovanec, Non-homologous
end-joining factors of Saccharomyces cerevisiae. FEMS Microbiol Rev (2004).
by the MRX-independent recruitment of the Ku (Yku70–Yku80) complex to DSB ends,
protecting the ends from degradation and directly inhibiting the resection activity of the
MRX complex [8, 15, 16]. The Ku complex is then the scaffold to which the remainder of
NHEJ proteins are recruited and allowed to complete repair (Fig. 1.2) [9, 16–19].
The core NHEJ machinery includes the proteins DNA Ligase IV (Dnl4/Lig4 in hu-
mans), Lif1 (XRCC4 in humans), and Nej1 (XLF in humans) (Fig. 1.2A) [16, 17].
Lif1/XRCC4 has been shown to be necessary for stabilizing DNA Ligase IV in vivo and
for recruiting Dnl4 to DSBs [20, 21]. The role of Nej1 is not entirely understood; however, it
has been shown to directly interact with Lif1, and when deleted, to be necessary for efficient
NHEJ [9, 22, 23]. Nej1 in concert with Lif1 appears to be critical for stable binding of
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the Ku complex to DSB ends [23, 24]. More recently, Nej1 may play an independent and
additive role in recruiting Rad27 and Pol4, which are responsible for end-processing and
gap-filling, respectively, and are occasionally required to ligate DSB ends by NHEJ (Fig.
1.2B) [17, 23]. Ultimately, the critical step in NHEJ is Dnl4 ligation, which due to its foot-
print, presumably occurs one strand at a time, even if two Dnl4 molecules are present [9].
Overall, NHEJ is error-prone with genetic loss due to end processing and the potential of
chromosomal translocations events [8, 15, 25, 26]. Thus, alternative methods of repair are
preferred when available.
1.1.4 Homologous Recombination
Similar to the restoration of a painting, homologous recombination (HR) proteins can
use homologous copies of the damaged DNA as a reference for repairing with greater fidelity
than NHEJ. During S phase and G2 phases, DNA replication produces homologous templates
for repair, making HR a viable pathway [8, 27, 28]. Interestingly, diploid cells always prefer
HR for repairing breaks even if there is only a homologous template [29]. As discussed earlier,
the occurrence of 5’→3’ nucleolytic resection commits the cell to HR. Resection proceeds in
two steps: i) MRX (Mre11)/Sae2-mediated; ii) Exo1/Dna2-Sgs1-mediated [8]. The initial
MRX and Sae2 resection is more robust in its ability to remove irregular end structures,
such as hairpins and bulky adducts; however, it is much less processive, leaving behind small
3’-ssDNA overhangs of a couple hundred nucleotides (nt) [8, 30]. This initial resection step is
facilitated by phosphorylation of Ku70 during S phase, enabling the MRX complex nuclease
activity [31] and activation of Sae2 by direct phosphorylation by Cdk1, a cell-cycle-regulated
6
kinase involved in the G1/S phase transition [32]. In addition, these ssDNA overhangs, in
turn, inhibit binding of Ku to the DSB ends [8]. Efficient HR requires longer tracts of up
to 1-kb ssDNA overhangs mediated by the second step in resection [30]. The Sgs1 helicase
may be critical for paving the way for processive 5’→3’ nucleolytic resection by the Dna2
nuclease with Exo1 nuclease playing a less critical but non-redundant role [30, 33, 34].
The second-step of resection causes dissociation of MRX, Sae2, and Tel1 and binding of
replication protein A (RPA) to 3’-ssDNA overhangs, serving to remove secondary structure,
prevent degradation, and recruit additional checkpoint signaling proteins (Fig. 1.3) [8, 35].
With the aid of various mediators, such as Rad52 (BRCA2 in humans), the recombinase,
Rad51 (RAD51 in humans) replaces RPA on the ssDNA, forming a filamentous nucleopro-
tein structure known as the presynaptic filament (Fig. 1.3) [36–39]. From this point, the
presynaptic filament engages in the homology search, scouring the genome for homologous
DNA to use as a template for repair; additional details describing this homology search mech-
anism will be provided below [27, 28]. Once a homologous dsDNA template is captured,
the presynaptic filament invades the captured dsDNA, displacing the non-complementary
strand, forming a D-loop structure and postsynaptic structure (Fig. 1.3) [27, 28].
Repair and resolution of the break can take two paths: i) synthesis-dependent strand-
annealing (SDSA) or ii) classical double-strand break repair (DSBR), forming double Hol-
liday junctions (dHJ) (Fig. 1.3) [27, 28]. During SDSA, polymerases, Pol δ and Pol ϵ, are
thought to fill in resected DNA using the complementary strand as a template and second-
end capture is prevented by anti-recombinase helicases, Srs2, Irc20, and Mph1 (FANCM
in humans) (Fig. 1.3) [1, 40, 41]. Thus, SDSA obligatorily produces noncrossover events
(NCO), limiting loss of heterozygosity (LOH). During DSBR, the non-complementary strand
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Figure 1.3: Models and outcomes of the homologous recombination pathway. 5’→3’
resection of the broken ends creates 3’-ssDNA tails that are rapidly coated by RPA (light blue).
RPA is replaced by Rad51 (green) to form the nucleoprotein filament, which can initiate pairing
and strand invasion with the homologous duplex DNA. The 3’-end of the invading strand is ex-
tended by DNA synthesis using the donor duplex as a template. In the SDSA model, the invading
strand is displaced and pairs with the other 3’-ssDNA tail, allowing DNA synthesis to complete
repair. In the DSBR model, second end capture forms an early strand exchange intermediate.
Processing of this precursor by Mus81–Mms4 (Eme1) generates crossover products, and ligation
of this precursor creates a dHJ. Dissolution of the dHJ (via Sgs1 [BLM]–TopoIII￿-Rmi1) gives
rise to noncrossover products, whereas resolution (via Yen1 [GEN1]) can lead to either crossover
or noncrossover products. This figure was reproduced with permission from Mimitou, E.P. and
L.S. Symington, Nucleases and helicases take center stage in homologous recombination. Trends
Biochem Sci (2009).
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of the captured dsDNA is bound and used as a template for repairing the second end of the
ssDNA overhang, also known as second-end capture (Fig 1.3) [1, 27, 28]. Once second-end
captured has occurred, the joint-molecule (JM) can either resolve into NCO or crossover
(CO) events (Fig. 1.3) [1, 27, 28]. When the JM evolves into a dHJ structure, the helicase
Sgs1 (BLM in humans), topoisomerase Top3 (Topo III￿ in humans), accessory factor Rmi1
(RMI1 in humans), and potentially helicase Mph1 are responsible for dissolution of the dHJ
by convergent branch migration into NCO events [34, 42–44]. Endonucleases Yen1 (GEN1),
Mms81-Mms4, and Slx1-Slx4 appear to play a large role in the formation of crossover events,
but it is not entirely understood how all of these resolvases act independently to achieve
crossover events (Fig. 1.3) [34, 42, 45, 46]. In addition to these resolvases, recent work
has pointed to Mlh1-Mlh3 and Sgs1 as the primary actors in the formation of crossover
events during yeast meiosis [44]. As discussed below, the pathway chosen for DSB repair is
dependent upon whether the DSB was formed during mitosis or meiosis [47, 48].
1.1.5 Mitotic Recombination
In the late 1960s, a series of experiments looking at yeast sensitivity to γ-radiation led
to the discovery of a confluence of mutant genes displaying inherited spontaneous mutability
[49, 50]. It was soon found that a series of proteins in the RAD50 to RAD57 loci were
also critical for γ-radiation sensitivity [51–53]. Understanding that ionizing radiation (IR)
caused double-stranded breaks, Michael Resnick and Patricia Martin discovered the first
protein, Rad52, to be directly responsible for repairing these breaks [54, 55]. Eventually,
additional loci were discovered to be responsible for the repair of double-strand breaks and
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the RAD52 epitasis group was formed which includes, RAD50, RAD51, RAD52, RAD54,
RAD55, RAD57, RAD59, RDH54, MRE11, and XRS2 [56]. Although the MRX (Rad50-
Mre11- Xrs2) complex was mentioned earlier as part of DNA-end resection, the focus of the
section will be to cover the recombination roles of members of the RAD52 epistasis group
post-resection and required recombination protein, RPA. The reader is encouraged to seek
a recent review that explores DNA-end resection more extensively [57].
1.1.5.1 Replication Protein A
As discussed earlier, after DNA-end resection and formation of 3’-ssDNA overhangs,
replication protein A (RPA) binds to the ssDNA to remove secondary structure, prevent
degradation, and recruit checkpoint and other HR proteins (Fig. 1.3) [8, 35]. Interestingly,
unlike many of the other HR proteins, the discovery of RPA has its origins in bulk bio-
chemistry rather than genetics. In an attempt to understand the host proteins required for
simian virus 40 (SV40) replication, HeLa cell extracts were systematically fractionated with
one fraction containing the first eukaryotic protein with DNA binding activity highly specific
for ssDNA over dsDNA and resistant to high salt, reminiscent of previous studies of E. coli
SSB [58]. Due to its involvement in replication, this protein was soon purified, characterized
as a heterotrimer of 70, 32, and 14 kDa subunits with ssDNA-binding activity, and given
the name replication protein A (RPA) [59]. Soon after, Steven Brill and Bruce Stillman
unsuccessfully tried to reproduce in vitro SV40 replication with yeast extracts. However,
they identified a yeast homolog of human RPA with similar structural characteristics (het-
erotrimer with 70, 34, and 11kDa subunits) and ssDNA-binding activity [60]. In a separate
attempt to isolate the S. cerevisiae proteins that catalyze strand exchange as seen previously
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in E. coli [61], a single 132 kDa polypeptide was identified to be heavily overrepresented in
the fractions [62]. The 34 kDa subunit was purified and shown to be able to mediate E. coli
RecA strand-exchange in a similar manner to E. coli SSB [63]. Eventually, all of these yeast
protein complexes were realized to be one in the same, yeast RPA, expressed by three genes
RFA1, RFA2, and RFA3, and with roles in both replication and strand exchange [64–66].
Deletion of any of these three genes is lethal, making every subunit essential for yeast sur-
vival [67]. Additionally, genetic studies have successfully parsed RPA’s diverse roles in DNA
replication and repair with the discovery of the rfa1-t11 (L45E) mutant, which appears to
hinder DNA repair but not DNA replication [68, 69]. This section will focus on RPA’s role
in recombination.
Biochemically, RPA is a highly conserved ssDNA-binding protein with subnanomo-
lar affinities (Kd ∼ 10−8 − 10−10 M), low cooperativity, and 50-fold greater affinity for
pyrimidines over purines with low sequence specificity overall [70–73]. This exceptional
ssDNA-binding affinity serves two primary purposes: i) protection of ssDNA from degrada-
tion and ii) secondary structure removal. In vitro, RPA has been shown to protect 3’-ssDNA
overhangs from degradation while simultaneously promoting end-resection and processing
by MRX and Exo1 [74]. Similar results were found in vivo with the prediction that RPA
protects ssDNA degradation from endonuclease Dna2 [35, 75]. RPA’s duplex melting prop-
erties in low salt conditions was one of the first properties discovered and appeared to not
require ATP [76–78]. More recently, RPA has been show to be necessary to prevent DNA-
end hairpin formation at palindromic sequences during DNA processing [35]. Additionally,
hRPA has been show to melt G-quadruplexes in a 5’→3’ direction and this directionality
was shown kinetically in duplex DNA melting [79, 80]. Finally, this DNA melting has been
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shown visually in single-molecule experiments with long tracts of M13mp18 ssDNA extended
with the aid of hydrodynamic flow [81].
RPA’s exceptional affinity for ssDNA poses a problem for recombination since RPA
must eventually exchange with Rad51 and mediators to form the presynaptic filament for the
homology search to begin (Fig. 1.3) [8]. Single-molecule experiments with ssDNA curtains
have shown that RPA is, in fact, quite dynamic in its ssDNA binding activity [38, 70].
Although fluorescently-labeled RPA can remain stably bound to ssDNA for hours without
free RPA in solution, once unlabeled RPA is introduced into the system, the unlabeled
RPA quickly exchanges with labeled RPA and visa versa [38, 70]. Furthermore, without
the need of mediators and as long as free RPA is not in the system, Rad51 can freely
exchange with RPA-ssDNA complexes [38, 72]. This phenomenon led to the proposal of
microscopic dissociation events by RPA allowing facilitated exchange with other RPA or
Rad51 molecules without mediators [38, 72]. RPA’s ability to dynamically bind ssDNA lies
in its unique structure.
Structurally, RPA is a heterotrimer composed of 70, 32, and 14 kDa subunits, Rpa1,
Rpa2, and Rpa3, respectively [73]. In total, RPA has six oligonucleotide-binding (OB) folds
that mediate its DNA-binding properties and a winged helix (Wh) domain that mediates
its protein partner interactions [82]. Rpa1 contains four of these OB folds, DNA-binding
domains (DBD) F, A, B, and C with flexible linkers in between. Rpa2 has one fold, DBD-
D, and the Wh domain, while Rpa3 has DBD-E. In vitro, these six DBD’s coordinate to
produce three distinct salt-concentration-dependent DNA-binding modes [83, 84]. The first
8-10 nt binding mode is mediated by Rpa1’s DBD-A and DBD-B domains followed by an
intermediate 12-20 nt mode thought to be mediated by the addition of DBD-C [83]. The
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final 30 nt mode is mediated by the addition of Rpa2’s DBD-D [83]. It is hypothesized that
the coordination of these OB folds and their dynamic binding modes are what allow RPA to
have both high affinity for ssDNA and microscopic dissociation events that enable facilitated
exchange [38, 70, 72, 85].
1.1.5.2 Rad52
Although the Rad51 presynaptic filament can form on RPA-bound ssDNA in the ab-
sence of free RPA, free RPA is presumably always present in the cell. In vitro, when free
RPA is present, it competitively inhibits Rad51’s exchange and thus mediators are required
to allow Rad51 nucleation on the ssDNA, the rate-limiting step for Rad51 filament formation
[38, 72, 86]. Rad52 is one of these critical mediators. Although, non-essential, rad52 yeast
strains are deficient in DSBR, thus, connoting its critical role in the pathway [15, 28, 87].
As discussed earlier, Rad52 was the first DSBR protein found and thus the titular member
of the RAD52 epistasis group [51–55]. Rad52 quickly became of great interest to the scien-
tific community with the gene being cloned, sequenced, and primary structure determined
soon after [88, 89]. However, due to its role in DSBR, Rad52 remained rather elusive until
the characterization of recombinases Rad51 and Dmc1 (discussed later). Genetically, it was
shown that K. lactis Rad52 could partially complement a S. cerevisiae rad52 background and
a dominant negative effect in a wild-type background, which could be overcome by Rad51
overexpression, suggesting a competitive interaction with Rad51 between a non-productive
K. lactis Rad52 and wild-type S. cerevisiae Rad52 [90]. This study further demonstrated a
Rad51-Rad52 interaction with a yeast two-hybrid experiment [90].
One of the first in vitro biochemical properties found for Rad52 was its ability to
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specifically bind Rad51 in a study focused on the identification of a eukaryotic RecA-like
protein [91]. A Rad52-focused study showed that recombinantly expressed Rad52 could
bind both single- and double-stranded DNA with a slight preference for ssDNA [92]. This
study also demonstrated that Rad52 could anneal a partially melted “Y” DNA structure
in a homology-dependent manner with second-order kinetics [90]. Rad52’s binding to the
recombinase Rad51 in addition to its strand annealing property, led to the hypothesis that it
participates in strand annealing after Rad51 strand exchange [90]. The significant reduction
in the formation of Holliday junctions in vivo in a rad52 background, but not for strains with
deletions of other members of the RAD52 epistasis group, further implicated the purpose
of Rad52’s strand-annealing property [93]. The importance of Rad52’s strand-annealing
property for second-end capture was then shown in vitro, establishing Rad52’s critical role
in the DSBR pathway (Fig. 1.4) [94].
Rad52 was also found to have a mediator function for Rad51 presynaptic filament
formation. It was shown that Rad52 could help Rad51 overcome free RPA inhibition of
Rad51 strand-exchange activity, elucidating its mediator role in recombination [86, 95].
Simultaneously, a yeast two-hybrid study showed that Rad52 interacts directly with RPA in
vivo [96]. All of these biochemical properties and genetic findings coalesced into a coherent
Rad52 mechanism of action when an in vitro study demonstrated that Rad51 nucleation on
RPA-ssDNA filaments is the rate-limiting step for presynaptic filament formation, Rad52
stimulates Rad51 displacement of RPA on ssDNA, and Rad52 binds to RPA-bound ssDNA
[97]. A new model was proposed: RPA first removes secondary structure from ssDNA and
recruits Rad52 to this RPA-ssDNA complex to allow nucleation and presynaptic filament
formation by Rad51 [97].
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Figure 1.4: Rad52-mediated second-end
capture as part of DSBR. Rad52-
mediated second-end capture as part of
DSBR. (Step I) RPA binds to the 3’-
terminated ssDNA tails of the resected DSB.
(Step II) Rad52 binds to the RPA–ssDNA
complex. (Step III) Rad52 mediated dis-
placement of RPA by Rad51 to form a Rad51
nucleoprotein filament (Left end); Rad54
binds and stabilizes the Rad51 nucleoprotein
filament. (Step IV) The Rad54–Rad51–DNA
nucleoprotein filament catalyzes DNA strand
invasion to form a D-loop, displacing the res-
ident strand in the target dsDNA; the dis-
placed strand is bound by RPA and Rad52.
(Step V) Rad54 clears Rad51; the invad-
ing 3’-end primes DNA synthesis; extension
causes the displaced strand to advance un-
til an ssDNA region complementary to sec-
ond resected DNA end is exposed; Rad52
mediates annealing of the RPA-complexed
displaced strand to second end (Right end).
(Step VI) Additional DNA synthesis, branch
migration, and ligation generate dHJs. (Step
VII) Resolution to produce cross-overs or
noncrossovers. This figure was reproduced
with permission from Nimonkar, A.V., R.A.
Sica, and S.C. Kowalczykowski, Rad52 pro-
motes second-end DNA capture in double-
stranded break repair to form complement-
stabilized joint molecules. PNAS (2009).
Recent single-molecule work on ssDNA curtains has confirmed all of these results with
interesting additions to the proposed model in Figure 1.4 [38]. When Rad52 foci were bound
to the labeled-RPA-ssDNA complex and unlabeled RPA was flowed into the system, most
RPA turned over by the facilitated exchange mechanism mentioned earlier; however, those
RPA clusters with Rad52 did not turnover suggesting that Rad52 prevents the proposed
microscopic dissociations by RPA [38]. As expected, these Rad52 foci nucleated Rad51
presynaptic assembly, but many RPA-Rad52 clusters were left behind and were shown to
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be able to then nucleate Rad52 filament formation from these clusters [38]. This Rad52-
RPA-Rad51-ssDNA presynaptic complex is proposed to be mechanistically important for
stabilizing the noncomplementary strand after dsDNA capture and further downstream HR
processes [38]. The biological relevance of this complex is further corroborated by in vivo
evidence of RPA and Rad52 present at DSB’s before, during, and after Rad51 presynaptic
filament formation [38].
Structurally, there is little know about yeast Rad52 other than its ability to form mul-
timeric rings by electron microscopy (EM) [98], with Rad52’s diversity in function delineated
by protein truncations and point mutations. Rad52’s RPA, Rad51, and DNA-interacting
domains are thought to be located in its C-terminus [87]. Rad52’s N-terminus is responsible
for oligomerization of Rad52, DNA-binding and ssDNA-annealing activity for second-end
capture, and binding of Rad59 (discussed later) [99]. When this N-terminus is mutated,
rad52-R70A strains are capable of promoting Rad51 loading as well as wild-type, mediating
strand invasion; however, these strains are unable to complete recombination, confirming
the importance of Rad52’s DNA-binding and annealing activity for second-end capture [99].
Overall, there remains significant work in understanding the structure-function relationship
of Rad52 and Rad52’s exact mechanism during multiple steps of DSBR.
1.1.5.3 Rad55 and Rad57
Rad55 and Rad57 were first identified as part the original RAD52 epistasis during an
IR-sensitivity screen [51–53]. The role of Rad55/57 in regulating Rad51 filament stability
was first shown by the effects of temperature on IR sensitivity [100, 101]. While rad55 and
rad57 yeast strains show IR sensitivity similar to rad51 at lower temperatures (20 °C), rad55
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IR sensitivity was significantly suppressed at 30 °C [100, 101]. Through a yeast two-hybrid
screen with Rad51, Rad55, and Rad57, Rad55 and Rad57 interact with each other and with
Rad51 through an interaction with Rad55, suggesting Rad55/57’s role as a heterodimer
[102]. Temporal analysis of Rad55/57 in vivo shows Rad55/Rad57 foci form at the break
after Rad51 foci formation, indicating that the complex is unlikely to serve a role in Rad51
nucleation in addition to its stabilization activity [103, 104].
In vitro bulk biochemical assays demonstrated Rad55 and Rad57 form a heterodimer
with a Kd < 2.0×10−10 M [105]. Simple structural analysis shows that Rad55 and Rad57 are
paralogs of Rad51, sharing 20-30% sequence identity, containing putative nucleotide-binding
Walker A and B motifs [27]. Rad51 paralogs represent an important, but poorly understood
class of proteins that promote the stability and/or assembly of the presynaptic complex [27].
Consistent with their similarity to Rad51, both Rad55 and Rad57 show ssDNA-binding and
ATPase activity; however, this activity is not ssDNA- or dsDNA-dependent and these pro-
teins are not independently capable of strand-exchange activity [105]. In this same study,
it was shown that Rad55/57 increased Rad51 strand-exchange activity by aiding in Rad51
nucleation in the presence of RPA; however, this conflicts with previous temporal in vivo
studies and potentially an artifact of the Rad55/57-stabilization behavior [105]. A com-
bination of genetics and bulk biochemistry further progressed the Rad55/57-stabilization
hypothesis by uncovering a series of Rad51 mutations that partially suppressed ionizing
radiation in a rad55 rad57 background [106]. One of these mutants, Rad51-I345T, was
shown to be a dominant mutation in vivo and to have a higher binding affinity for both ss-
and dsDNA and to overcome RPA competitive inhibition for DNA binding in vitro [106].
Rad55/57 role in Rad51 stabilization was further elucidated by gel electrophoresis assays
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involving high salt conditions or the presence of the antirecombination helicase, Srs2, that
showed Rad51 presynaptic instability can be overcome by the presence of Rad55/57 [107].
Although there are potentially more functions of the Rad55/57 heterodimer, it appears that
its main function in HR is as an essential accessory factor for Rad51.
1.1.5.4 Rad54
As with other members of the RAD52 epistasis group, Rad54 was first identified dur-
ing the original IR-sensitivity screen in the 1970s [51–53]. Interestingly, during the same
temperature-sensitive study for Rad55 mentioned earlier, Rad54 was found to have the op-
posite effect—the rad54 strain IR sensitivity was suppressed by colder temperatures [100].
Similarly to Rad52, Rad54 was then shown to be involved in DSBR and the rad54 repair
defect showed similar temperature-sensitive effects to the earlier IR sensitivity study [108].
Further evidence of Rad54’s involvement in the IR damage response was shown by Rad54’s
upregulation after γ-radiation exposure [109]. It was later demonstrated that Rad51 di-
rectly interacts with Rad54 in vivo by yeast two-hybrid studies [110, 111] and through the
N-terminus of Rad54 by in vitro far-western and pull down assays [111]. Additional in vivo
evidence of the potential antirecombinase activity Rad54 was demonstrated by the synthetic
lethality of rad54 srs2 [112].
The first biochemical characterizations of yeast Rad54 came over twenty years after its
identification in the original IR-sensitivity screen and presented results seemingly in conflict
with the antirecombination hypothesis from in vivo studies [113]. Rad54 was shown to have
DNA-dependent ATPase activity with double the magnitude in the presence of dsDNA ver-
sus ssDNA and three-orders of magnitude greater than that of Rad51 [113]. Although it was
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previously shown that Rad54 carried the putative helicase motifs of the Swi2/Snf2 translo-
case family [114], it did not show helicase activity in vitro [113]. It was shown that Rad54
promoted Rad51 homologous pairing and D-loop formation but did not have pairing activity
by itself [113]. Soon after, a study showed that this homologous-pairing-mediation activity
was dependent on Rad54’s ATPase activity and ATPase dead mutants were sensitive to
MMS in vivo [115, 116]. This study also demonstrated that Rad54 forms a dimer/oligomer
in a DNA-dependent manner and this oligomer state could negatively supercoil relaxed DNA
plasmid in an ATP-hydrolysis-dependent manner, lending credence to the earlier finding of
Rad54 containing helicase motifs [116]. This helicase activity is hypothesized to be respon-
sible for Rad51’s homologous pairing enhancement in vitro and important for the homology
search in vivo [116]. Later in vitro bulk biochemistry experiments established an optimal
order and stoichiometry for Rad54’s role in mediating Rad51 homologous pairing. Specif-
ically, Rad54 is introduced after the formation of Rad51-ssDNA presynaptic filaments but
before homologous dsDNA in a 1:1 ratio [117]. This work presented a new model of Rad54
binding as a co-complex along presynaptic filaments in preparation for the homology search
[117]. This stoichiometry was later confirmed by immobilizing ssDNA-Rad51 on polystyrene
beads by a biotin-streptavidin interaction, showing Rad54 co-complex stoichiometrically and
Rad54 stabilization of the presynaptic filament [118].
At this point, the exact purpose of Rad54’s helicase activity and its connection to
homologous pairing mediation still needs to be established. Rad54 was shown in vitro to
produce both negative and positive supercoils, which was simulated by Rad51 [119]. Ad-
ditionally, this remodeling allowed relaxed DNA to be contorted such that ssDNA was
exposed, allowing access for Rad51 presynaptic filaments and a new hypothesis for Rad54’s
19
homologous pairing mediating activity [119]. This remodeling behavior was then shown to
directly act on chromatin, mediating bidirectional movement of nucleosomes across DNA
and this activity was stimulated by Rad51-ssDNA presynaptic filaments [120]. This ATP-
dependent chromatin remodeling behavior was then demonstrated in vivo during HR at the
MAT locus [121]. Eventually, it was directly shown that Rad54’s chromatin remodeling be-
havior mediated the joint formation on chromatin in vitro, further evidence of the Rad54’s
remodeling behavior in mediating Rad51 pairing [122]. In addition to applying supercoiling
and chromatin-remodeling, Rad54 was shown to disassemble partially Rad51-bound dsDNA
dead-end complexes in an ATP-dependent manner, thus demonstrating antirecombinase ac-
tivity and drawing the connection to the rad54 srs2 synthetic mutant discussed earlier [112,
123, 124]. Thus, Rad54’s ATPase activity serves a multitude of functions towards mediating
Rad51 homologous pairing.
An in vivo study demonstrated that Rad54’s helicase activity also acts postsynapti-
cally, showing that gene conversion to heterologous DNA templates decreased with over-
expression of Rad54 and increased with expression of ATPase-dead mutants [125]. This
potential postsynaptic behavior was then shown in vitro with human RAD54 preferentially
binding to branched DNA molecules and could branch migrate synthetically generated Hol-
liday Junction-like DNA molecules [126].
Single-molecule experiments have elucidated some of Rad54’s biophysical properties,
including a dsDNA translocation rate of ∼301 bp/s, processivity of ∼11.5 kbp, and ATP
concentration-dependent velocity with a Km ∼97 µM [127]. More recently, it has been shown
by single-molecule DNA curtains that Rad54 can bind to ssDNA only when Rad51-ssDNA fil-
aments have formed, confirming earlier bulk biochemistry results [128]. Additionally, Rad54
20
remained bound upon Rad51 dissolution by ATP depletion [128]. Together, these results
combined with known Rad54 DNA-binding activity suggest that Rad54 does not stabilize
Rad51 filaments and binds in clusters at the gaps between filaments that are too small
for RPA-binding [128]. This finding suggests that Rad54 does not form co-filaments with
Rad51-ssDNA and that the 1:1 optimal stoichiometry shown in earlier bulk experiments is
not due to homogenous binding of Rad54 but clustering between filaments [128].
Structurally, Rad54 has a primary and secondary Rad51 binding site at the N-terminus
and is not necessary for remodeling [129]. The C-terminus, chromatin-modeling domain has
been crystalized, revealing interesting relationships between structure and function (Fig.
1.5) [129]. Of note, there are two superfamily 2 (SF2) helicase-like lobes that act almost
as a palm along the presumed dsDNA-binding axis with two α-helical domains (HD1 and
2) which are the Swi2/Snf2-related domains that act as the fingers onto the chromatin for
remodeling (Fig 1.5) [129].
1.1.6 Meiotic Recombination
Since mitotic and meiotic recombination both abide by the guiding principles of the
DSBR model, there is significant overlap in the major proteins involved. However, as men-
tioned earlier and to be discussed further later, the initiation and end products of meiosis
and mitosis are different. Thus, the roles of mitotic factors may change during meiotic
recombination, and additional HR-related proteins are expressed exclusively during meiosis.
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Figure 1.5: Overview of the structure of zebrafish Rad54 (dnRad54∆N). The structure of
the core of Rad54. SWI2/SNF2 specific elements are depicted in magenta (HD1) and green (HD2),
the RecA-like helicase domains are blue (lobe 1) and red (lobe 2), and NTD and CTD are yellow
and cyan, respectively. The locations of the individual domains in the sequence are shown below
the structure. This figure was reproduced with permission from Thoma, N.H., et al., Structure of
the SWI2/SNF2 chromatin-remodeling domain of eukaryotic Rad54. NSMB (2005).
1.1.6.1 Spo11
Since DSBs need to be present for recombination to occur, arguably one of the most
critical meiotic proteins is Spo11, which produces the programmed break. SPO11 was first
gene discovered in a series of genetic experiments looking for mutants that were deficient
in sporulation [130–133]. Twenty years after this finding, a genetic study showed that DSB
formation was necessary for meiotic recombination initiation by monitoring changes in a
yeast plasmid containing a meiotic initiation site and strategically placed restriction sites
[134]. Spo11 became a candidate for producing this DSB when examination of a meiotic
recombination hot spot at HIS4-LEU2 failed to show a break in spo11 or rad50 backgrounds
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[135]. Further explorations demonstrated that X-ray-induced breaks could suppress the
non-sporulating phenotype of spo11 strains, implicating Spo11’s role in initiation of meiotic
recombination [136]. Eventually, two separate groups, in quick succession, demonstrated
Spo11 was responsible for initiation DSBs during meiotic recombination [137, 138]. Both
groups used the findings of a previous study, which showed that rad50S (a non-null Rad50
mutation) caused the accumulation of DSBs without further processing and an unknown
covalently-bound protein attached to the 5’ of the DNA fragments hypothesized to be a type
II topoisomerase [139]. One of these groups used primary structure alignment to demon-
strate that Spo11 had homology with subunit A of a known Sulfolubus shibatae type II
topoisomerase and predicted that Tyr135 was the catalytic amino acid [137]. Furthermore,
they demonstrated that a Y135F mutation prevented the formation of DSBs during mitosis
[137]. More definitively, another group used trypsin-digestion and mass spectrometry to
show that Spo11 was the covalently-bound protein on the 5’-end of unprocessed DSBs [138].
Structurally, Spo11 is considered a type IIB topoisomerase, an archaeal relative of
topoisomerase VI, which initiates the programmed DSB during leptotene to zygotene stage
of meiotic prophase I by cutting both strands of the DNA through the formation of covalent
protein-5’-end linkages in a topoisomerase-like mechanism [140, 141]. Specifically, a Spo11
dimer binds to the dsDNA and each Spo11, with a divalent ion cofactor, performs a trans-
esterification reaction by attacking the phosphorus in the phosphodiester linkage with the
nucleophilic hydroxyl-group on Try135, forming a tyrosyl phosphodiester linkage (Fig 1.6)
[140, 141]. Spo11 must be removed to allow 5’→3’ resection and the subsequent HR steps.
Evidence points to Mre11 endonuclease of the MRX complex along with Sae2 cleaving the
DNA behind each Spo11 [142, 143]. It is unclear whether Spo11 can turnover its covalently
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bound oligonucleotide and is hypothesized to be on a “suicide” mission that self-regulates
the number of DSBs that can form [140, 141, 143]. It would not be efficacious for meiotic
recombination to happen across totally randomly placed DSBs across the genome, and thus
DSB hotspots have been hypothesized [144]. Recently, by combining deep sequencing with
microarray hybridization, a set of general principles of Spo11 preference has been generated
with >88% of DSBs occurring at promoters [144].
1.1.6.2 Mei5-Sae2
After resection, RPA binds to 3’-ssDNA overhangs allowing formation of Rad51 and
meiotic-specific recombinase, Dmc1, nucleofilaments through the aid of mediators. One of
these mediators, the Mei5-Sae3 heterodimer, is meiosis specific (only in budding yeast), and
appears to serve a comparable function to Rad52 for Rad51 in mitosis [87]. Sae3 was the
first of the two to be determined necessary for the proper progression of meiosis [145]. In this
study, transcription analysis by Northern blot demonstrated that Sae3 was a meiotically-
expressed protein, and physical analysis of recombination by Southern blot showed sae3
strains had hyper-resected DSBs [145]. Additionally, cytological analysis showed cells were
stalled in the third stage of meiotic prophase, pachytene [145]. Mei5 was first shown to be
critical in meiosis a few years later in a systematic genetic screen of over 301 ORFs with
monitoring of meiosis by fluorescence microscopy and flow cytometry [146]. Strains with
a mei5 background were able to complete premeiotic S phase but did not initiate nuclear
division nor sporulate [146]. By fluorescence microscopy, two studies showed that Mei5,
Sae3, and Dmc1 spatially and temporally overlap during meiosis, and this localization is
mutually dependent on both Mei5 and Sae3. Additionally, Mei5 and Sae3 promoted Dmc1
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Figure 1.6: Structural model for Spo11-induced DSB formation. (A) A Spo11 dimer is
modeled using a surface rendering of the structure of Methanococcus jannaschi TopoVIA, with one
monomer in green and the other in blue. Approximate positions of the catalytic tyrosine of one
monomer and the metal-binding pocket of the other monomer are indicated. B-form DNA (drawn
approximately to scale) is docked onto the dimer. The metal binding pockets of the two monomers
are appropriately spaced to place them in proximity to the scissile phosphates which would give
the two-nucleotide 5’overhang known to be generated by Spo11 and TopoVI. The tyrosines in the
TopoVIA structure are far from these phosphates; however, so it is assumed that a conformational
change in the protein moves the tyrosines into position to cleave (small white arrows). (B) Cleavage
of the DNA backbone leaves Spo11 covalently attached to the DSB ends. For clarity, the Spo11
dimer interface has been interrupted to show how the two monomers are attached. Analogous
separation of the DNA ends is what opens a gate to allow strand passage for TopoVI; whether the
Spo11 dimer interface might be disrupted in this manner is not known. After DNA cleavage, Spo11
is released from DSB ends by endonucleolytic single-strand cleavage on either side of the break,
most likely mediated by Mre11 endonuclease activity. The strands where nicking occurs are
25
Figure 1.6: (cont.) colored red and highlighted with the black dots. Asymmetric nick spacing is
shown, but the disposition of nicks around individual DSBs is not yet known. (C) The DSB ends
are further processed by 5’→3’ single-strand resection. The shorter Spo11- bound oligonucleotides
may be small enough to be readily dissociated, but the longer oligonucleotides would need to be
actively unwound. This feature may result in capping of one of the DSB ends, which may in turn
influence the behavior of this end during subsequent recombination reactions. This figure was
reproduced with permission from Keeney, S., Spo11 and the Formation of DNA Double-Strand
Breaks in Meiosis. Genome Dyn Stab (2008).
assembly due to the reduced number of Dmc1 foci compared to Rad51 foci in mei5 and sae3
backgrounds [147, 148]. Furthermore, one of these studies showed direct interaction of Mei5
and Sae3 in vivo by co-immunoprecipitation [147].
The first biochemical work was performed only in the last 10 years with Mei5-Sae3
shown to directly bind RPA and DNA with a preference for ssDNA and prevent inhibition
of Dmc1 assembly by free RPA, analogously to Rad52 [149]. More recently, Mei5-Sae3 was
shown to preferentially bind DNA fork structures over ss- and dsDNA and to interact with
Rad51 through the N-terminus of Mei5. However, Mei5-Sae3 lacked Rad52’s homologous-
pairing-mediator and ssDNA-annealing activity [150]. This Rad51-Mei5-Sae3 interaction was
later shown to enhance Dmc1 D-loop formation [151]. Together, these biochemical studies
demonstrate that the Mei5-Sae3 heterodimer is important for Dmc1 assembly, stabilization,
and homologous pairing; however, further work is needed to understand the heterodimer’s
exact mechanism [152].
1.1.6.3 Hed1
During a screen for suppressor mutants of non-sporulating red1 (a meiotic protein dis-
cussed later) strains, a new ORF was found, HED1 (high-copy suppressor of red1), previously
undetected due to a one-nucleotide error in the Saccharomyces Genome Database [153]. By
26
sequencing upstream of the new ORF, they found that HED1 had a previously identified
meiotic-specific gene expression sequence [153, 154]. In this same study, it was shown that
hed1 could suppress dmc1’s reduced meiotic DSB repair, Hed1 co-localized with Rad51 at
meiotic DSB foci by immunostaining, and Hed1 interacted with Rad51, in vivo, by yeast
two-hybrid analysis [153]. Hypothesizing that Hed1 might inhibit Rad51 during vegetative
growth, Hed1 was expressed through a galactose-inducible promoter, resuilting in a strain
more sensitive to MMS than wild-type [153]. Another interesting finding from this study
that will be discussed in more detail later was that although hed1 could suppress dmc1’s lack
of meiotic DSB repair, the level of crossover events were far less than wild-type, suggesting
that Rad51 is capable of repairing meiotic DSB’s but not able to form crossover events to
the same extent [153]. A subsequent study, discussed in more detail later, expanded on this
finding, showing that hed1 dmc1 lost the meiotic bias towards homologs [155].
The first biochemical characterization of Hed1 came soon after this original genetic
study, showing that Hed1 binds ssDNA and directly interacts with Rad51 without inter-
fering with presynaptic filament assembly but blocks its interaction with Rad54 and the
subsequent Rad54 mediation behavior discussed earlier [156]. They then showed that this
Rad54 blocking occurs in vivo by expressing Hed1 mitotically during galactose-inducible
DSB formation and demonstrating a lack of Rad54 recruitment to the DSB by ChIP [156].
Recent single-molecule work has shed more light on Hed1’s Rad54-blocking mechanism
[128]. Fluorescently-labeled Hed1 bound tightly and uniformly to Rad51-ssDNA presynaptic
filaments, suggesting a Hed1-Rad51-ssDNA co-filament [128]. Interestingly, this complex
did not increase presynaptic filament stability, and Hed1 appeared to dissociate with Rad51
once ATP was depleted and hydrolyzed [128]. This co-filament also prevented the binding
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of Rad54, leading to the hypothesis that Hed1 fills in the gaps between Rad51 filaments
that Rad54 usually binds to [128]. It was then shown that Hed1 and Rad54 competitively
inhibit each other when added in unison on naked Rad51-ssDNA filaments and neither
could remove the other once bound to the filament [128]. These results together led to a
new meiotic kinetic model where the timing of Rad51, Rad54, Dmc1, and Hed1 expression
is critical for determining the presynaptic filament character in early and late meiosis (Fig.
1.7) [128].
1.1.6.4 Hop2-Mnd1
HOP2 was first identified in a screen for mutants that were defective in meiotic gene
conversion [157]. It was shown to have a similar transcription profile to another meiotic-
specific gene discussed later, RED1, and to localize to meiotic chromosomes prior to and
during synapsis [157]. The hop2 mutants arrested in prophase, failed to repair DSBs, and
showed high densities of Dmc1 remaining on the chromosomes, suggesting that recombina-
tion was not completed [157]. Curiously, hop2 mutants seemed to show synapsis between
nonhomologous chromosomes, and thus, it was hypothesized that its primary role is to en-
sure homologous pairing during meiosis [157]. MND1 was discovered genetically and found
to be critical for meiosis in the same genome-wide screen used to find MEI5 discussed earlier
[146]. By genetic deletion strains, MND1 was then shown to be important in early prophase
I, chromosome synapsis, and the interhomolog bias during meiosis, suggesting a role with
Dmc1 (discussed further later) [158]. Eventually, interdependent colocalization to meiotic
chromosomes and coprecipitation assays established the Hop2-Mnd1 complex in vivo [159].
Using these genetics studies, a group used bulk biochemistry to show that Hop2-Mnd1
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Figure 1.7: Model for kinetic completion between Rad54 and Hed1 as a mechanism for
defining presynaptic filament identity. (A) Cartoon diagram depicting proposed models for
Rad54 or Hed1 binding to the Rad51 presynaptic complex. We propose that Rad54 binds to small
regions of exposed ssDNA present between Rad51 filaments. This model postulates that while initial
recruitment to the filament is dependent on Rad51, stable association of Rad54 with the presynaptic
complex is mediated primarily through Rad54 interactions with the ssDNA. In contrast, Hed1
associates directly with Rad51 and does not require stable interactions with the underlying ssDNA
for binding stability. Hed1 prevents Rad54 association by blocking access to the small ssDNA gaps
present at the ends of the Rad51 filaments, and this inhibition requires the ssDNA‐binding amino
acids within Hed1. (B) Cartoon diagram showing the differences between mitotic and meiotic
presynaptic complexes and also depicting that transition from mitotic presynaptic filaments to
meiotic presynaptic filaments is controlled by a kinetic competition between Rad54 and Hed1
that is ultimately related to the relative abundance of each protein. During meiosis, Rad54 will
bind to the Rad51 presynaptic complexes when Hed1 abundance is low, whereas Rad54 will be
blocked from interacting with Rad51 presynaptic complexes when Hed1 abundance is high. Once
assembled, transitions between the two types of complexes will only take place if the proteins are
actively removed from the ssDNA. Additional details are presented in the main text. This figure
was reproduced with permission from Crickard, J.B., et al., Regulation of Hed1 and Rad54 binding
during maturation of the meiosis-specific presynaptic complex. EMBO (2018).
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formed a heterodimer in solution which could bind dsDNA and stimulate Dmc1 D-loop
formation by more than 30-fold in a concentration-dependent manner [160]. A later in vitro
study showed that Hop2-Mnd1 may mediate this stimulation in two ways: i) by stabilizing
the Dmc1 presynaptic filament from disassembly and ii) by enhancing presynaptic filament
dsDNA capture [161].
A recent crystal structure of full length G. lamblia Hop2-Mnd1 heterodimer is a remark-
able example of the structure-function relationship (Fig. 1.8) [162]. The dsDNA-binding
C-teriminus of each protein features a wing-helical domain, which, as a dimer, was predicted
to distort dsDNA base pairs using MD simulations [162]. The N-terminus features three
consecutive leucine zipper domains that were modeled to perfectly fit between the grooves
of a known RecA presynaptic crystal structure (Fig. 1.8) [162]. Using this structural infor-
mation, a combined model using known genetic, biochemical, and structure was developed
and represented in Figure 1.8 [162].
1.1.6.5 The Synaptonemal Complex (SC)
At the formation of presynaptic filaments, it is important to understand the extreme
complexity of the meiotic homology search problem. Not only must a 1kb length of ssDNA
find its homologous target within the genome, but it must additionally avoid the sister
chromatid and recombine with one of the two homologs (discussed further later) [141]. Thus,
architectural organization in the form of the synaptonemal complex (SC) is critical for proper
meiotic recombination (Fig 1.9) [163].
Due to its impressive size and organization, the synaptonemal complex has been ob-
served during meiosis for as least one hundred years [164], although work by Moses [165] and
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Figure 1.8: A model for Hop2–Mnd1-assisted strand invasion. (A) A model of Hop2–
Mnd1 binding to RecA nucleofilament. The structural model obtained from the MD simulation was
fitted into the groove of the crystal structure of RecA (yellow) bound to ssDNA (red) (PDB entry:
3CMU). The Site II residues are shown in sticks (blue), and representative distances are indicated.
(B) A model for Hop2–Mnd1-assisted strand invasion. The Hop2–Mnd1 molecules catch the Dmc1
nucleofilament, which is then closely juxtaposed to (highly distorted) dsDNA bound to the WHD
pair. If sequence matches most preferably at the end of the filament, DNA joint molecule is formed
and strand invasion proceeds subsequently. This would require concomitant with Hop2–Mnd1
detachment from both dsDNA and the Dmc1 filament for the propagation of the heteroduplex.
This figure was reproduced with permission from Costa, Y., et al., Two novel proteins recruited by
synaptonemal complex protein 1 (SYCP1) are at the centre of meiosis. JCS (2005).
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Figure 1.9: Model of SC structure. Shown is a cross section of a segment of the SC with lateral
elements (LE), transverse filaments, central element (CE), and central region. The arrangement
of transverse filament proteins, as determined experimentally for Zip1p and SCP1, is shown at
bottom. Also shown is a hypothetical arrangement of cohesins/condensins (blue ovals) and other
LE proteins (green ovals) along the LEs. This figure was reproduced with permission from Page,
S.L. and R.S. Hawley, The genetics and molecular biology of the synaptonemal complex. Annu
Rev Cell Dev Biol (2004).
Fawcett [166] in 1956 is often credited for the original description in crayfish and various
vertebrate spermatocytes. The wealth of meticulous cytological descriptions of the observed
phenomena by light and electron microscope merited hundreds of papers and many reviews
well before the widespread adoption of molecular genetics as a tool for understanding the
basis of such structures [167, 168]. In order to grasp the significance of this structure and
its meiotic arrival, a review of meiosis is essential. Briefly, meiosis involves two rounds of
chromosome segregation after DNA replication: i) meiosis I, which separates homologs, and
ii) meiosis II, which separate sister chromatids to form haploid gametic cells. These rounds
of segregation can be further sub-divided cytologically into prophase (chromosomes condense
and recombination occurs), metaphase (chromosomes align across equator of cell), anaphase
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(chromosomes begin separating towards opposite poles of cell), telophase/cytokinesis (cyto-
plasm division and formation of the cleavage furrow). The prophase stage during meiosis I,
prophase I, can be further subdivided cytologically into five substages: leptotene, zygotene,
pachytene, diplotene, and diakinesis. During leptotene, the first appearance of SC elements
occur with axial elements (orange elements in Fig. 1.10) assembling along the length of the
each homolog (Fig. 1.10) [169]. By zyogotene, transverse elements (blue and white chains
in Fig. 1.10) begin assembling across the homologs in a zipper-like fashion (Fig. 1.10) [169].
At pachytene, the homologs are fully synapsed. This is when crossover events are thought to
occur, leading to visible chiasmata by diplotene (Fig 1.10) [169, 170]. The formation of these
chiasmata is critical for proper segregation of the homologs [170, 171]. Although complex SC
formation is not required for homologous pairing in yeast, the lack of SC formation greatly
reduces these pairing interactions [172].
One of the first SC-associated genes identified in yeast was HOP1 by showing a lack
of SC formation by EM in a homozygous hop1 background [173]. It was later shown that
HOP1 was transcriptionally expressed during meiosis and primary structure analysis showed
the existence of a zinc-finger motif that when mutated from a cysteine to a serine, led to a
similar phenotype to hop1 null [173]. Simultaneously, another gene, RED1, was shown to
lead to chromosome nondisjunction during meiosis I and significant aneuploidy in the few
spores that did form [174]. A follow-up study showed that red1 chromosomes did not form
the SC either [175]. In addition, Red1 is implicated in reducing the interhomolog template
bias seen during meiosis, suggesting the importance of the SC in template bias [176].
Eventually, it was shown using fluorescently-labeled antibodies that Red1 and Hed1
localize at meiotic chromosomes, which combined with their early arrival during prophase,
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Figure 1.10: Diagrammatic representation of the development and structure of the
synaptonemal complex (SC) throughout the prophase I stages. The two chromatids of
each homologue (red) are associated with the chromosome scaffold (yellow axes) that underlies the
position of the cohesin axes (green pieces). The axial/lateral elements (orange pieces) of the SC
are assembled at each homologue during leptotene. By zygotene, the homologous chromosomes
pair and align provoking that their lateral elements run parallel. At this stage, synapsis initiates
as the transverse filaments (white and blue chains) interconnect the lateral elements in a zipper-
like structure, which is completed by the arrangement of the central element (purple pieces). At
pachytene, the SC extends the entire length of homologues, completing synapsis. Meiotic stages
and structures are indicated in the figure. This figure was reproduced with permission from Maloy,
S., K. Hughes, and ebrary Inc., Brenner’s encyclopedia of genetics. Elsevier (2013).
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suggested that they formed the lateral elements of the SC (blue elements in Fig. 1.9, orange
elements in Fig. 1.10)[177, 178]. A third gene, ZIP1, was identified to not properly form
SC’s during this same period in the late 80s and early 90s [170]. Due to its URS1-like
meiotic gene promoter and a clever Zip1-β-galactosidase fusion assay, it was determined
that Zip1 is expressed exclusively during meiosis [170]. After primary structure analysis of
Zip1 showed an α-helical coiled-coil motif and fluorescent antibodies to Zip1 localized to
meiotic chromosomes, Zip1 was hypothesized to be a structural element of the SC (orange
elements in Fig. 1.9, transverse elements in Fig. 1.10, represented by blue and white chains)
[170]. Beyond homolog proximity, there is additional evidence that the SC can transduce
signals through structural changes due to DSBs in the attached chromosomes such that
additional DSBs are not made nearby, a concept referred to as interference [171]. Of course,
there are many more proteins involved in the assembly of the SC, but these original three
provided the molecular genetic evidence for the importance of the SC in homologous pairing,
crossover events, template bias and meiotic recombination more generally.
1.1.6.6 Meiosis in Dmc1-less Eukaryotes
Neither C. elegans nor D. melanogaster have Dmc1 and thus use Rad51 as the re-
combinase for meiotic recombination [171]. Unlike yeast, these species are able to enagage
in homologous pairing without DSB formation. C. elegans rapidly aligns homologs dur-
ing meiosis without the initiation of recombination or synapsis-related proteins [171]. D.
melanogaster seems to have DSB-independent somatic pairing associations [171]. Together,
it appears that homologous pairing is recombination independent in these species [171]. If
there are eukaryotic species that can thrive with one recombinase, why did eukaryotes evolve
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a separate recombinase for meiosis?
1.1.7 Mitotic versus Meiotic HR
For the most part, mitotic and meiotic recombination differ in their purpose and thus,
their respective outcomes (Fig 1.11) [47, 48, 179]. Generally, mitotic recombination is em-
ployed to repair spontaneous DSBs with minimal LOH, whereas meiotic recombination is
employed to produce chiasmata between homologs from programmed breaks to ensure proper
segregation [47, 48, 179]. Consequently, mitotic and meiotic recombination differ in two
distinct ways: i) production of noncrossover (NCO) versus crossover (CO) events; ii) homol-
ogous template choice for repair [47, 48, 179]. Since the goal of mitotic recombination is to
repair spontaneously formed DSBs with minimal LOH, NCO events are heavily biased [47,
48, 179]. In order to ensure NCO events, SDSA is the primary mode of repair for mitotic
HR [47, 48, 179]. Meiotic recombination, on the other hand, requires CO events to ensure
physical linkages between homologs, and thus, DSBR is the primary pathway [47, 48, 179].
However, DSBR can result in CO and NCO events so, as mentioned earlier, Mlh1-Mlh3 and
Sgs1 appear to be employed during meiosis to ensure that CO events occur [44]. In addition,
evidence points to the Mms4-Mms81 endonuclease complex as an additional player in CO
formation with the central regulator of meiosis I, Cdc5, phosphorylating and activating the
complex for resolution during meiosis [45].
Mitotic and meiotic recombination differ in their choice of templates for repair (Fig.
1.11) [179]. During mitosis in diploids and meiosis, a broken chromosome has the choice
of three templates: its exact copy sister chromatid and two homologs containing single
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Figure 1.11: Meiotic versus mitotic recombination. Meiotic and mitotic recombination are
fundamentally different in several aspects, including function, initiating lesions, timing during the
cell cycle, and outcome. In this figure, a single pair of homologous chromosomes is shown in
each nucleus. Both DNA strands of each chromatid are shown. This figure was reproduced with
permission from Andersen, S.L. and J. Sekelsky, Meiotic versus mitotic recombination: two different
routes for double-strand break repair: the different functions of meiotic versus mitotic DSB repair
are reflected in different pathway usage and different outcomes. Bioessays (2010).
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nucleotide polymorphisms (SNPs) [179]. In order to prevent LOH, mitotic recombination
prefers the sister chromatid as a template with an inter-sister (IS) to inter-homolog (IH)
ratio of 4:1, despite the fact that there are 1:2 sister chromatid to homolog substrates for
repair [179]. To ensure formation of chiasmata and proper chromosomal segregation, meiotic
recombination biases the homolog with a 5:1 IH:IS ratio [179]. Although the factors that
contribute to differences in template bias remain poorly understood, these biases appear to
be in part mediated by the recombinases involved in meiosis and mitosis [179].
During mitosis, Rad51 is the only recombinase expressed for repair of spontaneous
breaks [179]. During meiosis, Rad51 is expressed together with the Rad51 paralog Dmc1
(DMC1 in humans) [179]. Normally, during meiosis, Rad51 and Dmc1 form mixed presynap-
tic filaments with recent evidence pointing to self-segregation of Dmc1 and Rad51 in vitro
[180, 181]. However, the meiotically-expressed Rad51 regulatory protein, Hed1, is expressed
and inhibits the activity of Rad51 during meiosis [179, 181]. In fact, hed1 strains appear
to decrease the IH:IS bias from 5:1 to 4:1, implicating Rad51 in a IS bias (Fig. 1.11) [179].
Furthermore, hed1 dmc1 strains show a complete reversal of bias with a 1:9 IH:IS bias during
meiotic recombination [179]. In addition, when a dsDNA-binding-deficient rad51-II3A mu-
tant is introduced, the IH:IS bias is seemingly unaffected, pointing to Dmc1’s primary role
in meiotic recombination [151, 179]. Thus, this work, in aggregate, suggests that Rad51 and
Dmc1 have differing properties to facilitate their roles in mitotic and meiotic recombination
template bias.
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1.1.8 Eukaryotic Recombinases Rad51 and Dmc1
In the 1960s, E. coli RecA was the first recombinase identified, playing a crucial role
in recombination by UV-sensitivity experiments [182, 183]. It wasn’t for another ten years
that RecA was purified and shown to have ATP-dependent homologous pairing activity in
vitro [61]. Thirteen years later, Rad51 [91] and Dmc1 [184] were determined to be the yeast
recombinases, by comparing the amino acid sequences with RecA’s, demonstrating the ac-
cumulation of DSBs in rad51 and dmc1 strains, and additionally, showing that Rad51 could
bind to mediator, Rad52, and DNA [91, 184]. Two years later, yeast Rad51 was purified
and shown to have ATP-dependent homologous-pairing and strand-exchange activity [185].
Yeast Dmc1 was finally shown to have homologous pairing activity seven years later but
much weaker than Rad51 and RecA due to incomplete filament formation [186]. It was
later determined that Ca2+ was necessary to promote longer Dmc1 filaments in vitro and
comparable activity could be recovered when this divalent ion was included into the reaction
[187]. Overall, biochemically, yeast Rad51 and Dmc1 share similar ATP-dependent presy-
naptic filament assembly, DNA-dependent ATPase activity [185, 187], and strand-exchange
activity.
Structurally, both eukaryotic recombinases Rad51 and Dmc1 are remarkably similar
[37, 39, 188, 189]. Yeast Rad51 and Dmc1 share 45% sequence identity (55% for humans)
[190], both carry Walker A and B ATPase motifs [191]. By transmission electron microscopy
(TEM), yeast Rad51 and Dmc1 appeared to form similar right-handed helical filaments
across ssDNA with persistence lengths of 543 ± 45.3 nm and 507 ± 45.2 nm, respectively,
helical pitches of 11.9 ± 0.8 nm and 11.2 ± 0.7 nm, respectively, and helical widths of 10.2
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± 0.8 nm and 10.4 ± 0.8, respectively [192]. Both recombinases have been shown to stretch
DNA by ∼1.5 times [192]. Crystal structures of human RAD51 and E. coli RecA in pre-
and postsynaptic forms have elucidated a rather unique asymmetry in this stretching with
each recombinase binding 3-nt of DNA with B-form-like properties and a ∼8 Å between each
triplet [36, 39]. Presumably, yeast Rad51 and Dmc1 share these properties as well.
1.1.9 Recombinase Loops L1 and L2
The Rad51/RecA family of DNA-binding proteins interact with DNA substrates
through two highly conserved loop regions, referred to as loop 1 (L1) and loop 2 (L2). The
recombinase loops L1 and L2 were first identified by Thomas Steitz in his E. coli RecA crys-
tal structure in 1992 [193]. Although the electron density did not appear due to presumed
disorder, the loops were defined as between residues G157-M164 and I195-T209, respectively
[193]. When aligned with the available low-resolution EM-structure of the RecA filament,
the loops appeared to lie closest to the ssDNA in presynaptic form [193]. Later crystal
structures of E.coli RecA [36, 194, 195], S. solfataricus RadA (L1: R217-R229; L2: M258-
H275) [196], yeast Rad51(L1: F290-L296; L2: V328-N348) [37], human DMC1 (L1: R230-
R242; L2: N268–R300) [188, 189], and human RAD51 (L1: Y232-L238; L2: V270-I287)[39]
confirmed that these loops are conserved across the RecA/Rad51 family of recombinases.
Interestingly, although the loops in RecA were unstructured when RecA is unbound to DNA,
portions of the loops become ordered once RecA forms a presynaptic filament [36]. In the
postsynaptic structure, a few residues in L1 become more ordered and appear to make con-
tacts with the captured DNA [36]. Unfortunately, the RecA L1 significantly diverges from
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eurkaryotic L1’s so directly comparing them is difficult. Yeast Rad51’s loops are disordered
in the filamentous form of the protein [37] and hRAD51’s loops are disordered in the pre-
and postsynaptic forms of the protein [39]. Conversely, hDMC1’s L1 is fully structured
and L2 partially structured (268-272, 285-300) although hDMC1 is crystalized unbound to
DNA and as an octomeric ring [188, 189]. This may imply that the differing amino acids
in hDMC1’s loop from those in yeast and human Rad51’s loops confer a more stable state,
contributing to how it functions in meiotic recombination.
One function of these loops is ssDNA binding. Crosslinking [197, 198] and mutational
fluorescence spectroscopic analysis [199] confirmed that E. coli RecA loop’s L1 and L2 inti-
mately interact with ssDNA. One group purified a 20 amino acid peptide from L2 (193-212)
with a F203W mutation and used linear dichroism to determine that this peptide alone was
capable of stiffening and restricting the motion of ssDNA in a similar manner to full-length
RecA [200]. Using the previously discussed postsynaptic RecA crystal structure, another
group decided to mutate D161 to an alanine due to its close proximity to complementary
DNA strand and implied electrostatic repulsion with the DNA backbone [201]. They found
that the D161A mutant lost the wild-type preference for ssDNA over dsDNA and that D161N
mutation had the same effect, suggesting that D161 is important for RecA’s ssDNA prefer-
ence and charge is one of the primary reasons for this effect [201]. During a study with yeast
Rad51 looking for suppression of rad57 IR sensitivity, three L2 mutations V328A, P339S
and I345T were discovered and shown to have much greater affinity for ssDNA by EMSA
and salt titration [106, 202]. In addition, these mutants showed no significant sensitivity
to IR in an otherwise wild-type background but a greater sensitivity in an srs2 background
than srs2 and RAD51, further demonstrating these mutants increase presynaptic filament
41
stability and L2’s role in ssDNA binding [106, 202]. A study looking at human RAD51
found that an L2 mutation, F279W, could bind and hydrolyze ATP and bind dsDNA but
was significantly defective in ssDNA binding [203]. A dominant mutation in mouse DMC1
L2, A272P, causing male sterility and decreased fertility in females, was found to have a
3-fold reduction in ssDNA binding and no strand-exchange activity1 [204].
In addition, the loops appear to be involved in recombinase ATPase activity. One study
systematically made all 380 single mutations in E. coli RecA L2 (195-209) and used lambda
plaque, UV sensitivity, and mitomycin C sensitivity assays, finding that any substitution
of R196 ablated ATPase activity [205]. Combined with the previously known DNA-binding
function of L2, this study led to the hypothesis that L2 is responsible for linking RecA’s
DNA-binding to its ATPase activity [205]. Similarly, yeast Rad51 F290A (L1) was able to
bind ssDNA and dsDNA in an ATP-dependent manner but was ATPase dead, suggesting
this amino acid is also important for communicating between the ATP hydrolysis and DNA
binding [206]. A third study showed that mutation, K342E, in yeast Rad51 L2 led to
DNA-independent ATPase activity, again suggesting L2’s role in linking ATP-binding, DNA-
binding, and ATP hydrolysis [207, 208]. Mutations in Methanococcus vitae RadA’s L2,
H276N and H280N, reduced and ablated ATPase activity [209].
Recombinase loops have also been found to contribute to dsDNA-capture and strand-
exchange activity. The yeast Rad51 L2, K342E, mention earlier, caused a defect in dsDNA
capture, implicating L2’s role in dsDNA capture [207, 208]. Interestingly, this mutation
led to filament formation in the absence of DNA by direct observation on EM [207, 208].
In addition, yeast Rad51 L2 mutants, V328, P339S and I345T, all showed greater in vitro
1ATPase activity was not tested.
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strand-exchange activity than WT [106, 202]. A mutation in human RAD51 L1, R235E,
could bind ssDNA but not bind to dsDNA by gel shift or to dsDNA single-molecule cur-
tains [210]. In this same study, hRAD51 L2 K284A did not affect assembly or binding to
dsDNA curtains but was deficient in a bulk strand-exchange assay [210]. During a muta-
tional fluorescence spectroscopic analysis, hRAD51 L1 mutant, D231W, had normal ssDNA-
and dsDNA-binding activity but had no strand-exchange activity [203]. Additionally, in this
study, L1 mutant, Y232W, had normal ssDNA binding but had a dsDNA-binding defect and
had no strand-exchange activity [203]. A series of studies using site-specific linear dichroism
and modeling found hRAD51 Y232 is important for intercalating stretched DNA triplets in
presynaptic ssDNA, and R235 is near the phosphate backbone of captured strand. [211–213].
Overall, structural and biochemical studies have demonstrated that recombinase loops
L1 and L2 are intimately involved in the critical functions of ATP, ssDNA, and dsDNA
binding, ATP hydrolysis, and strand-exchange activity. Many independent studies have
shown that L1 and L2 are proximal to ssDNA and captured DNA in pre- and postsynaptic
structures. Thus, any potential differences between Rad51 and Dmc1 at these loops could
translate into differences in how Rad51 and Dmc1 engage captured dsDNA and suggest why
eukaryotes evolved an additional meiotic recombinase.
1.1.10 Conclusion
The hypothesis-driven scientific method requires independent discoveries across many
fields that converge on common truths of nature. This is no different in the case of homolo-
gous recombination for which decades of work from initial studies using molecular genetics
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laid the foundation for biochemical, structural biological, and single-molecule fields to un-
cover the vastly complex coordination of the many proteins involved in the HR pathway.
Yet, questions still remain. The focus of this work is to understand why eukaryotes evolved
two recombinases for mitotic and meiotic recombination. Developments in single-molecule
biophysics have allowed high-throughput analysis of recombinase on ssDNA curtains (Chap-
ter 2), revealing subtle differences between Rad51 and Dmc1 in response to mismatches in
captured dsDNA that were otherwise lost in bulk biochemical assays (Chapter 3). By al-
tering additional properties of the captured dsDNA, we test the limits of Dmc1’s tolerance
towards various sequence imperfections in order to understand the potential mechanism of
this tolerance (Chapter 4). Using primary and crystal structure alignment, we predict that
recombinase loop L1 is responsible for this differential behavior through single-molecule
and in vivo studies (Chapter 5). Finally, through the combination of bulk biochemistry
and single-molecule techniques, a novel function for BARD1-BRCA1 in facilitating human
RAD51 dsDNA capture will be shown (Chapter 6).
1.2 DSBR and Disease
1.2.1 Introduction
Unrepaired double-strand breaks pose an incredible hazard to human health as seen
in the plethora of diseases related to mutated DNA-repair proteins. These diseases not only
reveal the importance of studying DNA repair, but their common disease signs, symptoms,
and imaging findings suggest human cell-types where DSBR plays a disproportionately large
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role. Hypomorphic autosomal recessive mutations in repair proteins often support normal
overall health but a higher propensity for developing cancer later in life if the patient is
heterozygous for the gene. However, in the cases of homozygosity or dominant mutations,
the prognosis is much worse, leading to an almost inevitable death by cancer early in life
with additional immunodeficiency, infertility, and neurological abnormalities. Since most of
the syndromes discussed have overlapping pathophysiology, diseases will be organized based
on their “primary” pathophysiology with additional discussion of their mechanistic cellular
pathways, diagnosis, prognosis, and treatment. When applicable, footnotes will note yeast
homologs, which can be referenced in the previous section for more detailed mechanistic
details. Footnotes will also contain medical definitions when appropriate.
1.2.2 DSBR and Oncology
1.2.2.1 BRCA1/2 and Cancer Risk
Due to its role in maintaining genetic integrity, DSBR is critical for preventing the
development of malignant neoplasms. When individuals are heterozygous for recessive mu-
tations causing hypomorphic DSBR proteins, the only resulting phenotype may be a higher
rate of malignancy several decades after birth. Two of the most well-known tumor suppres-
sor genes within the DSBR pathway are BRCA1 and BRCA2. Amongst all women, the
prevalence of BRCA1 mutations is about 1 in 800-1400, whereas BRCA2 has a prevalence
of 1 in 450-800 [214]. This prevalence is as high as 2.5% amongst Ashkenazi Jews [215]. For
both BRCA1/2, the lifetime risk of breast cancer is 45-80% [214]. For BRCA1, the lifetime
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risk for ovarian cancer is 45- 60% whereas for BRCA2, this risk is slightly lower at 11-35% 2
[214]. In fact, between the high risk and prevalence, BRCA1/2 mutations account for 2-6%
of breast cancers and 10-15% of epithelial ovarian cancers [214]. Most clinically relevant
BRCA1/2 alterations result in an inactivated protein due to missense, frameshift, nonsense,
or splice mutations [214].
Cells without BRCA1 or BRCA23 are sensitive to DNA-damage, and these proteins
have been shown to play a critical role in repair [216]. BRCA1 has been implicated in many
cell functions including transcription regulation, cell-cycle checkpoint activation, and DNA
repair, resulting in critical tumor suppressor activity [216]. During HR, BRCA1 is thought to
aid in 5’→3’ resection of DSBs to generate 3’-ssDNA overhangs directly through interactions
with CtIP4 and the MRN5 complex and indirectly through exclusion of anti-resection protein,
53BP1 [216]. BRCA1 has also been shown to aid in RAD51 loading by recruiting BRCA2 to
DSBs [217]. Most recently, in collaboration with the Patrick Sung Lab at Yale University,
this work will later (Chapter 6) show how, in complex with BARD1, BRCA1 promotes
RAD51 homologous dsDNA capture without affecting the stability of the dsDNA on the
postsynaptic filament [218]. BRCA2 is modeled to facilitate RAD51 nucleation on ssDNA
and stabilization of the RAD51 presynaptic—essentially the human analog to yeast Rad52
[219].
Since the primary phenotype of BRCA1/2 mutations is malignancy several decades
2Lifetime risk of breast cancer and ovarian cancer amongst general female population is 1 in 8 and 1 in
70, respectively [214]




into life, early detection is critical to long-term survival of patients. Reasons for genetically
testing individuals can be a history of breast or ovarian cancer in the family or Ashkenazi
Jewish ancestry [214]. For those individuals who carry a mutation, prophylactic6 bilateral
mastectomy7 and bilateral salpingo-oophorectomy8 (BSO) can be an extremely effective
preventative measure [214, 220]. In one study, BSO was shown to have a 96% reduction in
BRCA-related gynecological cancer [220]. Pre-menopausal patients who receive a BSO will
undergo early-onset menopause and can receive hormone replacement therapy9 (HRT) to
ease symptoms [214]. Many patients may instead opt for surveillance, which can be moder-
ately effective for breast cancer through mammography and physical breast exams; however,
no effective screening strategy has been found for ovarian cancer [214]. Once ovarian cancer is
found, the classic standard of care is surgical removal by BSO, total abdominal hysterectomy
or other procedures depending on cancer stage and then postoperative chemotherapy with
combination platinum (e.g. cisplatin) and taxane (e.g. paclitaxel) compounds [220]. More
targeted therapies, such as bevacizumab10, pazopanib, nintedanib, and PARPi, in combina-
tion with surgery and/or chemotherapy have been shown to improve outcomes [221]. The
standard of care for breast cancer is similar to ovarian with additional potential targeted
therapies including olaparib, veliparib, talazoparib, and rucaparib [222].
A still lingering question in the field of BRCA1/2 research is if these proteins are
6A medical procedure or treatment to prevent probable disease
7Partial or complete removal of breast tissue.
8 Concatenation of salpingectomy, removal of fallopian tubes, and oophorectomy, removal of ovary
9Typically a mixture of estrogen and progesterone.
10New immuno/targeted therapies are often referenced as biologics. Suffix -mab, means it is a monoclonal
antibody, -zumab: humanized antibody; -umab: human; -ximab: chimeric; -omab: mouse; -amab: rat.
Suffixes with –ib typically indicate a small-molecule inhibitor.
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important for DNA-repair why do the malignancies tend to be localized to gender-specific
and hormone-regulated tissues? Little is known about BRCA2’s role in this gender bias;
however, studies trying to connect these dots have shown that BRCA1 serves an inhibitory
role in activation and transcription of the estrogen receptor, providing negative regulation to
the gene expression and cell proliferation from estrogen [223]. In addition, BRCA1 appears
to reduce transcription of progesterone receptors, PRA and PRB, and has a direct interaction
with the progesterone receptors, leading to polyubiquitination and protein degradation [223].
BRCA1 also appears to be directly involved in estrogen biosynthesis regulation by decreasing
aromatase expression through the ovary-specific promoter PII, although the exact mechanism
is not entirely understood [223]. This finding was confirmed by a study showing higher
serum estradiol and progesterone levels in postmenopausal women with BRCA1/2 mutations
[224]. This increase in steroid hormone likely promotes breast epithelial cells and, combined
with deficient HR repair, could bias malignancies toward these hormone-regulated tissues
[225]. Together, these results begin to tackle the connection between BRCA1/2 and female
hormone-regulated tissues.
BRCA1/2 have also been implicated in fertility. BRCA1 mutations have been shown
to reduce fertility in male mice but not females [226]. BRCA1 appears necessary for proper
formation of X-pericentric heterochromatin and implicated in chromatin changes to produce
a functional XY body [226]. As with RAD51, BRCA2 has been shown to promote DMC1’s
strand-exchange activity [227]. Together, these results suggest that females with BRCA1/2
mutations would have reduced fertility, but retrospective studies have suggested the opposite.
Women with BRCA1/2 mutations bear more children, have shorter intervals between births,
and reproduce later in life than their BRCA1/2 WT counterparts [228]. One potential
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explanation is that BRCA1/2 mutations have been shown to prevent normal telomerase
shortening with age [228, 229]. A separate study looking at telomere length and in vitro
fertilization (IVF) showed that eggs with longer telomeres were significantly more likely
to conceive than those with shorter telomeres [228]. Another study looking at 50-year-old
women showed a positive correlation between telomere length and reproductive lifespan
[228]. Although the evidence is still weak, the hypothesis of the intersection of BRCA1/2,
telomeres, and fertility seems quite compelling.
1.2.2.2 RAD51 and Cancer Risk
Rad51 null mutations in mice results in embryonic lethality [230], thus, loss of function
mutations in RAD51 rarely result in viability. Interestingly, there have been a few cases of
hypomorphic mutations where heterozygous RAD51 phenotype only increases cancer risk.
One of these mutations is RAD51 R150Q, which was found in two patients with a strong
family history and bilateral breast cancer [231]. This mutant protein was later purified and
shown to have WT-like ATPase activity and similar ssDNA- and dsDNA-binding preference
in low (45mM) and high (200mM) NaCl conditions. However, the RAD51 R150Q mutant
showed faster migration on ssDNA-binding gel-shift assay as compared with WT [232]. The
subtly of the defect might explain the minor phenotype as compared with the A293T mu-
tation. This study also identified two more mutations, D149N and G141D, associated with
tumorigenesis, which along with R150Q, mapped to the Schellman loop of RAD51 [231, 233].
A study looking at all three mutations showed that R150Q, contrary to the previous
group, and G141D had reduced ATPase activity, whereas D149N has similar activity to
WT [233]. Interestingly, their strand-exchange activity was similar to WT [233]. The only
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perceivable difference was a noticeable structural defect of G151D and R150Q filaments on
ssDNA by EM, showing less stiff filaments and pronounced differences in the migration of
mixed presynaptic filaments with WT [233]. Together these results point to the potential of
these mutants to negatively impact the structure and stiffness of the presynaptic filaments, a
property hypothesized to be important for yeast Rad51 presynaptic filament mobility [234].
In addition to mutations within the RAD51 ORF, a 135G>C polymorphism in the
5’-untranslated region of RAD51 has been shown to reduce mRNA transcription and cause
an increase in risk for breast cancer [235, 236]. Beyond germline mutations, there is also
evidence of two mutations in RAD51, Q268P and Q272L, which occur during tumorigenesis,
further increasing genomic instability [237]. These mutations were found to have reduced
ATPase, DNA-binding, and strand-exchange activity along with a dominant negative effect
on strand-exchange activity when WT and mutant mixed filaments were formed [227]
1.2.2.3 Fanconi Anemia
Individuals with a dominant negative RAD51 mutation or homozygous for BRCA1/2
develop a condition called Fanconi Anemia (FA). Patients with FA present with develop-
mental abnormalities, progressive bone marrow failure, and a strong disposition to cancer
[238]. FA is generally autosomal recessive and quite genetically heterogeneous, resulting
from mutations in one of sixteen different FANC11 genes (FANCA-FANCT), all part of the
DNA-damage repair pathway [239, 240]. Mutations in FANCA, C, and G (XRCC9) repre-
sent 85% of FA cases and mutations in FANCB12, D1 (BRCA2), D2, E, and F represent 13%
11Many of these FANC genes have more common names (e.g. FANCD1 = BRCA2) and will be noted in
parenthesis when appropriate.
12Only X-linked, non-autosomal FA gene [240].
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[240]. Many of these genes express proteins within the FANC “core complex” involved in
DNA-damage signaling by ubiquitination or independently signal and process DNA-damage
upstream of many of the main HR and NHEJ proteins discussed earlier [240].
Due to FA’s genetic complexity, proteins within the FANC family involved primarily
in HR will be the focus in this section, including FANCD1 (BRCA2), FANCU (XRCC2),
FANCO (RAD51C), and FANCR (RAD51). The most common FA protein of this group
is FANCD1 (BRCA2), the mechanism of which was discussed earlier. A review of 30 re-
ported biallelic mutations showed that the most severe and fast majority of cases resulted
in a frameshift or truncation [239]. Within this group, there were recurrent congenital
birth defects, including microencephaly (Fig. 1.12A), café‐au‐lait spots (Fig. 1.12B) , short
stature, abnormal thumbs, and renal anomalies [239]. The most severe case was a patient
homozygous for the 1548del4 mutation that had VATER13 features, a Wilm’s tumor14, and
a neuroblastoma by age 3 [239]. The prognosis can vary greatly depending on the extent
of protein dysfunction. In terms of treatment, chemotherapy options are limited due to the
progressive bone marrow dysfunction and sensitivity to chemotherapeutic agents, such as
diepoxybutane and mitomycin C [240].
Due to the infrequency of carriers, the more rare forms of FA are often the result of
consanguinity [241]. One of these rare forms is due to mutations in FANCO (RAD51C), a
gene expressing a RAD51 paralog part of the BCDX2 and CX3 complexes [241, 242]. A sub-
complex of BCDX2, the BC (RAD51B-RAD51C) complex, has been shown to be important
in RAD51 loading when put in competition with RPA for ssDNA binding [243]. The CX3
13VATER features: vertebral defects, anal atresia, cardiac defects, tracheo-esophageal fistula, renal
anomalies, and limb abnormalities.
14Primary renal cancer commonly found in children
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Figure 1.12: Common features of Fan-
coni Anemia. (A) Microencephaly of 4-mo
child. (B) Café-au-lait spots. A was adapted
with permission from Moi, M.L., et al., Zika
virus infection and microcephaly in Vietnam.
Lancet Infect Dis (2017). B was adapted with
permission from Klein, C., E. Haraux, and R.
Gouron, Pathological tibia fracture in an 18-
month-old child. The Lancet Child & Adoles-
cent Health (2017).
(RAD51C-XRCC3) complex has been shown to be involved in Holliday Junction (HJ) pro-
cessing with mutations in either XRCC3 or RAD51C, causing decreased HJresolvase activity
[242]. Four children from first cousins who both carried a FANCO R258H mutation had very
severe phenotypes [241]. Both the second and third child showed sensitivity to mitomycin
C and died 2 days and 2 months after birth, respectively, with extensive congenital abnor-
malities including absent and vestigial thumbs, congenital heart defects, imperforate anuses,
and hydronephrosis15 [241]. The fourth pregnancy resulted in miscarriage after 11 weeks
[241]. At the time of the study, the fifth child was still alive at age 10 but had sensitivity
to diepoxybutane and mitomycin C with congenital abnormalities including short stature,
bilateral radial hypoplasia16, anal atresia17, bilateral cryptorchidism18, small genitalia, bi-
lateral cystic dysplasia of the kidneys19, and chronic renal failure [241].
FANCU (XRCC2) is another RAD51 paralog and part of the BCDX2 (RAD51B-
RAD51C-RAD51D-XRCC2) complex and DX2 (RAD51D-XRCC2) subcomplex. A study
looking at RAD51 foci post-gamma radiation demonstrated that the BCDX2 acts upstream
15Kidney swelling due to urine accumulation generally because of a blockage downstream.
16Underdevelopment of the radius bone.
17Imperforate anus.
18Absence of one or both testicles.
19Formation of cysts in the kidney.
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of presynaptic filament formation, where as the CX3 complex acts downstream. Although,
its exact role in HR is still not entirely understood [244]. Similarly to RAD51, the DX2
subcomplex has been shown to form a multimeric ring structure in solution, assemble into a
filamentous structure on ssDNA, and have strand-exchange activity in vitro [245]. When two
healthy first cousins with a FANCU truncating nonsense mutation conceived a homozygous
child, he was born with left facial nerve palsy (paralysis), microcephaly (Fig. 1.12), bilat-
erally absent thumbs, and an ectopic left kidney [246]. He was later found to have severe
growth deficiency, continued microcephaly, and sensitivity to diepoxybutane [246].
The first discovered autosomal dominant mutation causing FA was RAD51 A293T
[238]. The de novo mutation caused growth retardation, microcephaly (Fig. 1.12), hydro-
cephalus, skeletal abnormalities, an imperforate anus, and a left testicular malformation
when examined at 2.5 years of age [238]. The researchers then recombinantly expressed
the protein in E. coli and showed that the protein had a lower ATPase activity that was
not stimulated by DNA, formed short and distorted filaments by scanning force microscopy
(SFM), and inhibited RAD51 WT from binding ssDNA and dsDNA, explaining the domi-
nant negative effect [238]. More recently, it was found that this A293T mutation prevents
replication fork protection from MRE11-mediated degradation [247].
1.2.2.4 Bloom, Werner, AND Rothmund-Thomson Syndromes
The last set of rare autosomal recessive diseases discussed in DSBR and oncology derive
from mutations in the RECQ family of SF2 helicases, BLM, WRN20, and RECQ4, which
20Yeast Sgs1 homolog.
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cause Bloom, Werner, and Rothmund-Thomson21 syndromes, respectively [248]. Common
features of RECQ helicases are their binding to ssDNA, movement in the 3’→5’ direction,
and ATP- and ssDNA-dependent unwinding of dsDNA [248]. However, these helicases differ
in the types of DNA structures that they bind. For example, BLM, in complex with topoi-
somerase IIIα, RMI1 and RM2 (BTR complex), has been shown to promote dissolution of
double HJs, suppressing crossover events between sister chromatids [249]. Patients homozy-
gous for mutations in BLM have pronounced dwarfism due to pre- and postnatal growth
retardation, congenital telangiectatic erythema (Fig. 1.13A), immunodeficiency, male infer-
tility, and an extremely high risk of cancer [250]. Generally, patients do not survive past
childhood, with most succumbing to cancer [248].
The WRN helicase has 3’→5’ exonuclease activity at the N-terminus and appears to
localize at stalled replication forks in response to DNA-damage agents, such as, camptothecin
(CPT), etoposide, 4-nitroquinolin-N-oxide and bleomycin, facilitating repair by HR [251].
Patients with Werner syndrome typically present with hyperkeratosis (Fig.1.13B), “bird-
like” facial features (Fig 1.13C), alopecia (baldness), juvenile bilateral cataracts, diffuse
arteriosclerosis, telangiectasia (Fig. 1.13D), diabetes mellitus, and hypogonadism [252].
Patients with Werner syndrome have a far better outcome than those with Bloom syndrome
with a median age survival of 54 years. Atherosclerotic cardiovascular disease and cancer
are the most common causes for death [253].
RECQ4, also known as RECQL4, is markedly different from BLM and WRN in that
it is the only RECQ helicase in mitochondria and appears to be expressd disproportionately
21RECQ4 mutations are also the cause of RAPADILINO Syndrome and Baller-Gerold-Syndrome (BGS)
and have similar clinical findings to Rothmund-Thomson syndrome.
54
Figure 1.13: Common features of RecQ-related syndromes. (A) Telangiectatic erythema
of forehead. (B) Palmer hyperkeratosis. (C) “Bird-like” facial features of teenager with Seckel
Syndrome. (D) Ocular telangiectasia. A was adapted with permission from Martinez, C.A., et al.,
Adenocarcinoma of the Right Colon in a Patient with Bloom Syndrome. Case Rep Surg (2016). B
adapted reproduced with permission from Sehgal, V.N., et al., Hand dermatitis/eczema: current
management strategy. J Dermatol (2010). C was adapted with permission from Arora, S., B. Ghai,
and V. Rattan, Anesthetic management of a child with Seckel syndrome for multiple extractions
and restoration of teeth. J Anaesthesiol Clin Pharmacol (2012). D was adapted with permission
from Alakloby, O.M., et al., Ataxia telangiectasia with abnormal cellular immunity. International
Journal of Case Reports and Images (2012).
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in thymus and testis cells during the S phase [248, 254]. The N-terminus has been shown
to be responsible for specific binding to RNA, HJ, and G-quadruplex DNA [254]. At birth,
individuals with Rothmund-Thomson syndrome (RTS) have typically unremarkable findings
but the RTS rash begins to manifest within three to six months of birth, eventually devel-
oping into poikiloderma22 [255]. Eventually, the clinical findings evolve into small stature,
alopecia, premature aging, cataracts, skeletal abnormalities and a high risk for neoplasm, es-
pecially osteosarcoma [255]. Patients with RTS have the best outcomes of the RECQ-related
diseases with an unaffected life span assuming cancer does not develop [256].
1.2.3 DSBR and Immunology
1.2.3.1 V(D)J Recombination
Adaptive immunity is critical for humans to combat short-lived, rapidly evolving
pathogens. With the ability to create a combinatorial library of 108 unique receptors, V(D)J
recombination is the means by which progenitor T and B cells can recognize various antigens
produced by these evasive pathogens within a single lifetime of a human [257]. There are
six total loci involved in this process: three immunoglobulin (Ig) loci, one heavy chain and
two light chains, κ and λ, and three TCR loci, α/δ23, β, and γ [257]. Each locus has multi-
ple V (variable) and J (junction) segments and sometimes D (diversity) segments with the
final recombination products containing one of each, creating the combinatorial diversity.24
Immunoglobulins (Ig) have two heavy and two light chains with the heavy chain containing
22Skin condition consisting of hypopigmentation, hyperpigmentation, telangiectasias and atrophy.
23TCRδ is located within the TCRα locus [258].
24Constant regions are part of immunoglobulin and TCR development, however, processed after tran-
scription and polyadenylation by RNA splicing [258].
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V, D, and J segments while light chains contain only V and J [257]. Similarly, TCRβ and
δ have all three segments while TCRα and γ contain only V and J [259]. This process
of removing and joining segments is initiated by RAG1/2 which introduces DSBs at the
recombination-signal sequences (RSS) between segments and recruits Ku70/80, initiating
NHEJ [257].25
1.2.3.2 Severe Combined Immunodeficiency (SCID)
When RAG1/2 or downstream proteins in NHEJ are mutated, the resulting syndrome
is called T-/B-/NK+ Severe Combined Immunodeficiency (SCID) due to the absence of
developed B and T cells but presence of natural killer cells. SCID affects 1 in 58,000 people
in the U.S with a 1 in 2000 incidence amongst certain Native American populations and
is generally autosomal recessive with some dominant and X-linked exceptions [260]. At
least a quarter of SCID cases are of the T-/B-/NK+ SCID subtype and can be further
subdivided into non-radiosensitive, RAG1/2, and radiosensitive, downstream NHEJ proteins
[260, 261]. Depending on the severity of mutations, the T-/B-/NK+ SCID course can vary
greatly, however, the general immunodeficiency findings are similar. For the most part these
patients present with life-threatening bacterial, viral, and fungal infections early in life,
chronic diarrhea, and failure to thrive [261, 262]. Interestingly, findings can be delayed by
several months after birth due to residual maternal antibodies [261]. The only cure for the
disease is hematopoietic cell transplantation (HCT) with 50-88% longterm26 survival and
RAG1/2 deficiency having the best outcomes for patients [261]. Radiosensitive forms of
25NHEJ is also required for class switch recombination (CSR) in B-cells (i.e. from IgG to IgM) but follows
a separate DSB initiation mechanism from RAG1/2 [257].
26Patients were followed for up to 25 years after birth.
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T-/B-/NK+ SCID have additional symptoms that lead to their poorer prognosis.
1.2.3.3 Artemis Deficiency
The most common radiosensitive T-/B-/NK+ SCID is Artemis deficiency [263].
Artemis is a protein involved in dsDNA processing after the formation of DSBs, eventually
allowing ligation of dsDNA ends. Alone, Artemis has 5’→3’ exonuclease activity, however,
in complex with DNA-PKcs, can open hairpins, such as those formed by RAG1/2, and en-
donucleolytically cleave 5’- and 3’-ssDNA overhangs [264]. Based on the clinical findings of
the disease, it would appear that Artemis’s function is most critical in response to V(D)J
recombination and ionizing-radiation repair since immunodeficiency and radiosensitivity are
its defining clinical features. Malignancies are not common in these patients although often
patients either are cured or die within one year of birth27 [261]. There has also been one
reported case of a DNA-PKcs missense mutation (L3062R), which only seemed to affect its
interaction with Artemis and had similar clinical features [265]. In terms of cures beyond
HCT, recent advances in gene therapy have demonstrated that Artemis deficiency can be
corrected using the lentivirus and potentially a transformative technique for other SCID’s
[266].
1.2.3.4 LIG4 Syndrome
Two very rare forms of radiosensitive SCID are DNA Ligase IV deficiency or LIG4
syndrome with only 28 known global cases and XLF/Cernunnos deficiency [263, 267]. DNA
27One exception is the hypomorphic forms of Artemis cause a less severe immunodeficiency and lack of
radiosensitivity, however, partially functional B-cells allow a predisposition to Epstein-Barr virus (EBV)-
associated lymphomas [263].
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ligase IV in complex with XRCC4 and XLF is responsible for ligation of DNA ends during
NHEJ [268, 269]. Thus, due to XLF and DNA ligase IV’s widespread function, the clinical
features of LIG4 syndrome can be more extensive than those of radiosensitive SCID depend-
ing on the severity of the mutation with some individuals showing no phenotype except for
radiosensitivity and susceptibility to malignancy [267]. The more severe forms can present
with serious Seckel-like musculoskeletal abnormalities (Fig. 1.13C), hypogonadism, and mi-
crocephaly [267]. Treatment for these severe forms is limited and supportive, although there
have been isolated cases of successful HCT [267, 270]. HCT’s lack of efficacy for these defi-
ciencies may be due in part to the frequent occurrence of acute Graft-Versus-Host Disease28
(GVHD) [263].
1.2.4 DSBR and Neurology
1.2.4.1 DSBR and Neuroscience
The neurological findings in patients with mutated DSBR genes, in many ways, are
the most fascinating since unlike oncology, immunology, and fertility, it is not immediately
obvious why DSBR plays such a critical role in the nervous system. Due to the wide range of
neurological diseases with faulty DSBR, recent work has uncovered a critical role of HR and
NHEJ in normal neurological function and development. When examining mouse embryos,
there was unexpected spatiotemporal demarcation of NHEJ and HR during neurological
development [271]. Specifically, Xrcc2-/- mice, eliminating the ability of mice to repair with
HR, showed significant apoptosis in early proliferating neural stem cells in the ventricular
28As apposed to the more common transplant rejection by host, GVHD is the graft rejecting the host,
leading to wide spread organ failure.
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zone, whereas Lig4-/- mice, eliminating NHEJ, showed greater apoptosis in the later stage,
postmitotic subventricular zone [271].29 Although it is not entirely surprising that HR is
more important than NHEJ in rapidly dividing cells, these findings hone in on how smaller
deficits in DSBR could lead to subtle disruptions in neural development and manifest into
neurological findings at birth and later in life.
More recently, several studies have begun to draw direct links between DSBR and
physiological brain activity [6, 272]. While examining the effects of Alzheimer’s-related hu-
man amyloid precursor protein (hAPP) on DSB formation in transgenic mice, researchers
found an unexpected result [272]. By looking at phosphorylation of the histone protein
H2A variant X at Ser139 (γH2A.X), which in focal accumulations connotes DSB formation,
researchers expectedly found that hAPP mice had 2-3.5 times more γH2A.X positive cells
than WT in several different brain regions which was further confirmed by finding a three-
fold increase in γH2A.X after culturing primary neurons from WT mice with hAPP [272].
Serendipitously, while moving WT mice from their home cages to a new environment, they
found a several fold increase in γH2A.X in many parts of the brain, most pronounced in
the dentate gyrus, a brain region critical for learning and memory [272]. Fascinatingly, this
effect went almost completely away after 24 hours in the environment [272]. To show that
neural activity and not stress hormones from moving to a novel environment was sufficient
for increases in γH2A.X, they exposed anesthetized mice to a visual stimulus and showed
increases of γH2A.X in the primary visual cortex, V1 [272]. In addition, activation of the
striatum by optogenetics showed greater levels of γH2A.X [272]. With these findings, the
29These mutations were embryonically lethal, however, could be rescued with an addition of p53-/-,
further confirming p53’s importance in cell cycle regulation and apoptosis—though these mice died from
tumors quickly after birth.
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group hypothesized that DSBs might serve as an adaptive function to aid in the significant
chromatin remodeling and gene expression necessary for physiological neural activity [272].
Although seemingly farfetched, this hypothesis was further demonstrated with a more recent
study examining the relationship between DSBs and the expression of early-response genes
in neurons[6].
In order to understand the connection between DSBR and neural activity, groups out
of MIT incubated cultured primary neurons with etoposide, a chemotherapy drug known
to bind topoisomerase II (Topo II) and DNA and then induce double-stranded breaks [6].
By using next-generation RNA sequencing (RNA-seq), the groups noticed an enrichment of
Fos, FosB, Npas4, and Egr1, genes associated with neural activity or early-response genes
[6]. To demonstrate that this enrichment was not a product of the DNA-damage signaling
pathway, the group repeated this experiment with an inhibitor to ATM (ATMi), leading to
a reduction in γH2A.X but no effect on enrichment [6]. Interestingly, other DSB-inducing
agents, such as bleomycin and neocarzinostatin, did not lead to enrichment, suggesting that
enrichment is a Topo II-mediated process [6].
Knowing that neural activity can induce DSBs from previous work [272], the groups
wanted to see if there were particular areas of the genome with a greater likelihood of breaks
after neural activation. By incubating NMDA, a neural agonist, with primary neurons and
using γH2A.X ChIP-seq, they found enrichment of 21 loci including Fos, FosB, Npas4, Egr1,
Nr4a1, and Nr4a3. The groups then sought to understand the connection by performing
Topo IIβ ChIP-qPCR under basal conditions, finding enrichment of Topo II￿ at the Fos
and Npas4 promoters. Since Topo II is known to relieve torsional stress on chromatin
[273], they showed that this precipitated Topo IIβ could relax supercoiled plasmid DNA
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in vitro [6]. They hypothesized at this point that Topo IIβ , relieves torsional stress to
allow greater transcription. To ensure that transcription itself does not create torsional
stress leading to breaks, they used an RNA Polymerase II inhibitor, 5,6-Dichloro-1-b-D-
ribofuranosylbenzimidazole (DRB), prior to NMDA treatment and showed no change in the
enrichment of DSBs [6]. They also pointed out that, although there was a greater amount
of Topo IIβ binding after NMDA treatment, the DSBs only formed at loci where Topo IIβ
had been previously bound during basal conditions [6].
To show that DSB formation at Fos and Npas4 promoters leads to greater expression
of the genes that these transcription factors act on, the groups created primary neurons with
Fos and Npas4-regulated luciferase and, as a control, Bdnf-regulated luciferase, and showed
increases in fluorescence of the former and not the latter [6]. Using Topo IIβ ChIP-qPCR at
different time points after NMDA treatment, they showed that activity-induced DSBs were
repaired within two hours [6]. Finally, the group shows that NHEJ is critical for repairing
these DSBs by preincubating primary neurons with a specific inhibitor of DNA-PK (NU7026)
and showed a lack of repair two hours after NDMA treatment [6]. All together, these results
demonstrate that there is a direct linkage between DSB and physiological neural activity,
potentially explaining the neurological findings when DSBR is disrupted.
1.2.4.2 Ataxia Telangiectasia
One DSBR-related neurodegenerative disease is Ataxia Telangiectasia30 (A-T), an au-
tosomal recessive disorder resulting from the truncation or inactivation of the ATM protein—
30Hypomorphic mutations in MRE11A is A-T like disorder (ATLD) with milder symptoms and a later
onset of symptoms [274].
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typically via missense mutations [274]. The incidence of A-T is about 1 in 20,000, although
about 1.2-2% of Caucasians in the U.S. are carriers [275]. The disease presents with the
classical clinical triad of ataxia (loss of voluntary coordination), cerebellar degermation (at-
rophy) (Fig. 1.14A), and ocular telangiectasia (Fig. 1.13D) [276] with additional features
including radiosensitivity, thymic degeneration, immunodeficiency, recurrent sinopulmonary
infections, premature aging, gonadal dysgenesis and significant predisposition to lymphoma
and leukemia [277].
Mechanistically, ATM31 is a phosphoinositol-3 kinase-related kinase (PIKK) in the
family of Ser/Thr protein kinases and part of the DNA-damage signaling pathway, arresting
cells at the G1/S, intra-S, or G2/M checkpoints [278]. After the MRN complex binds at the
site of a DSB, it recruits and activates ATM, converting it from its dimer and oligomer forms
to a monomer [278]. ATM then phosphorylates a number of checkpoint proteins including
p53, BRCA1, and CHK2, arresting the cell cycle. Although cells without ATM show a
defect in the activation of the cellular response to DSBs, the DSBR response is attenuated
not abolished, suggesting redundancy in protein kinases [274].
Clinically, children often show no signs of illness for the first year of life and begin
walking at a normal age, however, the earliest symptom of ataxia presents soon after [275].
The neurodegeneration progresses slowly, leading to further problems with gait and balance
and eventually deficits in speech [275]. The prognosis is poor with the median age of survival
being 25 years and most succumbing to cancer or interstitial lung disease (Fig. 1.14B)
secondary to repeated pulmonary infections [275]. Treatment options for A-T remain limited
and supportive management is the consensus course of action [275].
31Yeast Tel1 homolog.
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Figure 1.14: Common features of Ataxia Telangiectasia (A-T) (A) Cerebellar degermation
(atrophy). Left image features sagittal MRI of normal cerebellum in a child (but not corpus
collusum) circled in red. Right image features sagittal MRI of atrophied cerebellum in a child
circled in red. (B) Interstitial lung disease by chest x-ray. Left, normal; right, clinical finding. A
(left/normal) was adapted with permission from Siffredi, V., et al., Neuropsychological profile of
agenesis of the corpus callosum: a systematic review. Dev Neuropsychol (2013). A (right/abnormal)
was adapted with permission from Alakloby, O.M., et al., Ataxia telangiectasia with abnormal
cellular immunity. International Journal of Case Reports and Images (2012). B (left/normal)
was adapted with permission from Joarde, R. and N. Crundwell, The Normal Chest X-ray: An
Approach to Interpretation, in Chest X-Ray in Clinical Practice, J. R. and C. N., Editors. Springer
(2009). B (right/abnormal) was adapated with permission from Chapman, J.T. Interstitial Lung
Disease. Center for Continuing Education (2010)
1.2.4.3 Seckel Syndrome
Seckel syndrome is an autosomal recessive disease characterized by short stature, mi-
crocephaly, and “bird-like” facial features (Fig. 1.13C) most frequently resulting from mu-
tations in the ATR (ATM and Rad3-related) protein [279, 280]. Seckel syndrome was once
an over-diagnosed syndrome and, in fact, only four families have been reported to have this
ATR-related disease [280]. Like ATM, ATR is also a phosphoinositol-3 kinase-related kinase
(PIKK) that is part of the DNA-damage signaling pathway [279]. In complex with ATR
interacting protein (ATRIP), ATR/ATRIP phosphorylates H2AX, 53BP1, p53, NBS1 and
CHK1, arresting cells at the intra-S and G2/M checkpoints [279]. However unlike ATM,
ATR is activated by RPA-bound ssDNA resulting from stalled replication forks and is essen-
tial for embryonic development and somatic cell growth [279]. Since it is essential, reported
mutations result in hypomorphic ATR that reduce its activity and do not completely abolish
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it [279]. Due to limited cases of this disease, prognostic information is limited but anecdo-
tal reports suggest these individuals can live past age 50, assuming no malignancies. No
treatments are available and symptom management is the goal of care [280].
1.2.4.4 Nijmengen Breakage Syndrome
Alternatively known as Ataxia Telangiectasia Variant 1, Nijmegen Breakage Syndrome
(NBS) is a recessive disorder presenting with microcephaly at birth and later with progressive
microcephaly (Fig. 1.12A), dysmorphic “bird-like” facial features (Fig. 1.13C), growth
deficits, intellectual disability, and, in females, hypogonadism [281, 282]. NBS is relatively
rare and isolated to Eastern European countries with an estimated incidence of 1 in 95,000 in
the former Czechoslovakia and 1 in 154-190 carrying the mutation in three Slavic countries
[283]. The mutant protein responsible for NBS, NBS132, was first discovered by haplotype
mapping of genomic DNA extracted from the blood samples of 51 patients with related
symptoms [284, 285].
In the cell, NBS133 is apart of the MRN complex and thus essential for proper DNA
repair, although its exact function is not fully understood as it does not have DNA-binding
nor kinase activity [282, 286]. NBS1 may also have critical functions outside of DSBR,
including interstrand crosslink repair34, ICL, potentially explaining the wider range of ma-
lignancies presented in heterozygous carriers of mutant NBS1 [287]. Although NBS does not
cause neurodegeneration, progressive microcephaly results in mild to moderate intellectual
32Yeast Xrs2 homolog.
33Rad50 deficiency causes an NBS-like disorder [285].
34NBS1 has been shown to bind RAD18 and initiate Polη-dependent translesion synthesis (TLS) by
PCNA ubiquitination [287].
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deficits by age 7 to 10 with particularly reduced growth in the frontal lobes and corpus
callosum [283]. Interestingly, the cerebellum appears relatively intact by MRI, potentially
explaining the lack of ataxia or abnormal gait, as seen in A-T [283]. NBS also presents with
café-au-lait spots (Fig. 1.12) and vitiligo spots in about 50-70% of patients [282]. As with
the other DSBR syndromes, the prognosis is poor with most patients dying of cancer35 and
infections and the median age of survival being seven years [283]. There is no cure for NBS
and treatment is limited to symptom management and infection prophylaxis [283].
1.2.5 Conclusion
The purpose of MD/PhD programs is to bridge the gap between scientists and med-
ical professionals. Often, the mechanistic findings of molecular genetics, biochemistry, and
biophysics are cited in aiding our understanding of disease. However, less often cited is the
reverse relationship—the manifestations of disease can tell us something about the path-
ways that might otherwise be overlooked. For DSBR, the common neurological findings in
many patients with mutations in the pathway suggest that proper DSB repair is critical for
physiological neural function. Recent studies have begun exploring this connection although
significant questions still remain. Thus, physician scientists have the unique privilege to
not only use their scientific pursuits to aid in the curing of disease but may use the clinical
manifestations as a way of understanding the mechanisms behind disease.
3540% develop cancer before 20 years of age with most being lymphomas although there are cases of
glioma, rhabdomyosarcoma, and medulloblastoma [257].
66
Chapter 2
Single-Stranded DNA Curtains for Studying Homologous
Recombination
This chapter is adapted from work originally published as: “Single-Stranded DNA
Curtains for Studying Homologous Recombination,” Chu J. Ma*, Justin B. Steinfeld*,
and Eric C. Greene. Methods in Enzymology (2017). *C.J.M. and I contributed equally to
researching and writing this methods paper.
2.1 Abstract
Homologous recombination is an important pathway involved in the repair of double-
stranded DNA breaks. Genetic studies form the foundation of our knowledge on homol-
ogous recombination. Significant progress has also been made toward understanding the
biochemical and biophysical properties of the proteins, complexes, and reaction intermedi-
ates involved in this essential DNA repair pathway. However, heterogeneous or transient
recombination intermediates remain extremely difficult to assess through traditional ensem-
ble methods, leaving an incomplete mechanistic picture of many steps that take place during
homologous recombination. To help overcome some of these limitations, we have established
DNA curtain methodologies as an experimental platform for studying homologous DNA re-
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combination in real-time at the single- molecule level. Here, we present a detailed overview
describing the preparation and use of single-stranded DNA curtains in applications related
to the study of homologous DNA recombination with emphasis on recent work related to
the study of the eukaryotic recombinase Rad51.
2.2 Introduction
2.2.1 Homologous Recombination
Homologous recombination (HR) is a highly conserved pathway that enables the ex-
change of genetic information between identical or closely related DNA molecules, and is
an important driving force in genome evolution. HR plays crucial roles in the repair of
double-stranded DNA breaks (DSBs), the rescue of stalled or collapsed replication forks,
chromosomal rearrangements, horizontal gene transfer, and meiosis in sexually reproducing
organisms [28, 288–290].
Much of our knowledge of HR comes from the study of DSB repair in the budding
yeast Saccharomyces cerevisiae [291–293]. Here, we briefly highlight some of the key steps
and proteins involved during the early stages of DSB repair in S. cerevisiae (Fig. 2.1); for a
more in-depth discussion of HR, we refer the reader to several excellent reviews [28, 289, 293].
Upon formation of a DSB the newly liberated DNA ends are processed to yield long 30 single-
stranded DNA (ssDNA) overhangs. Replication protein A (RPA) binds to these overhang
to remove any potential secondary structure and also protect the ssDNA from degradation
by nucleases. RPA is then replaced, with the help of mediators such as Rad52, by the
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Figure 2.1: Early stages of eu-
karyotic homologous recom-
bination. DSBs are resected
to yield long 3’ ssDNA over-
hangs that are first bound by
RPA. Rad52 then binds and as-
sists loading of the Rad51, which
forms long filaments on the ss-
DNA and these Rad51–ssDNA
filaments are referred to as the
presynaptic complex. The presy-
naptic complex then searches for
a homologous DNA and pairs the
processed ssDNA overhang with
its homologous partner to gener-
ate a D-loop intermediate.
recombinase Rad51, an ATP-dependent DNA-binding protein that forms an extended right-
handed helical filament on the ssDNA overhang [294, 295]. This nucleoprotein filament,
referred to as the presynaptic complex, is responsible for aligning and pairing the ssDNA
overhang with a homologous double-stranded DNA (dsDNA) sequence present elsewhere in
the genome. The 3’ end of the presynaptic ssDNA can prime replication using homologous
dsDNA as a template and the resulting intermediates can be channeled through a number
of distinct pathways that will restore the originally broken DNA molecule [28, 289, 293].
The highly simplified view of HR presented earlier belies the fact that recombination
requires the coordinated action of a complex repertoire of proteins. Highly organized macro-
molecular assemblies are responsible for sensing DNA damage, recruiting essential factors to
the damaged sites, and repairing the damaged DNA. Many of these proteins belong to the
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RAD52 epistasis group of genes, which were initially identified in S. cerevisiae as mutants
that exhibited extreme sensitivity to ionizing radiation [51], and many other HR proteins
have been identified in subsequent years. In total, at least 45 different proteins are known
to be directly involved DSB repair in S. cerevisiae [293].
Genetic experiments have provided the basis for most of the current body of knowledge
in HR and continue to yield important new insights [292, 293]. Cell biology studies have also
yielded an enormous amount of information regarding the protein and DNA components
involved in eukaryotic HR [8, 296, 297]. Biochemical and biophysical studies have been
employed to study several aspects of the reaction, and these experiments have revealed some
crucial insights into HR mechanisms [294, 295]. More recently, structural approaches have
unveiled atomic-level details of some proteins and protein–DNA complexes that are essential
to HR [36, 37]. However, many questions related to the HR mechanisms cannot be addressed
through any of these types of approaches because the underlying intermediates are either
transient or heterogeneous. Single molecule fluorescence-based methods offer the potential
for direct visual analysis of individual HR reaction components or complexes, which in turn
can enable the direct detection of subpopulations within an otherwise heterogeneous mixture
and can also capture rare or transient intermediates along a reaction trajectory.
2.2.2 Single-Molecule Biology
Single-molecule approaches are technically demanding, and it is relevant to ask whether
it is worth the trouble to study complex biological systems at the scale of individual compo-
nents. As an analogy, take the study of salmon swimming upstream to spawn. One could
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tag 1000 salmon at a river inlet, and then wait upstream to determine, for instance, how
many fish reached their spawning grounds, how long it took them to get there, and how
many fish actually spawned. Such a study would provide valuable information about the
salmon population and basic insight into their life cycle. However, the study as presented
could not answer why some salmon survived and some did not, what factors dictate precise
arrival time, or why some salmon successfully spawn whereas others do not. To address
these types of questions, the study must be redesigned to follow individual fish within the
population as they swim toward the spawning grounds. Through this type of study, one
might find that some salmon were harvested by anglers or bears, others may be unable to
navigate fish ladders, and still others may have experienced too much stress during their
travels to spawn successfully. Suddenly, the picture of salmon reproduction becomes much
more detailed. Similarly, ensemble biochemical or genetic studies typically can look only
at some well-defined intermediate state or the final output from a process, and may over-
look heterogeneous intermediates or transient states that are important for understanding
the overall nature a particular reaction. Experimental approaches capable of interrogating
individual macromolecules or complexes over the course of a biochemical reaction trajectory
now offer new possibilities for understanding many types of biological problems in greater
depth than previously possibly.
2.2.3 Overview of DNA curtains
Two challenges users of single-molecule methods face are the difficulties associated with
collecting statistically relevant information and the problem of nonspecific surface absorp-
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tion, which arises because most single-molecule bases methods require that the biomolecules
under investigation be anchored to a solid supporting surface without compromising bio-
logical activity. To help overcome these problems we have developed ”DNA curtains,” in
which ds- or ssDNA molecules can be organized into defined patterns on the surface of a
microfluidic sample chamber (Fig. 2.2) [298–301]. In brief, DNA curtains are prepared by
first depositing metal barriers and anchors on the surface of a fused silica microscope slide
by electron beam (e-beam) lithography. The slide is then coated with a fluid lipid bilayer,
which prevents nonspecific surface adsorption and provides a mobile platform for anchoring
DNA molecules through a biotin–streptavidin linkage. Buffer flow is then used to push the
DNA molecules into the barriers where they all align with one another [298, 301]. If desired,
the second end of the DNA can be attached to a downstream anchor point [299, 300]. This
approach allows for the direct observation of hundreds of individual DNA molecules within
the typical field of view of an optical microscope, providing a flexible experimental platform
that can be used to study different types of protein–DNA interactions [299, 300, 302–310].
In subsequent sections, we describe how to prepare ssDNA curtains [81] and provide brief
examples of how this technique has been applied to the study of HR with emphasis on recent
experiments using the eukaryotic DNA recombinase Rad51 [305, 306].
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Figure 2.2: Different types
of DNA curtains. (A)
Schematic illustration of a
single-tethered DNA curtain
made with a linear bar-
rier. (B) Double-tethered
DNA curtain where the down-
stream ends of the DNA are
tethered to the exposed an-
chor points that project above
the bilayer. Both formats
are compatible with either
dsDNA or ssDNA. Adapted
with permission from Silver-
stein, T. D., Gibb, B., &
Greene, E. C. (2014). Visu-
alizing protein movement on
DNA at the single-molecule
level using DNA curtains.
DNA Repair (Amst), 20, 94–
109.
2.3 Methods
2.3.1 Total Internal Reflection and Instrumentation
We use total internal reflection fluorescence microscopy (TIRFM) for visualizing DNA
curtains. TIRFM uses spatially selective laser excitation to reduce background signal by
several orders of magnitude relative to conventional wide-field illumination techniques [311].
Detailed descriptions of TIRF microscopes are widely available, and below provide a compo-
nent list describing our most recent instruments, which uses inverted Nikon Eclipse micro-
scopes equipped with custom laser illumination systems for dual-color prism-type TIRFM
illumination (Fig. 2.3 and Table 2.1).
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important details of the
TIRFM systems used to
visualize DNA curtains.
Details of the schematic
and system components
are presented in the main
text.
Table 2.1: TIRF Microscopy Instrumentation.
Microscope Body Nikon Eclipse Ti-E with Perfect Focus System (PFS)
Camera Two Andor iXon X3 EMCCDs (Model: DU-897E-C50-#BV)
Objective Nikon CFI PLAN APO 60X WI
Filter cube Chroma TE2000/Ti filter cube (Part No. 91020)
Chroma ET525/50 m band pass filter
Chroma ET575lp long pass filter
Chroma ZT561rdc dichroic mirror
Additional Filter Chroma ZT488rde-UF1 dichroic
Illumination Coherent Sapphire LP (488 nm, 200 mW)
Coherent Sapphire LP (561 nm, 200 mW)
TIRF prism Thor Labs, custom-made, uncoated, fused silica
Shutter Vincent Uniblitz VCM-D1 Single Channel Uni-Stable Shutter
Objective heater Bioptech Objective Heater (150819-19)/Controller (150803)
Slide heater Custom Al casing, Omega Mini Benchtop Controller (CSC32J)
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Figure 2.4: Flow cell fabrication. (A) Slides are first coated with two layers of PMMA, a layer
of AquaSAVE, and an electron beam is then used to etch through these layers. Chromium is
deposited on the surface and the remaining PMMA is removed, leaving behind the nanofabricated
barriers. Schematic illustrations (B) and photographs (C) depicting the different stages of flow
cell assembly. Adapted with permission from Greene, E. C., Wind, S., Fazio, T., Gorman, J.,
& Visnapuu, M. L. (2010). DNA curtains for high-throughput single-molecule optical imaging.
Methods in Enzymology, 472, 293–315.
2.3.2 Flow Cell Fabrication
Our DNA curtain experiments are performed using flow cells that are machined and
assembled in-house (Fig. ??). In brief, each flow cell is made from a fused silica microscope
slide. Inlet and outlet holes are bored into each slide using a diamond-coated drill bit.
Metallic patterns are deposited on the surface of the slide by e-beam lithography, and the
patterns can be designed for either single- or double-tethered formats. These modified slides
are then cleaned and assembled into the flow cells that are used for making DNA curtains.
Later, we summarize each of these procedures, and detailed explanations of each step have
also been previously published [312].
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2.3.2.1 Slide Preparation
First, two holes are cut through each fused silica slide to allow sample delivery in the
completed flow cell (Fig. 2.4). The holes are drilled using a 1.4-mm diamond-coated drill
bit (Shor International, Cat. No. DIB-211.00). While drilling, the slides are submerged in a
water bath to cool the bit and prevent inhalation of fused silica dust [312]. The drilled slides
are then cleaned by submersion in piranha solution (3:1 mixture of concentrated sulfuric acid
(97%) and 30% hydrogen peroxide). For cleaning, up to 10 slides are placed in a glass slide
rack and the rack is placed within rectangular glass staining dish (e.g., Electron Microscopy
Sciences, Cat. No. 70312-20). The dish is then filled with 150 mL of sulfuric acid followed
by the addition of 50 mL cold hydrogen peroxide. The slides are incubated in the piranha
solution for 30 min. Extreme care must be taken when handling piranha solution to avoid
contact with exposed skin. Following the 30-min submersion in piranha solution, the slides
should be rinsed with copious amounts of deionized water.
The cleaned and drilled slides must now be prepped for lithography by deposition of a
positive photoresist and conductive polymer layer (Fig. 2.4A). For this, the slides are spin-
coated with a layer of 3% (w/v) polymethylmethacrylate (PMMA; molecular weight 25 kDa),
dissolved in anisole (MicroChem, Newton, MA), followed by a layer of 1.5% (w/v) PMMA
(495 kDa), also dissolved in anisole. The PMMA layers are then topped off with a final layer
of AquaSAVE conducting polymer (Mitsubishi Rayon, Tokyo, Japan). Each of these layers
is spun at 4000 rpm for 45 s using a ramp rate of 300 rpm/s using a Laurell Technologies
Corp spincoater (WS-650MZ-23NPP). The slides are now ready for e-beam lithography. We
use an FEI scanning transmission electron microscope equipped with nano pattern generator
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system software (Nabity, Inc.), which controls the e-beam as it writes patterns on coated
fused silica slides. Dosage tests can be used to determine the current and writing time that
yield the best combination of time and resolution for the desired patterns. The slides are
then developed to remove the PMMA from the areas exposed to the e-beam. This step is
performed by placing the slide within a 50-mL falcon tube containing a developing solution
comprised of a 3:1 mixture of methyl isobutyl ketone:isopropanol cooled to –20°C. The tube
is sonicated in an icy water bath sonicator (Branson 1800, power LOW, 60 s processing
time), and rinsed off with isopropyl alcohol (IPA). A thin layer of chrome (∼20-nm) is then
deposited onto the patterned surfaces using a Semicore E-beam Evaporation System (SC
2000LT). The remaining PMMA is then removed by first washing the slides with acetone
from a squirt bottle. The slides are then submerged in acetone and sonicated for 5–10 min.
Finally, the patterned slides are rinsed with clean acetone from a wash bottle. To prevent
formation of deposits from the acetone drying, acetone is cleaned away with IPA and dried
with a stream of nitrogen gas.
2.3.2.2 Flow Cell Assembly and Disassembly
Prior to use, the patterned slides must be assembled into flow cells that can be con-
nected to a sample deliver system (Fig. 2.4B,C). The flow cells are made by using double-
sided tape to create a sample chamber between the patterned slide and a glass coverslip.
Later we provide a step-by-step description of the flow cell assembly procedure, as well as
information describing how the flow cells can be dismantled and reused.
1. Center a rectangular paper template (35 x 5 mm) over a piece of double- sided tape
77
(19 mm width) and tape over the chrome pattern on the slide.
2. Use the paper template as a guide to excise a channel in the double-sided tape.
3. Place a coverslip (Fisher Scientific, Fisher Finest Premium cover glass, Cat. No. 12-
548-5E) on top of the tape and apply pressure to seal the coverslip to the tape.
4. The assembled flow cell is sandwiched between glass slides (Fisher Scientific, Frosted
microscope slides 12-550-343) and held by binder clips on all four sides to distribute
pressure evenly.
5. Bake the assembly under vacuum for 45 min at 140°C to seal the tape.
6. Remove from the oven, release the binder clips and the glass slides.
7. Glue Nanoports (Idex, Cat.No.N-333) over the drilled port holes with a hot glue gun.
The flow cell is now complete and can be stored under vacuum at room temperature
until use.
8. Patterned slides can be reused after each experiment. Submerge the slide in ethanol
for 48 h, and then remove the ports, coverslip, and double-sided tape. The slides
are then cleaned by submersion in the following solutions with constant stirring: 2%
Hellmanex solution for 48 h; rinse with Milli-Q water; 1 M NaOH for 40 min, rinse
with Milli-Q water; 100% ethanol for 30 min. The cleaned slides are then ready for
reuse.
2.3.3 ssDNA Curtains
The assembled flow cells can now be used for the preparation of the ssDNA curtains.
First, a lipid bilayer is used to passivate the flow cell surface. The ssDNA substrate is then
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attached to the lipid bilayer through a biotin– streptavidin–biotin linkage, and buffer flow is
used to push the anchored ssDNA molecules into position along the chrome barriers. Finally,
the ssDNA is labeled and extended by injecting fluorescently tagged RPA into the sample
chamber. The following sections provide step-by-step details necessary to complete each of
these procedures.
2.3.3.1 Liposome Preparation
1. Lipid stocks are prepared by dissolving the following components in 10 mL of chlo-
roform: 1 g DOPC (1,2-dioleoyl-sn- glycero-3-phosphocholine), 100mg PEG-2000
DOPE (18:1 PEG- 2000: 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy
(polyethylene glycol)-2000] (ammonium salt)), 5 mg biotinylated DOPE. The dissolved
lipid mixtures can then be stored at –20°C. All lipids are purchased from Avanti Polar
Lipids, Inc.
2. The lipid stock solutions are used to make liposomes. Liposomes are typically prepared
in 2 mL batches, using the following step-by-step procedure, and can stored at 4°C for
4–8 weeks.
a) Clean an organic-solvent compatible syringe with chloroform and transfer 200 µL
(1/10th of the final desired volume) of the lipid stock to a new 2-mL glass vial
(National Scientific, Cat. No. C4015).
b) Using a very low pressure stream of nitrogen gas, evaporate the chloroform from
the lipid stock slowly over several minutes. During this time, the lipid stock
will form a solid residue on the side of the vial. After all the chloroform is
evaporated, slightly increase the pressure and continue blowing nitrogen until all
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traces of liquid are removed.
c) Place the uncapped glass vial under vacuum overnight.
d) Add 2 mL of lipid buffer (10 mM Tris–HCl [pH 8.0], 100 mM NaCl) to the dried
lipid stock and cap the vial. Incubate at room temperature for an hour and then
vortex until all the lipid stock has dissolved into solution.
e) Transfer the mixture to a 5-mL polypropylene culture tube(Falcon, Cat. No.
35-2058) and sonicate in an ice bath using a microtip sonicator (Misonix S-4000)
until the solution becomes clear.
f) The solution is then filtered through a 0.22−µm nylon syringe filer (Fisherbrand,
Cat. No. 09-720-3) and the resulting liposomes are ready for use.
2.3.3.2 Preparation of ssDNA
Our ssDNA curtain experiments make use of relative long ssDNA substrates (￿40,000
nucleotides) that are made by rolling circle replication with a bio- tinylated oligonucleotide
primer and a circular ssDNA template [81], as described later.
1. The biotinylated primer is first annealed to a circular M13 DNA tem- plate in a 100−µL
reaction containing: 40 mM Tris–HCl [pH 8.0], 50 mM NaCl, 10 mM MgCl2, 10 ￿g
(89.4 nM) of M13mp18 (New England Biolabs, Cat. No. N4040S), and 45nM primer
(5’-BIO- TEG-TTT TTT TTT TTT TTT TTT TTT TTT TTT TTT GTA AAA
CGA CGG CCA GT). The sample is placed in near boiling water ( 95°C) in a 1-L
beaker for 5 min, and the beaker is then transferred to the benchtop and allowed to
cool slowly to room temperature. The annealing reactions are then in buffer containing
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10 mM Tris–HCl [pH 8.0], 50 mM NaCl, and 5 mM MgCl2 to a total volume of 300
µL and stored at –20°C until use.
2. A fresh preparation of ssDNA is made for each ssDNA curtain experi- ment. Rolling
circle reactions (50 µL) are prepared containing: 10 µL of 5 reaction buffer (250 mM
Tris–HCl [pH 7.5]), 20 mM DTT, 50 mM ammonium sulfate, and 50 mM MgCl2), 1
µL annealed M13 template (see earlier), 1 µL of 10 mM dNTP mix, 1 µL purified ϕ29
polymerase (10 µM stock) [81], and 37 µL water. Mix by pipetting, do not vortex.
Incubate at 30°C for 25 min, and use immediately after preparation.
2.3.3.3 Lipid Bilayer Deposition and ssDNA Attachment
The following section describes how the bilayer is deposited onto the flow cell surface
and how the ssDNA substrate is attached to the bilayer. These steps are all performed
manually at the benchtop using hand held syringes. Extreme care should be taken to prevent
any air from entering the flow cell once the bilayer has been deposited, and all tubing and
syringe attachments should be made using drop-to-drop connections. If air bubbles pass
through the sample chambers, they will destroy the lipid bilayer.
1. Fill two 3 mL syringes with Milli-Q water. Connect one of the syringes to the inlet
port and push 1 mL of water through the flow cell. Connect the second syringe to the
outlet port and push–pull the water between the inlet and outlet syringes to remove
any air from the flow cell. Very small air bubbles may appear near the edge of the
tape, but these are generally not problematic.
2. Mix 40 µL of liposome solution with 1 mL of lipid buffer (10 mM Tris– HCl [pH 8.0],
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100 mM NaCl). Push 250 µL of the mixture into the flow cell approximately every 5
min until all of the liposome mixture is used. After the final injection, allow the lipids
to form a cohesive bilayer by incubating at room temperature for 30 min.
3. Further passivate the surface with 1 mL of BSA buffer (40 mM Tris–HCl [pH 8.0], 2
mM MgCl2, 1 mM DTT, and 0.2 mg/mL BSA). Incubate 5 min. The rolling circle
replication reaction can be started at this time (see Section 2.4.2).
4. Mix 10 µL of streptavidin (1 mg/mL, Invitrogen, Cat. No. S888) with 790 µL of BSA
buffer and push the solution through the sample chamber in two 500 µL steps with a
5 min incubation between steps.
5. Rinse the sample chamber with 3 mL of BSA buffer to remove free streptavidin.
6. Dilute the freshly prepared rolling circle reaction with 450 µL of BSA buffer and slowly
push the ssDNA solution through the sample chamber over a 10 min period. Mount
the flow cell on the microscope stage and adjust the focus as necessary.
7. After mounting the flow cell on the microscope stage, the input and the output ports
are connected to a sample injection system comprised of a syringe pump (KD Scientific,
KDS-201) and a high-pressure switch valve (IDEX Health & Science, MXP9900-000).
Again, it is essential that all connections be made using drop-to-drop connections to
avoid inadvertently injecting air bubbles through the sample chamber.
2.3.3.4 Using RPA–eGFP to Visualize ssDNA
DNA curtains made with dsDNA can be visualized using an intercalating dye such as
YOYO1. However, ssDNA is not readily labeled with intercalating dyes and the reactive
oxygen species generated when these dyes are illuminated by laser light can rapidly nick the
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ssDNA, which is problematic because a single nick will result in release of the ssDNA from
the flow cell surface. In addition, ssDNA forms extensive secondary structure, which must be
removed in order to visualize extended molecules along their full contour lengths. To over-
come these problems, we use a GFP-tagged version of the eukaryotic ssDNA-binding protein
RPA both to label the ssDNA and to remove secondary structure so that the molecules can
be easily extended by buffer flow (Fig. 2.5)[81]. RPA offers the additional benefit that
RPA-coated ssDNA is the physiological substrate for assembly of the eukaryotic presynaptic
complex[73, 294]. The following steps outline a typical procedure for labeling and extending
the ssDNA curtains with RPA–eGFP.
1. Begin by diluting an appropriate amount of S. cerevisiae RPA–eGFP into 20 mL of
BSA buffer. RPA has a very high affinity for ssDNA [73], so working concentrations
of just 0.1 nM RPA–eGFP are sufficient to label and extend the ssDNA.
2. Flush the RPA-containing buffer through the sample chamber at a rate of 1.0 mL/min
for approximately 15 min. The ssDNA will immediately be visible by TIRFM upon
injection of RPA–eGFP. The RPA–eGFP– ssDNA complexes initially appear as short
molecules that slowly extend with time as secondary structure is removed (Fig. 2.5).
3. After 2 min of RPA buffer flow, a 500 µL pulse of 7 M urea is flushed through the
sample chamber at 1 mL/min to help remove any residual ssDNA secondary structure,
ϕ29 DNA polymerase, or M13 circular ssDNA template.
4. For double-tethering, a row of pentagon-shaped pedestals is lithographed downstream
of the barriers (Fig.2.2). These pedestals serve as anchor points for the nonspecific
adsorption of the RPA–ssDNA, which stick to the exposed chromium surfaces. Nonspe-
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cific interactions between the downstream end of the RPA–ssDNA and the chromium
pedestals allow the ssDNA to remain extended and visualized by TIRFM even in the
absence of buffer flow.
2.3.3.5 Presynaptic Complex Assembly
The RPA–eGFP-coated ssDNA can serve as the starting point for assembly of the
presynaptic complex, and we have used this as a substrate for the assembly of presynap-
tic complexes made from a variety of Rad51/RecA recombinases, including Escherichia coli
RecA, S. cerevisiae Rad51, human Rad51, as well as the meiosis-specific recombinases S.
cerevisiae Dmc1 and human Dmc1 [304, 306]. We use unlabeled Rad51/RecA recombinases
for our experiments so successful assembly of the presynaptic complex is revealed by the
displacement of the fluorescent RPA–eGFP (Fig. 2.6). Here, we briefly describe the proce-
dure used for making an S. cerevisiae Rad51 presynaptic complex, but this protocol can be
readily adapted for other Rad51/RecA recombinases.
1. Wash the RPA–eGFP-bound ssDNA curtains with HR buffer (30 mM Tris-Acetate
[pH 7.5], 20 mM Mg-Acetate, 50 mM KCl, 1 mM DTT, 0.2 mg/mL BSA) plus 2.5 mM
ATP for 2 min at a flow rate of 1 mL/ min to remove any free RPA and equilibrate
the sample chamber in HR buffer.
2. Inject a 50− µL sample of S. cerevisiae Rad51 (2 ￿M) in HR buffer plus 2.5 mM ATP.
Terminate buffer flow once Rad51 enters the sample chamber and incubate the sample
in the absence of buffer flow for 15 min at 30°C.
3. Confirm assembly of the presynaptic complex by visual inspection of the ssDNA before,
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Figure 2.5: RPA-coated ssDNA curtains. (A) Wide-field TIRFM image of a double-tethered
ssDNA curtain bound by RPA–eGFP. (B) Kymograph showing what takes place when single-
tethered ssDNA molecules are labeled with RPA–eGFP. The ssDNA slowly becomes longer as
RPA–eGFP binds and disrupts existing secondary structure. (C) Kymograph showing facilitated
dissociation of RPA from the ssDNA when free RPA is injected into the sample chamber. RPA–
eGFP is shown in green, and RPA– mCherry is shown in magenta, and the color-coded arrowheads
indicate successive injections of each protein. (D) Kymographs of a single-tethered ssDNA showing
that the exchange of wild-type RPA–eGFP with wild-type RPA–mCherry does not alter ssDNA
length (upper panel), whereas exchange of the RPAt48 mutant, which is defective for ssDNA
binding, with wild-type RPA–mCherry coincides with an increase in ssDNA length. Adapted with
permission from Deng, S. K., Gibb, B., de Almeida, M. J., Greene, E. C., & Symington, L. S.
(2014). RPA antagonizes 405–412; Gibb, B., Silverstein, T. D., Finkelstein, I. J., & Greene, E.
C. (2012). Single- stranded DNA curtains for real-time single-molecule visualization of protein-
nucleic acid interactions, Analytical Chemistry, 84, 7607–7612; Gibb, B., Ye, L. F., Gergoudis, S.
C., Kwon, Y., Niu, H., Sung, P., et al. (2014). Concentration-dependent exchange of replication
protein A on single-stranded DNA revealed by single-molecule imaging. PloS One, 9, e87922;
Gibb, B., Ye, L. F., Kwon, Y., Niu, H., Sung, P., & Greene, E. C. (2014). Protein dynamics during
presynaptic-complex assembly on individual single-stranded DNA molecules. Nature Structural
and Molecular Biology; and Qi, Z., Redding, S., Lee, J. Y., Gibb, B., Kwon, Y., Niu, H., et al.
(2015). DNA sequence alignment by microhomology sampling during homologous recombination.
Cell, 160, 856–869.
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during, and after the Rad51 injection. Successful assembly of the presynaptic complex
results in dissociation of RPA–eGFP from the ssDNA (Fig. 2.6). Once RPA–eGFP
has been displaced from the ssDNA flush the sample chamber with additional HR
buffer to remove any unbound Rad51.
4. The resulting Rad51 presynaptic complexes remain stable for at least 2 h if ATP is
maintained in the buffer, and the stability of the complexes can be assessed using RPA–
eGFP [306]. RPA–eGFP will only bind to the ssDNA after dissociation of Rad51, so
the integrity of the presynaptic complex can be readily confirmed by injecting HR
buffer containing 0.1 nM RPA–eGFP (Fig. 2.6).
2.4 Applications
Here, we briefly summarize some of the studies we have conducted using ssDNA cur-
tains, which include analysis of RPA-binding dynamics, Rad51 presynaptic complex assem-
bly, the association of protein cofactors with the Rad51 presynaptic complex, and interac-
tions between the presynaptic complex and fluorescently tagged dsDNA fragments.
2.4.1 RPA-Binding Dynamics
RPA is a heterotrimeric complex composed of Rfa1, Rfa2, and Rfa3 sub- units, and par-
ticipates in all aspects of nucleic acid metabolism involving an ssDNA intermediate [73, 313].
RPA–ssDNA complexes are stable for over 2 h, without any detectable dissociation when
free RPA is removed from solution [38, 70]. However, the bound RPA can undergo rapid
exchange when free RPA is present in solution, which can be visualized as a change in fluo-
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Figure 2.6: Kymographs showing presynaptic complex assembly reactions. (A) RPA–
eGFP– ssDNA curtains were first incubated with 1 µM S. cerevisiae wild-type (unlabeled) Rad51
and 2.5 mM ATP. Binding of Rad51 to the ssDNA is revealed as a rapid loss of RPA–eGFP
fluorescence signal. The sample chambers were then flushed (1st chase) with buffer containing 1.0
nM RPA–eGFP and either no nucleotide or 2.5 mM of the indicated nucleotide cofactor, followed
by a 30-min incubation. Disassembly of the Rad51–ssDNA presynaptic filaments is revealed by the
binding of RPA–eGFP to the exposed ssDNA. The sample chambers were then flushed (2nd chase)
with additional buffer containing 0.1 nM RPA–eGFP and no nucleotide cofactor, and incubated for
an additional 30-min. (B) Quantitation of the Rad51 filament stability in the presence of various
nucleotide cofactors, as indicated. Error bars represent s.d. Adapted with per- mission from Qi,
Z., Redding, S., Lee, J. Y., Gibb, B., Kwon, Y., Niu, H., et al. (2015). DNA sequence alignment
by microhomology sampling during homologous recombination. Cell, 160, 856–869.
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rescence color of the ssDNA when switching between RPA–eGFP and RPA–mCherry (Fig.
2.5C,D) [38, 70, 314]. This unusual behavior suggests that ssDNA-bound RPA undergoes
constant microscopic dissociation under all conditions, but these microscopic dissociation
events only result in macroscopically detectable dissociation into free solution when other
ssDNA-binding proteins are present to compete with the transiently unbound species for
exposed patches of ssDNA [38, 70]. This concentration-dependent disso- ciation mechanism
has been referred as facilitated dissociation [315], and it has now been reported for several
different proteins [316–320], suggesting that facilitated dissociation may have a widespread
impact on the turnover of nucleic acid- binding proteins.
2.4.2 Protein Cofactor Association with the Presynaptic
Complex
ssDNA curtains can be used to monitor the assembly and disassembly of pre- synaptic
complexes with either single- or double-tethered ssDNA molecules, and can also be used to
determine how other HR proteins bind to the presynaptic complexes. For instance, Rad52
is a mediator protein that promotes assembly of the Rad51 presynaptic complex during the
early stages of HR [321, 322], and is also required for the second strand capture and strand
annealing reactions that take place during the later stages of recombination [323–325]. We
have used ssDNA curtains to study the spatial and temporal progression of RPA and Rad52
association with Rad51 during presynaptic complex assembly [38, 70]. These studies revealed
that Rad52 can suppress RPA turnover, highlighting an unanticipated influence on protein
dynamics, and also showed that both Rad52 and RPA can remain associated with the Rad51
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presynaptic complex. As indicate earlier, there are ∼45 different proteins that participate
in DSB repair in S. cerevisiae, and in many instances we have only a cursory understanding
of how these proteins function. Future studies using ssDNA curtains help reveal how these
proteins interact with and influence the Rad51 presynaptic complex.
2.4.3 Duplex DNA Binding by the Presynaptic Complex
We have used ssDNA curtains along with short (70-bp) fluorescently tagged dsDNA
molecules containing short tracts of sequence microhomology complementary to the presy-
naptic ssDNA to study processes that take place as S. cerevisiae Rad51, human Rad51, S.
cerevisiae Dmc1, human Dmc1, and E. coli RecA presynaptic complexes are attempting
to align and pair homologous DNA sequences [304, 306]. This work revealed that dsDNA
sequences bearing fewer than 8-nucleotides (nts) of micro- homology are rapidly sampled
and rejected within seconds through a mechanism that gives rise to characteristic power law
kinetics [306]. However, dsDNA molecules bearing 8-nts of microhomology are more tightly
bound, and the resulting intermediates exhibit single-exponential kinetics with lifetimes cor-
responding to tens of minutes (Fig. 2.7). Increasing the length of microhomology from 8- to
15-nt reveals changes in lifetimes that take place in 3-nt increments, suggesting that strand
exchange takes place in 3-nt steps, with each step exhibiting a characteristic energetic sig-
nature that appears to be broadly conserved among the Rad51/RecA family members (Fig.
2.7) [305, 306].
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Figure 2.7: Duplex DNA binding by the S. cerevisiae Rad51 presynaptic complex.
(A) Experimental schematic for measuring the survival probability of fluorescently tagged dsDNA
oligonucleotides bound the presynaptic complex. (B) Example of a kymograph showing the bind-
ing of single Atto565–dsDNA molecules to a ScRad51 pre- synaptic complex. White arrowheads
highlight individual dsDNA dissociation events. (C) Schematic of the 70-bp dsDNA substrates.
All substrates contain an internal 8- to 15-nt tract of microhomology (as indicated) flanked by
nonhomologous sequence. (D) Survival probability data for substrates with 8- to 15-nt of micro-
homology, as indi- cated; survival probability curves for the 10- and 11-nt substrates superimpose
with the 9-nt and are omitted for clarity, and the 13- and 14-nt substrates superimpose 12-nt data
sets and are also omitted for clarity. Data were analyzed by measuring the amount of time (dwell
time) that each Atto565–DNA molecule remained bound to the Rad51– ssDNA presynaptic com-
plexes after flushing unbound DNA from the sample chamber. (E) Atto565–dsDNA dissociation
rates (mean ± s.d.) for reactions with S. cerevisiae Rad51 in the presence of AMP–PNP. Each data
point was calculated from an average of ∼150 molecules (N = 70–250). Arrows indicate stepwise
reductions in dissociation rates coincident with recognition of the 3rd base of each triplet, dashed
lines report the mean rate for each step, and the free energy changes (∆∆G‡) associated with each
triplet step are indicated. Adapted with permission from Lee, J. Y., Terakawa, T., Qi, Z., Steinfeld,
J. B., Redding, S., Kwon, Y., et al. (2015). DNA recombination. Base triplet stepping by the
Rad51/RecA family of recombinases. Science, 349, 977–981.
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2.5 Data Collection and Analysis
In the following sections, we describe how to collect and analyze data from ssDNA
curtain experiments using measurements of dsDNA binding to an unlabeled S. cerevisiae
Rad51–ssDNA presynaptic complex as an example. Similar procedures can be used to study
dsDNA-binding properties of other Rad51/RecA family members, or adapted to study inter-
actions between the unlabeled presynaptic complexes and any fluorescently tagged protein
or DNA component that binds to the presynaptic complex.
2.5.1 dsDNA Binding by the Rad51 Presynaptic Complex
To measure stable dsDNA binding, Rad51 presynaptic complexes are first prepared
as described earlier (see Section 2.3.3.5). Atto565-tagged dsDNA oligonucleotides (10 nM)
70-bp in length are injected into the sample chamber in HR buffer (30 mM Tris-Acetate [pH
7.5], 20 mM Mg-Acetate, 50 mM KCl, 1 mM DTT, 0.2 mg/mL BSA) plus 2.5 mM ATP.
Reactions are incubated for 10 min at 30°C in the absence of buffer flow and without laser
illumination. The free dsDNA is removed by quickly flushing the sample chamber with HR
buffer for 40 s at a flow rate of 1 mL/min. The flow rate is then reduced to 0.2 mL/min to
allow continuous replenishment of ATP and removal of any dissociated dsDNA fragments.
Data are acquired by capturing single 100 ms frames at either 20-, 30-, 40-, or 60-s intervals
and the laser remains shuttered between each acquired image to minimize photobleaching.
These measurements probe intermediates with lifetimes spanning a minute to tens of minutes
and the image acquisition frequency and overall duration of the experiments are adjusted
to accommodate the lifetime of each particular dsDNA substrate. Kymographs are then
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generated from the resulting images as described later.
2.5.2 Generating Kymographs
Images are acquired through Nikon NIS Elements software and exported as individual
tiff files for each exposure in the experiment. Using Fiji (ImageJ 1.48b, Wayne Rasband,
National Institutes of Health, USA), the tiff files are stacked to create a tiff stack (i.e., movie)
of the entire field of view. Kymographs representing individual presynaptic complexes are
then generated from the resulting tiff stack using the “Reslice” function in Fiji. A straight
line is superimposed on an ssDNA molecule and the corresponding image information for
every image within the tiff stack is compiled as a new image. Each resulting kymograph
represents a two-dimension projection of the events relating to a single presynaptic complex
over the course of a reaction trajectory—the y-component reflects the position information
and x-component represents time (Fig. 2.5-7). The resulting kymographs can then be used
to assess the dsDNA-binding distributions, as previously described [306], as well as the
lifetimes of fluorescent molecules bound to the presynaptic complex (see later) [305, 306].
2.5.3 Survival Probability
Dissociation kinetics are analyzed by measuring the amount of time (dwell time) that
each molecule of Atto565-labeled dsDNA remained bound to the Rad51–ssDNA presynap-
tic complexes after flushing the unbound dsDNA from the sample chamber (Fig. 2.7A-C).
Survival probability analysis allows one to extract lifetime information for the labeled ds-
DNA fragments bound to the unlabeled presynaptic complex. Multiple kymographs are
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first analyzed manually to determine the lifetime of each individual binding event that is
observed within the kymographs (Fig. 2.7B). These lifetimes are then plotted from shortest
to longest and the resulting curves are analyzed to extract dissociation parameters. For a
simple dissociation process, the distribution of lifetimes is expected to resemble a single-
exponential decay. The probability of survival at time t is then defined as the proportion of
molecules that remain bound to the ssDNA at time t, which can be defined as the number
of molecules whose lifetime exceeds a particular time point, divided by the total number of
observed binding events (Fig. 2.7D). Bootstrapping is a standard statistic method used to
estimate confidence intervals of a population mean by randomly resampling a subset of data
from within a larger data set [326]. Error bars for the survival probability measurements
are then expressed as 70% confidence intervals obtained through this bootstrap analysis.
Use of 70% confidence intervals for the bootstrapped data provides a close approximation to
expectations for one standard deviation from the mean because for any normally distributed
data set 68.27% of the values lie within one standard deviation of the mean.
2.5.4 Free Energy Changes During Base Triplet Stepping
Survival curves generated from experiments using the 70-bp dsDNA substrates bearing
8–15-nts of microhomology (Fig. 2.7C) can be fitted to a simple exponential decay function
of the form e−kt, where k is the experimentally observed dissociation rate constant and t is
time (Fig. 2.7D). This observed dissociation rate constant is comprised of two components:
the actual dsDNA dissociation rate constant and the Atto565 photobleaching rate constant.
Subtracting photobleaching rate, which must be determined separately [306], from the ex-
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perimentally observed dissociation rate k allows one to determine the actual dissociation
constant for the dsDNA substrates (kd). The Arrhenius equation can then be used to relate






where A is the jump frequency, kb is the Boltzmann constant, and T is temperature
[306]. The difference in the barrier heights (∆∆G‡) between two different dsDNA substrates
can be compared using the following relation:
∆∆G‡ = ∆G‡2 −∆G
‡




These ∆∆G‡ values can be normalized such that ∆G‡ for a dsDNA substrate containing
a single 8-nt of microhomology is set to zero, and all other ∆∆G‡ values for dsDNA fragments
harboring longer lengths of microhomology are expressed relative to the substrate bearing
8-nts of microhomology (Fig. 2.7E) [305].
2.5.5 Real-Time Binding Measurements
The experiments described earlier pertain to relatively stable reaction inter- mediates
with lifetimes on the order of tens of minutes. However, less stable intermediates can also be
readily detected by increasing the data acquisition frequency. For instance, transient dsDNA
sampling by the Rad51–ssDNA presynaptic complex can be detected over much shorter time
regimes [306]. This is accomplished by injecting the Atto565-tagged dsDNA substrate (10
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nM) into a sample chamber containing assembled pre- synaptic complexes. Buffer flow is
then terminated without flushing away the free dsDNA and images are acquired with 60
ms exposure time using continuous laser illumination in the absence of shuttering. The
resulting data for the transient binding intermediates can then be analyzed as described
earlier based on kymographs generated from the resulting tiff stacks. The dwell times for each
binding event are then defined as the difference between the first frame and the last frame
in which a particular molecule of Atto565- labeled dsDNA is observed bound to the Rad51
presynaptic complex. The data describing all of the transient dsDNA-binding events are
then synchronized such that the initial appearance of each bound Atto565-DNA was defined
as time zero, and then the probability that a bound molecule survived up to a particular time
point (t) was determined as the fraction of Atto565–DNA molecules that remained bound at
time t. Survival probability graphs can then constructed from the resulting data to analyze
dwell times, as described earlier for the more stable dsDNA-binding intermediates.
2.6 Conclusion
ssDNA curtains provide a powerful experimental platform, enabling new avenues of
investigation into the biochemical and biophysical proper- ties of Rad51/RecA–ssDNA presy-
naptic complexes. These studies offer the potential for new insights into the assembly, sta-
bility, and regulation of this crucial HR intermediate, and the procedures described here can
be adapted to study many different questions related to HR. Future ssDNA curtains studies
may help provide additional insights into the DNA transactions that take place during HR,
and may also provide important new clues into the dozens of other proteins that are neces-
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sary for HR to take place within living cells. Of particular interest will be work looking at
how nucleosomes and chromatin impact the interactions of the Rad51–ssDNA presynaptic
complex with dsDNA, and how these interactions are modulated by nucleosome-remodeling
proteins and posttranslational histone modifications. In addition, these ssDNA curtain meth-
ods can be adapted for studies involving other types of ssDNA-binding proteins, and with




Base Triplet Stepping by the Rad51/RecA Family of
Recombinases
This chapter is adapted from work originally published as: “Base triplet stepping by
the Rad51/RecA family of recombinases,” Ja Yil Lee, Tsuyoshi Terakawa, Zhi Qi, Justin B.
Steinfeld, Sy Redding, YoungHo Kwon, William A. Gaines, Weixing Zhao, Patrick Sung,
and Eric C. Greene. Science (2015). I was responsible for all the single-molecule stepping
data represented in Figure 3.5B.
3.1 Abstract
DNA strand exchange plays a central role in genetic recombination across all kingdoms
of life, but the physical basis for these reactions remains poorly defined. Using single-
molecule imaging, we found that bacterial RecA and eukaryotic Rad51 and Dmc1 all stabilize
strand exchange intermediates in precise three-nucleotides steps. Each step coincides with an
energetic signature (0.3kBT ) that is conserved from bacteria to humans. Triplet recognition
is strictly dependent on correct Watson-Crick pairing. Rad51, RecA, and Dmc1 can all step
over mismatches, but only Dmc1 can stabilize mismatched triplets. This finding provides
insight into why eukaryotes have evolved a meiosis-specific recombinase. We propose that
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canonical Watson-Crick base triplets serve as the fundamental unit of pairing interactions
during DNA recombination.
3.2 Introduction
Homologous recombination enables the exchange of genetic information between DNA
molecules and is a driving force in evolution. During homologous recombination, a presynap-
tic single-stranded DNA (ssDNA) is paired with the complementary strand of a homologous
double-stranded DNA (dsDNA), resulting in displacement of the noncomplementary strand
[294]. This strand exchange reaction plays essential roles in double-strand DNA break (DSB)
repair [293, 294], the rescue of stalled or collapsed replication forks [293, 327], chromosomal
rearrangements [293], horizontal gene transfer [1603, 328], and meiosis [141, 152]. These
reactions are promoted by the Rad51/RecA family of DNA recombinases, which are adeno-
sine triphosphate (ATP)–dependent proteins that form helical filaments on DNA [192, 294].
Crystal structures of RecA-ssDNA presynaptic complexes and RecA-dsDNA postsynaptic
complexes reveal that the DNA is organized into near B-form base triplets separated by ∼7.1
to 8.4 between adjacent triplets (Fig. 3.1A)[36, 329]; for brevity, we refer to these nucleic
acids as RS-DNA (Rad51/RecA-stretched DNA).
We previously developed single-molecule methods to study DNA recombination by
total internal reflection fluorescence microscopy (TIRFM) [306]. Using this approach,
we showed that presynaptic complexes search for homology by sampling dsDNA for ≥8-
nucleotide (nt) tracts of microhomology and rapidly reject sequences with ≤7 nt of micro-
homology [306]. We have also reported that strand exchange by Saccharomyces cerevisiae
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Figure 3.1: Structure of the
presynaptic complex and
experimental overview. (A)
Structure of the RecA-ssDNA
filament highlighting the base
triplet organization of the presy-
naptic RS-ssDNA [36]. (B) Car-
toon illustration of base triplet
stepping for S. cerevisiae Rad51.
Quantized reductions in bind-
ing energy are proposed to co-
incide with the third base of
each triplet. (C) Experimen-
tal outline for measuring the
survival probability of fluores-
cently tagged dsDNA oligonu-
cleotides bound to the presy-
naptic complex. (D)Example of
a kymograph showing the bind-
ing of single Atto565-dsDNA
molecules to a ScRad51 presy-
naptic complex. White arrow-
heads highlight individual ds-
DNA dissociation events.
Rad51 (ScRad51) occurs in 3-nt steps, presumably reflecting the base triplet organization of
RS-DNA (Fig. 3.1A, B) [306], and 3-nt stepping has also been proposed for bacterial RecA
[330]. Here, we sought to determine the underlying principles that contribute to base triplet
stepping and establish how these principles influence the mechanism and fidelity of DNA
recombination. To address these questions, we assembled presynaptic complexes on ssDNA
curtains (Fig. 3.1C and 3.2) using one of four different recombinases: Escherichia coli RecA
(EcRecA)[294]; ScRad51 or human Rad51 (hRAD51), eukaryotic orthologs of RecA [293];
or S. cerevisiae Dmc1 (ScDmc1), which is specialized for meiotic recombination (Fig. 3.3)
[152, 184].
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Figure 3.2: Preparation of ssDNA curtains
by rolling circle replication. (A) Schematic
showing the production of the presynaptic ss-
DNA by rolling circle replication (RCR) using
an M13mp18 circular ssDNA template. Each
substrate is biotinylated at the 5’end and is
comprised of multiple units of M13mp18. (B)
Schematic showing the ssDNA anchored to
the surface of the microfluidic sample cham-
ber. Each anchored substrate reflects 5 units
of M13mp18 (numbered 1 through 5); any ss-
DNA longer than the 5 units extends beyond
the anchor and is not monitored in the exper-
iments (as indicated). Green and magenta ar-
rowheads indicate the relative locations of the
two sets of dsDNA oligonucleotides used in the
binding experiments (see Tables 3.1, 3.2, ??.
(C) Schematic of an ssDNA curtain bound by
Rad51.
Figure 3.3: Relationship among
Rad51/RecA proteins used in this
study. (A) Sequence alignment of
EcRecA, ScRad51, hRAD51, ScDmc1
and hDMC1. Identical amino acids are
highlighted by a red background, sim-
ilar amino acids are highlighted in red
text and the locations of the Walker A
and B motifs are indicated, as are the L1
and L2 loops, which contact the presy-
naptic ssDNA. Arginine 169 in EcRecA,
which has been proposed to sense the
minor groove geometry of the postsy-
naptic dsDNA (9), is marked with an
asterisk. The numbering scheme for
EcRecA begins at residue 2 because
the N–terminal methionine is removed
in vivo. (B) Percent identity between
EcRecA, ScRad51, hRAD51, ScDmc1,
and hDMC1. (C) Phylogenetic rela-
tionship of RecA, Rad51 and Dmc1; the
three different lineages are color–coded,
and the five recombinases used in this
study are highlighted in yellow.
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3.3 Results
For visualization of strand exchange intermediates, 70–base pair (bp) Atto565-dsDNA
substrates were briefly incubated with the presynaptic complexes and unbound dsDNA was
flushed away. Complexes were visualized by TIRFM (Fig. 3.1C, D) and dissociation rates
were obtained from the survival probabilities of the bound Atto565-dsDNA (Fig. 3.4).
The dsDNA substrates bore 8- to 15-nt tracts of microhomology targeted to two different
regions of the presynaptic ssDNA (Fig. 3.2B, 3.5A and 3.6A and Table 3.1) [306]. The
dissociation rates for both sets of substrates scaled with microhomology length for each
of the recombinases. In each instance, pronounced changes in dissociation rates coincided
with recognition of the 9th, 12th, and 15th nucleotides, and similar results were observed in
reactions with the nonhydrolyzable ATP analogs adenylyl imidodiphosphate (AMP-PNP)
and adenosine 5’-O-(3-thiotriphosphate) (ATPγS) (Fig. 3.5 and 3.6). These binding patterns
demonstrate that 3-nt stepping is a broadly conserved feature of the Rad51/RecA family of
DNA recombinases.
Comparison of reactions with EcRecA, ScRad51, hRAD51, and ScDmc1 revealed that
the free energy change (∆∆G‡) associated with the binding of each base triplet was similar
for all recombinases (Fig. 3.5 and 3.6), corresponding to 0.30 ± 0.14 kBT (mean ± SD)
for completion of a single triplet step (Fig. 3.7). This result supports the conclusion that
the free energy changes associated with triplet steps during DNA recombination are broadly
conserved. In addition, reactions with AMP-PNP or ATPγS revealed no appreciable shift
in the free energy change associated with each triplet step (Fig. 3.5 and 3.6). Thus, the
physical determinants governing the energetics of strand exchange have been retained during
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Figure 3.4: Representative survival probability curves. (A) hRAD51, (B) EcRecA, (C)
ScDmc1, and (D) ScRad51 (plus AMP–PNP) using set #1 substrates with 8– to 15–nt of micro-
homology, as indicated; survival probability curves for the 10–, 11–, 13–, and 14–nt substrates
superimpose with the 9–nt and 12–nt data sets and are omitted for clarity. Data were analyzed by
measuring the amount of time (dwell time) that each Atto565–DNA molecule remained bound to
the Rad51–ssDNA presynaptic complexes after flushing unbound DNA from the sample chamber.
The probability that a bound molecule survived up to time point (t) was determined as the fraction
of Atto565–DNA molecules that remained bound at time t, and survival probability graphs for the
different substrates were constructed from the resulting data. N corresponds to the total number
of Atto565–DNA molecules measured. Error bars for survival probability plots represent 70% con-
fidence intervals obtained through bootstrap analysis; our choice of 70% confidence intervals for
the bootstrapped data provides a close approximation to expectations for one standard deviation
from the mean.
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Figure 3.5: Conservation of base triplet stepping among Rad51/RecA family members.
(A) Schematic of the 70-bp dsDNA substrates (set #2; see Table 3.1). All substrates contain an
internal 8- to 15-nt tract of microhomology (as indicated) flanked by nonhomologous sequence. (B)
Atto565-dsDNA dissociation rates (mean ± SD) for ScRad51 plus ATP. (C) EcRecA plus ATPγS.
(D) hRAD51 plus ATP. (E) ScDmc1 plus ATP. (F) ScRad51 plus AMP-PNP. In (B) to (F), each
data point was calculated from an average of ∼150 molecules (N = 70 to 250); the color-coded
shading highlights each base triplet; magenta shading indicates the minimum 8 nt necessary for
binding; purple shading corresponds to additional homologous nucleotides; arrows indicate stepwise
reductions in dissociation rates coincident with recognition of the third base of each triplet; dashed
lines report the mean rate for each step; and the free energy changes (∆∆G‡) associated with each
triplet step are indicated.
the evolution of the Rad51/RecA gene family.
Whereas base stacking dominates the stability of B-DNA [331], stacking interactions
are disrupted in RS-DNA, which suggests that the structure of RS-DNA may enhance the fi-
delity of recombination by relying more on correct Watson-Crick pairing. Therefore, we next
asked whether noncomplementary bases affect individual strand exchange steps (Fig. 3.8A).
These experiments demonstrated that a single mismatch anywhere within a base triplet
completely abolishes recognition of the entire triplet (Fig. 3.8B and 3.9). All noncomple-
103
Figure 3.6: Conservation of base
triplet stepping. (A) Schematic
of the 70–bp dsDNA substrates (set
#1; see Table 2.1). All substrates
contain an internal 8– to 15–nt
tract of microhomology (as indi-
cated) flanked by nonhomologous
sequence. (B) Atto565– dsDNA
dissociation rates (mean ± s.d.)
for ScRad51 plus ATP. (C)EcRecA
plus ATPγS. (D) hRAD51 plus
ATP. (E) ScDmc1 plus ATP. (F)
ScRad51 plus AMP–PNP. In (B-F),
the color–coded shading highlights
each base triplet, arrows indicate
stepwise reductions in dissociation
rates coincident with recognition of
the 3rd base of each triplet, and the
free energy changes (∆∆G‡) associ-
ated with each step are indicated.
Figure 3.7: Shared energetic signature for triplet stepping. Histogram showing the free en-
ergy changes associated with base triplet recognition for all individual steps (N=33 total) measured
for EcRecA, ScRad51, hRad51, ScDmc1 and hDmc1 (see Fig. 3.5, 3.6, 3.11). A Gaussian fit to the
distribution yields a value of 0.3 ± 0.14 kBT (mean ± s.d.) for the free energy change that takes
place during 3–nt strand exchange steps.
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Table 3.1: Sequences of 70–bp oligonucleotides with 8–nt to 15–nt tracts of microho-
mology. †Only the Atto565 labeled top strands of each oligonucleotide are shown; the tracts
of microhomology complementary to the M13mp18 ssDNA substrate are designated in underlined
bold italics. The corresponding bottom strands are complementary to the top strand sequences, but
lack a fluorescent label (not shown). Microhomology analysis confirmed that the sequences were
targeted to only a single region on M13mp18, corresponding the complement of the underlined
sequences.
mentary nucleotides abolished triplet recognition regardless of mismatch identity, and this
high level of discrimination was conserved across the Rad51/RecA family (Fig. 3.8B and
3.9). In addition, reactions with ATPγS or AMP-PNP revealed that ATP hydrolysis played
no discernible role in mismatch discrimination at the level of a single triplet step (Fig. 3.8B
and 3.9C,F).
We next sought to determine whether strand exchange could progress beyond a mis-
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Figure 3.8: Effects of mismatches on base triplet recognition. (A) Schematic highlighting
the design of dsDNA substrates (set #2; see Table 3.2) bearing mismatched bases within the fourth
nucleotide triplet, corresponding to the second strand exchange step; each mismatch position is
highlighted as an underlined magenta X. (B)Mismatch substrate binding for ScRad51, EcRecA,
hRAD51, and ScDmc1, as indicated. All indicated ∆∆G‡ values are relative to the step 1 binding
data for the substrate bearing 9 nt of microhomology (see Fig. 2.5); each data point was calculated
from an average of ∼150 molecules. The green and blue dashed lines correspond to data obtained
for non-mismatched substrates with each of the four different recombinases (see Fig. 3.5B-F). (C)
Substrate design (set #2; see Table 3.3) for testing whether Rad51/RecA is capable of stepping
over a mismatched triplet. (D) Triplet binding data illustrating how base mismatches within the
fourth triplet affect recognition of the fifth triplet. (E) Schematic highlighting the different models
predicted for mismatched substrates in reactions with RecA and Rad51 versus Dmc1.
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Figure 3.9: Effects of mismatches on
base triplet recognition (cont.). (A)
Schematic illustration of mismatched set #1
dsDNA substrates. The location of each mis-
match within the fourth base triplet is indi-
cated as an underlined, magenta “X”. The
corresponding sequence of the M13mp18
presynaptic ssDNA is shown to highlight the
identity of the mismatched pair (Also see Ta-
ble 3.2). (B) Changes in binding free energy
for mismatch substrates in reactions with
ScRad51, EcRecA, hRad51, and ScDmc1, as
indicated. The green and light blue dashed
lines correspond to step 1 and step 2, respec-
tively, obtained for non– mismatched sub-
strates with each of the different recombi-
nases (see Fig. 3.6)
match (Fig. 3.8C and 3.10A). Extending the length of homology by just a single triplet
allowed each recombinase to step past the mismatches, as evidenced by the correspond-
ing reduction in binding free energy (Fig. 3.8D and 3.10B). When EcRecA, ScRad51, or
hRAD51 stepped over a mismatched triplet, the mismatched triplets did not contribute to
the binding free energy of the resulting intermediates. This conclusion is based on the obser-
vation that the corresponding reduction in binding free energy was comparable to products
reflecting a second rather than a third strand exchange step (Fig. 3.8D and 3.10B). This
result supports a model in which these internal mismatch-bearing triplets remain destabi-
lized (Fig. 3.8E). In contrast, when ScDmc1 stepped over a mismatched triplet, the stability
of the resulting intermediates was comparable to expectations for completion of both the
second and the third strand exchange steps (Fig. 3.8D and 3.10B). The simplest interpre-
tation of this result is that in reactions with ScDmc1, the internal mismatched triplet was
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Figure 3.10: RecA, Rad51 and Dmc1 can
step over mismatched triplets. (A) Sub-
strate design based on oligonucleotide set #1
(Table ??) for testing whether Rad51/RecA is
capable of stepping over a mismatched triplet;
note that position 10 could not be altered
without introducing new tracts of microho-
mology, so mutations at this position were not
tested. (B) Triplet binding data illustrating
how base mismatches within the 4th triplet
affect recognition of the 5th triplet.
either partially or fully paired with presynaptic ssDNA (Fig. 3.8E). To determine whether
the ability to stabilize mismatched triplets is a conserved feature of the Dmc1 lineage, we
next performed experiments using human DMC1 (hDMC1). Like the other recombinases,
hDMC1 strand exchange intermediates were stabilized in 3-nt steps, triplet recognition coin-
cided with a change in free energy of ∼ 0.3kBT , and mismatches abolished triplet recognition
(Fig. 3.11A-D). Like ScDmc1, hDmc1 is able to step over mismatches, and also stabilizes
the mismatched triplets (Fig. 3.11E,F). Although Rad51, RecA, and Dmc1 can all step over
mismatches, the ability to stabilize mismatched triplets embedded within longer tracts of
homology is only conserved within the Dmc1 lineage.
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Figure 3.11: Strand exchange characteris-
tics of human DMC1. (A) Schematic of the
70–bp dsDNA substrates (set #1). All sub-
strates contain an internal 8– to 15–nt tract
of microhomology (as indicated) flanked by
nonhomologous sequences. (B) Atto565– ds-
DNA dissociation rates (mean /pm s.d.) for
hDMC1 plus ATP. (C) Schematic of mis-
matched substrates. (D) Mismatch substrate
binding for hDMC1. All indicated ∆∆G‡ val-
ues are relative to the step 1 binding data for
the substrate bearing 9–nt of microhomology.
(E) Substrate design for testing mismatch by-
pass. (F) hDMC1 binding data illustrating
how base mismatches within the 4th triplet af-
fect recognition of the 5th triplet.
It is not known why eukaryotes have evolved two recombinases. Rad51 is expressed
ubiquitously, but Dmc1 is present only during meiosis[152, 184]. A fundamental differ-
ence between mitotic and meiotic recombination is the choice of template used to direct
DSB repair [141, 152, 332]. Mitotic recombination is biased toward use of the identical
sister chromatid to ensure accurate repair. Meiotic recombination favors use of the ho-
molog, yielding crossovers and increasing genome diversity through reshuffling of parental
alleles and meiotic gene conversion [141, 152, 332]. The mechanisms that direct template
choice remain poorly defined [141, 152, 332]. Our findings reveal that Dmc1 can stabilize
mismatches, which may play a role in guiding template choice. For example, the inability
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of Rad51 to stabilize mismatches could help bias mitotic recombination toward use of the
sister chromatid by disfavoring interhomolog recombination. This bias may be enforced
through mismatch repair (MMR) anti-recombination activity [333, 334], which could selec-
tively disrupt mismatched intermediates arising from any attempts by Rad51 to promote
interhomolog recombination. Conversely, the ability of Dmc1 to stabilize mismatches may
allow recombination between polymorphic maternal and paternal alleles during meiosis by
masking mismatched intermediates from premature dissolution by the MMR machinery.
Dissociation of Dmc1 upon completion of strand invasion would then allow efficient gene
conversion through MMR-mediated repair of the mismatched heteroduplex.
We next sought a quantitative explanation for why strand exchange takes place in
3-nt steps. Given our findings, it is conceivable that base-pairing transitions within the
interior of the presynaptic complexes are governed primarily by the thermodynamic char-
acteristics of RS-DNA. Concordant with this view is the finding that the complementary
strand within the RecA-dsDNA postsynaptic complex is held in place mainly by Watson-
Crick hydrogen bonds [36]. However, the thermodynamic properties of RS-DNA cannot be
experimentally accessed outside the context of Rad51/RecA nucleoprotein filaments. As an
alternative, we used Monte Carlo and molecular dynamics simulations to explore how exten-
sion of every third phosphodiester bond may alter the melting and annealing transitions of
RS-DNA. These simulations used a coarse-grained model that recapitulates structural, ther-
modynamic, and mechanical characteristics of DNA [335]. Although more complex in silico
models can be envisaged, such models would require further assumptions that could only
serve to confuse the general argument that the physical architecture of RS-DNA itself may
be sufficient to define some mechanistic attributes of strand exchange. Monte Carlo simula-
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tions reveal that RS-DNA annealing is highly unfavorable because of the energetic penalty
associated with extension of the complementary ssDNA strand (Fig. 3.12A). However, an-
nealing becomes favorable when the incoming homologous ssDNA strand is constrained into
base triplets to mimic the effect of the recombinases (Fig. 3.12A). This result agrees with
the expectation that Rad51/RecA must locally stretch the incoming homologous DNA to
more closely conform to the extended configuration of the presynaptic RS-ssDNA [36, 329,
336]. Moreover, the free energy profiles for RS-DNA reveal pronounced energetic barriers
with 3-nt periodicity (Fig. 3.12A). Molecular dynamics simulations confirm that B-DNA
annealing and melting transitions occur in 1-bp increments; consistent with a 1-bp zippering
mechanism [335], the lifetimes of pairing intermediates are largely independent of nucleotide
position (Fig. 3.12B,D and Fig. 3.13A-C). In contrast, the annealing and melting transi-
tions for RS-DNA occur in 3-nt steps (Fig. 3.12C,D and Fig. 3.13D-F), and partially paired
RS-DNA triplets are highly transient relative to fully paired triplets (Fig. 3.12D and Fig.
3.13E). These simulations reveal that partially paired RS-DNA triplets are not stable, which
recapitulates a key feature of our experimental data—base triplet stepping—even though the
model intentionally omits any detailed contributions of the proteins or amino acid side chains
other than to stretch the DNA strands into an RS-DNA configuration. Together, the simu-
lations and experimental work suggest that canonical Watson-Crick base triplets act as the
fundamental pairing unit within RS-DNA.
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Figure 3.12: RS–DNA melting occurs in
3–nt steps. (A) Free energy profile of RS–
DNA annealing generated by Monte Carlo
simulation. (A) Molecular dynamics snap-
shots of B– DNA melting intermediates. (C)
Molecular dynamics snapshots of RS–DNA
melting intermediates. (D) Lifetimes of B–
DNA and RS–DNA intermediates calculated
from 50 separate simulation runs (5 × 108
total simulation steps). In (B) and (D),
the number of arrowheads between each im-
age corresponds to the number of interme-
diates necessary to reach the depicted state.
The data in (D) do not include the terminal
triplets.
3.4 Discussion
RecA, Rad51, and Dmc1 differ in many structural, functional, and mechanistic de-
tails; they each interact with different accessory factors; and they are adapted for diverse
biological functions [152, 293, 294]. Our work reveals that despite these differences, uni-
fying mechanistic principles underlie the process of strand exchange: Rad51/RecA family
members all stabilize strand exchange intermediates in 3-nt steps; each step coincides with
a broadly conserved energetic signature; and a single mismatch can abolish recognition of
an entire base triplet. We also show that RecA, Rad51, and Dmc1 can all step over mis-
matches, but only Dmc1 can stabilize mismatched triplets; this distinction likely reflects
the role of Dmc1 in promoting strand exchange between polymorphic alleles during meiosis.
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Figure 3.13: RS-DNA governs triplet
stepping during strand exchange. (A)
Molecular dynamics snapshots of B-DNA an-
nealing intermediates. Paired bases are num-
bered 1 to 3 for comparison to RS-DNA
triplets. (B) Sample annealing trajectory for
B-DNA. (C) Lifetimes of B-DNA intermedi-
ates calculated from 50 separate simulation
runs (5 × 108 simulation steps total). (D)
Molecular dynamics snapshots of RS-DNA.
(E) Sample annealing trajectory for RS-DNA.
(F) Lifetimes of RS-DNA intermediates calcu-
lated from 50 separate simulation runs (5×108
simulation steps total). In (A) and (D), the
number of arrows between each image corre-
sponds to the number of steps necessary to
reach the depicted state. The y axes in (B)
and (E) denote the position of the most distal
paired base relative to the pre-annealed end
of the DNA. The data in (C) and (F) do not
include the terminal triplets.
Our findings support a model in which a primary role of the Rad51/RecA family members
during strand exchange is to establish the structure of RS-DNA, whereas the mechanism,
energetics, and fidelity of the base-pairing transitions that take place during recombination
are all governed by the physical architecture of RS-DNA itself. We propose that RS-DNA
was selected at least ∼2 billion years ago by an ancestral recombinase as the most ener-
getically favorable solution for allowing efficient exchange of genetic information between
related DNA molecules.
113
3.5 Materials and Methods.
3.5.1 Fluorescent dsDNA substrates
Oligonucleotides were obtained from Integrated DNA Technologies (IDT) and purified
by HLPC reverse phase chromatography. Stock solutions were quantified by UV absorbance
and diluted to 100 µM oligonucleotide using 10 mM Tris–HCl [pH 8.5]. Fluorescently–
tagged and untagged complementary ssDNA oligonucleotides were mixed in a 1:1.2 ratio and
annealed in buffer containing 40 mM Tris–HCl [pH 8.0], 50 mM NaCl, and 10 mM MgCl2.
Reaction mixes were heated 5 minutes at 90 ◦C, then cooled slowly to room temperature over
a period of 4 hours. Annealed oligonucleotides were purified using a QIAquick Gel Extraction
Kit (#28704), and the purity of the annealed substrates was verified by electrophoresis on
12% DNA polyacrylamide gels. Fluorescent substrates were protected from light during
preparation and storage.
All dsDNA sequences (Table 3.1) were analyzed for microhomology to ensure that
they were targeted to a single unique location on the M13mp18 presynaptic ssDNA using
a MatLab algorithm (MathWorks, Inc., Natick, MA), as described [306]. This analysis was
essential to ensure that the survival probability data reflected the dissociation of Atto565–
dsDNAs bound to identical locations on the presynaptic ssDNA. In brief, the dsDNA strands
(top and bottom stands) were scanned in 3– to 10–nt increments along the M13mp18 ss-
DNA sequence to identify all corresponding tracts of microhomology. This process was also
repeated for all mismatched substrates (Tables 3.2 and 3.3) to ensure that introduction of
the mismatched bases did not also result in new ≥8–nt tracts of microhomology. If a de-
sired mismatch resulted in a new tract of microhomology, then we first attempted to modify
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Table 3.2: DNA sequences for 70–bp oligonucleotides with 12–nt microhomology tracts
bearing mismatched triplets. †Only the Atto565 labeled top strands of each oligonucleotide are
shown; the tracts of microhomology complementary to M13mp18 ssDNA designated in underlined
bold italics. The corresponding bottom strands are complementary to top strand sequences, but
lack fluorescent label. ‡“X” corresponds to the mismatched position, and the identity and location
of the mismatched bases in the DNA sequences are highlighted in magenta. All oligonucleotide
sequences were analyzed for microhomology to ensure that the introduction of the mismatched
bases did not result in new regions of microhomology; mismatches that resulted in new regions of
microhomology were excluded from this study.
nucleotides in the flanking sequences to remove the undesired microhomology. If it was not
possible to ensure that a particular mismatched dsDNA substrate was targeted to a single
region on M13mp18, then that substrate was omitted from the study.
3.5.2 DNA binding experiments and data analysis
Flowcells, presynaptic ssDNA substrates, and ssDNA curtains were prepared essentially
as described [81, 312]. Rad51/RecA presynaptic complexes were assembled as previously
described [306], using reaction buffers adapted from prior studies of EcRecA [337–339],
ScRad51 [340], hRAD51 [341], and ScDmc1 [342], as summarized in Table 3.4. Atto565–
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Table 3.3: DNA sequences for 70–bp oligonucleotides with 15–nt microhomology tracts
bearing mismatched triplets. †Only the Atto565 labeled top strands of each oligonucleotide are
shown; the tracts of microhomology complementary to M13mp18 ssDNA designated in underlined
bold italics. The corresponding bottom strands are complementary to top strand sequences, but
lack fluorescent label. ‡corresponds to the mismatched position, and the identity and location of the
mismatched bases in the DNA sequences are highlighted in magenta. All oligonucleotide sequences
were analyzed for microhomology to ensure that the introduction of the mismatched bases did not
result in new regions of microhomology; mismatches that resulted in new regions of microhomology
were excluded from this study.
tagged dsDNA oligonucleotides (2–10 nM) were then injected into the sample chamber in
the same buffers, and reactions were incubated for a period of 10 minutes at 30 ◦C in
the absence of buffer flow. Flowcells were quickly flushed (40 sec at 1.0 ml min−1) with
fresh buffer to remove unbound Atto565–dsDNA, and the flow rate was then reduced (0.2
ml min−1) to ensure removal of dissociated dsDNA and replenishment of free nucleotide
cofactor while images were being collected. Data were obtained by acquiring single 100–
msec frames at 30– or 60–second intervals. The data collection intervals were optimized
relative to the overall lifetime of each dsDNA substrate and the laser was shuttered between
acquired images to minimize photobleaching. Kymographs were then generated from the
resulting movies using Fiji. Survival probabilities were determined from analysis of the
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Table 3.4: Reaction conditions required for each of the recombinase.
resulting kymographs by measuring the time (dwell time) that each molecule of Atto565–
DNA remained bound to the presynaptic complexes after flushing the unbound DNA from
the sample chamber. The probability that a bound molecule survived to a particular time
point (t) was determined as the fraction of Atto565–dsDNA molecules that remained bound
at time t, and survival probability graphs were constructed from the resulting data. All
reported data points were calculated from an average of 150 different molecules (N=70–
250). In each instance, the dissociation kinetics for the different dsDNA substrates were
well described by single exponential fits to the survival probability data (Fig. 3.4) [306].
Error bars for the survival probability measurements and binding distributions represent 70%
confidence intervals obtained through bootstrap analysis, providing a close approximation of
expectations for one standard deviation from the mean [306]. All reported ∆∆G‡ values were
calculated from the dissociation rate data for the Atto565–dsDNA substrates, as previously
described [306], and the shared energetic signature (mean ± s.d.) reported in the main text
for EcRecA, ScRad51, hRad51, and ScDmc1 reflects the combined average of the first, second
and third triplet steps observed for all four recombinases using both sets of oligonucleotide
substrates (Fig. 3.5 and 3.6).
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3.5.3 Simulations
Simulations were performed using the Academic Center for Computing and Media
Studies (ACCMS) Cray XE6 supercomputer at Kyoto University. Monte Carlo and molec-
ular dynamics simulations were performed using a course–grained oxDNA model [335, 343].
The RS–DNA model was prepared by mapping the center of mass (COM) of the sugar
atoms in each base in the crystal structure of RecA–dsDNA postsynaptic filament (PDB
ID: 3CMX) [36] to the COM of each base in the coarse–grained representation of a DNA
molecule 15 base pairs in length. We performed a short low temperature (0 ◦C) simulation
with the COM of each base restrained in space to relax positions of base and backbone
beads. The structure of B–DNA was prepared using generate–sa.py provided by the oxDNA
software package.
In all of the simulations, one of the two DNA strands was constrained in space to mimic
the protein–bound presynaptic ssDNA. We refer to this constrained strand as the presynap-
tic strand, which is colored red in Fig. 3.12 and 3.13. We refer to the other strand as the
complementary strand, which is colored blue in Fig. 3.12 and ??. For both the B– DNA
and RS–DNA models the first three base pairs were also constrained in space by imposing a
harmonic potential (Stiffness parameter k = 34.3 kJ mol−1−2) on the COM of each of these
three base pairs. This constraint was applied so that the initial structural models within the
simulations represented a partially paired recombination intermediate. Two additional con-
straints were applied for the RS–DNA simulations. First, distances between adjacent base
triplets the complementary strand were restrained by a harmonic potential. Second, the
end–to–end distance of the complementary strand was also restrained by a harmonic poten-
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tial (Stiffness parameter k = 3.43 kJ mol−1−2). These constraints were intended to emulate
the expectation that Rad51/RecA would need to locally stretch the incoming complemen-
tary strand to more closely match the extended configuration of the presynaptic ssDNA [36,
329, 336, 344–346]. Monte Carlo simulations (see below) confirmed that RS–DNA duplex
formation was strongly disfavored in the absence of these constraints on the complementary
strand (Fig. 3.12A). Using these initial structures and constraints, we performed virtual
move Monte Carlo (MC) simulations to obtain canonical NVT ensemble at 27 ◦C [347], and
this ensemble was used to elucidate the free energy profiles of duplex formation for RS–DNA
(Fig. 3.12A). Umbrella sampling, where the number of base pairs with a negative hydrogen–
bonding energy was used as an order parameter, was used to enhance conformational sam-
pling [348]. Weight for each biasing potential was calibrated manually by iterating relatively
short MC simulations (108 steps). Each simulation was then performed for 109 steps and
the conformations were collected every 104 steps. The free energy profile was calculated
from the canonical conformational ensemble using the equation, –kBT log(P ), where kB is
the Boltzmann constant, T is temperature, and P is the probability of each conformational
state.
Molecular dynamics (MD) simulations were performed by integrating a Langevin equa-
tion using a diffusion coefficient of 12 2 picosecond−1 and an integral step size of 15 fem-
toseconds. The initial structure for the annealing simulations was prepared by performing a
short (106 steps) high temperature (100 ◦C) simulation to melt the duplex. The RS–DNA
and B–DNA annealing simulations were conducted at 27 ◦C, RS–DNA melting simulations
were performed at 80 ◦C, and B–DNA melting simulations were performed at 100 ◦C. The
temperature was kept constant using an Anderson–like algorithm. Each simulation was
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performed for 107 steps, and conformations were collected every 104 steps.
The melting and annealing trajectories of B–DNA and RS–DNA were then analyzed
to determine which bases were paired (Fig. 3.13B,E) as well as the duration (lifetime) of
these pairing interactions (Fig. 3.12B and 3.13C,F). Within the simulations, a base was
considered paired if the beads representing the two bases on complementary strands were
within 8.5 of one another, and the bases were considered unpaired if this distance exceeded
8.5 . We define the “n bases paired state” as when the nth base pair forms (where n = 1 to
15) and the base pair does not form (where k = 1 to 15 – n); examples of these states are
shown as snapshots in Figure 3.13A,D and graphical representation of the data are presented
in 3.13B,D where the y–axes reflect the position of the most distal base pair relative to the
pre–annealed triplet. We then calculated the lifetime (in simulation steps) of each paired
state. For annealing simulations, we report the lifetimes of each bases paired state (Fig.
3.13C,F). For the melting simulations, we report the lifetimes as the average value for each
nucleotide position within the base triplets (Fig. 3.12D). In both cases, lifetime data for the
terminal base triplets are excluded from the reported values.
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Chapter 4
Sequence Imperfections and Base Triplet Recognition by the
Rad51/RecA Family of Recombinases
This chapter is adapted from work originally published as: “Sequence imperfections
and base triplet recognition by the Rad51/RecA family of recombinases,” Ja Yil Lee, Justin
B. Steinfeld, Zhi Qi, YoungHo Kwon, Patrick Sung, and Eric C. Greene. J. Biol. Chem.
(2017). I was responsible for some of the single molecule experiments along with experimental
design and data analysis.
4.1 Abstract
Homologous recombination plays key roles in double-strand break repair, rescue, and
repair of stalled replication forks and meiosis. The broadly conserved Rad51/RecA family of
recombinases catalyzes the DNA strand invasion reaction that takes place during homologous
recombination. We have established single-stranded (ss)DNA curtain assays for measuring
individual base triplet steps during the early stages of strand invasion. Here, we examined
how base triplet stepping by RecA, Rad51, and Dmc1 is affected by DNA sequence imperfec-
tions, such as single and multiple mismatches, abasic sites, and single nucleotide insertions.
Our work reveals features of base triplet stepping that are conserved among these three
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phylogenetic lineages of the Rad51/RecA family and also reveals lineage-specific behaviors
reflecting properties that are unique to each recombinase. These findings suggest that Dmc1
is tolerant of single mismatches, multiple mismatches, and even abasic sites, whereas RecA
and Rad51 are not. Interestingly, the presence of single nucleotide insertion abolishes recog-
nition of an adjacent base triplet by all three recombinases. On the basis of these findings,
we describe models for how sequence imperfections may affect base triplet recognition by
Rad51/RecA family members, and we discuss how these models and our results may relate
to the different biological roles of RecA, Rad51, and Dmc1.
4.2 Introduction
Homologous recombination allows for the regulated exchange of genetic information
between two different DNA molecules of identical or nearly identical sequence composition,
and it is a driving force in evolution [349, 350]. Homologous recombination contributes to
double-strand DNA break (DSB)1 repair [292], the rescue of stalled or collapsed replication
forks [293, 327, 351], chromosomal rearrangements [1, 352, 353], horizontal gene transfer
[354], and meiosis [141, 152, 355]. Defects in recombination compromise genome integrity
and lead to the gross chromosomal rearrangements that are a hallmark of cancer [1, 352,
353]. During recombination, single-stranded DNA (ssDNA), derived from the nucleolytic
processing of a DSB or collapsed replication fork, is paired with the complementary strand
of a homologous double-stranded DNA (dsDNA), resulting in the displacement of the non-
1The abbreviations used are: DSB, double-strand DNA break; ssDNA, single- stranded DNA; nt, nu-
cleotide; eGFP, enhanced GFP; ATPγS, adenosine 5-O-(thiotriphosphate); RS-DNA, recombinase stretched-
DNA; RCR, rolling circle replication; MD, molecular dynamics.
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complementary strand from the duplex to generate a D-loop [295, 356]. This reaction is
referred to as strand invasion, and the resulting intermediate can be channeled through a
number of alternative pathways, any of which can allow for the repair of the originally broken
DNA molecule using information derived from the template [292, 293].
The homology search and strand invasion reactions are catalyzed by the Rad51/RecA
family DNA recombinases [294, 295, 356]. These recombinases are among the most highly
conserved of all DNA repair proteins [357], and prominent family members include bacterial
RecA, the archaeal protein RadA, and the eukaryotic recombinase Rad51 [294, 358]. In ad-
dition to Rad51, most eukaryotes also have the meiosis-specific recombinase Dmc1, although
the reason most eukaryotes require a second recombinase for meiosis remains an enduring
mystery [152, 184].
RecA is the archetypal recombinase originally identified in genetic screens for Es-
cherichia coli mutants defective in recombination [182], and much of our current under-
standing of recombination mechanisms can be attributed to studies of this recombinase
[295, 359]. Rad51/RecA family members are all ATP-dependent DNA-binding proteins
that form extended helical filaments on DNA [294, 295]. The bound DNA is extended by
∼50% relative to the contour length of B-form DNA [185, 192, 360–362], and crystal struc-
tures of RecA-ssDNA and RecA-dsDNA pre- and post-synaptic complexes reveal that the
bound DNA is organized into near B-form base triplets separated by ∼ 8 between adjacent
triplets (Fig. 4.1A) [36]. We have referred to this unique DNA architecture as recombinase
stretched-DNA (RS-DNA) to distinguish it from other forms of mechanically stretched DNA
and as a reflection of its unique structural and mechanistic properties [363]. To help better
understand the mechanisms of genetic recombination, we have established single-molecule
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Figure 4.1: Base triplet stepping by the Rad51/RecA family of recombinases. (A) Crys-
tal structure of the RecA-ssDNA pre-synaptic complex highlighting the base triplet organization of
the bound pre-synaptic ssDNA. (B) Schematic illustration of base triplet stepping, in which each
step coincides with complete pairing of all three bases within an RS-DNA triplet. (C) Experimen-
tal assay for quantitating the binding of Atto565-labeled dsDNA fragments to an unlabeled pre-
synaptic complex. These panels were adapted with permission from Lee, J.Y. et al. (2015) DNA
recombination. Base triplet stepping by the Rad51/RecA family of recombinases. Science 349,
977–981.
assays for studying how pre-synaptic complexes engage dsDNA during the early stages of
homologous recombination [306, 363, 364]. These experiments reveal that strand invasion
products are stabilized in 3-nt increments (Fig. 4.1B), with each 3-nt step exhibiting a
characteristic energetic signature that is conserved among the Rad51/RecA family members
[306, 363, 364].
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Here, we examine how sequence imperfections affect individual base triplet steps by
E. coli RecA, Saccharomyces cerevisiae Rad51, and S. cerevisiae Dmc1. We show that
RecA, Rad51, and Dmc1 all require perfect Watson-Crick pairing interactions to stabilize
base triplet pairing interactions at either the 5’or 3’termini of paired intermediates. Single
nucleotide insertions completely disrupt base triplet recognition by all three recombinases,
underscoring the importance of maintaining proper sequence register during strand exchange.
RecA and Rad51 can step over base triplets harboring single mismatches or abasic sites, and
Rad51 can step over tandem mismatches, but neither of these recombinases can stabilize
the imperfectly paired triplets. In contrast, the meiosis-specific recombinase Dmc1 can step
over and stabilize base triplets harboring single mismatches, multiple mismatches, and even
abasic sites. Our results are consistent with a model where Dmc1 makes compensatory
protein-DNA contacts with lesion-bearing or otherwise mismatched base triplets allowing
stabilization of the resulting intermediates.
4.3 Results
4.3.1 Assay for base triplet recognition with ssDNA curtains
We used ssDNA curtains and total internal reflection fluorescence microscopy to vi-
sualize RecA, Rad51, or Dmc1 pre-synaptic complexes. The ssDNA was generated using
M13 as a template for rolling circle replication and then tethered to a lipid bilayer through a
biotin-streptavidin linkage and aligned along chromium barriers, as described previously [81,
306, 363, 365]. The ssDNA unravels when incubated with RPA-eGFP, and the downstream
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ends of the RPA-ssDNA are anchored to exposed chromium pedestals through non-specific
surface adsorption. Addition of RecA, Rad51, or Dmc1, along with the required nucleotide
cofactor, results in the displacement of the fluorescent RPA-eGFP from the ssDNA [306,
363]. Once assembled, unbound proteins are flushed away, and dsDNA-binding activity
of the pre-synaptic complexes is probed by the addition of short (70-bp) dsDNA oligonu-
cleotides bearing a single tract of sequence microhomology 8–15 nucleotides (nt) in length
that is complementary to a unique location on the M13 ssDNA [306, 363]. Following a short
incubation, the unbound dsDNA is flushed away, and the stability of the remaining dsDNA
molecules is measured by survival probability analysis (Fig. 4.1C) [306, 363, 365].
4.3.2 Microhomology and base triplet recognition
We have previously reported assays in which the internal tract of microhomology was
incrementally extended from 8- to 15-nt in the 5’→ 3’direction relative to the complementary
strand within the fluorescent dsDNA [306, 363]. These assays, together with accompanying
molecular dynamics simulations, revealed that strand invasion intermediates were stabilized
in 3-nt increments [306, 363]. Here, we sought to determine whether similar results would
be obtained if we instead extended the tract of microhomology in the 3’→ 5’direction (Fig.
4.2A). To address this question, we used a series of 70-bp oligonucleotides labeled at one
end with a single Atto565 dye and bearing an internal tract of microhomology targeted to a
specific region on the pre-synaptic ssDNA. The internal tracts of microhomology were flanked
by non-homologous sequences that lacked any microhomology exceeding 7-nt in length (Table
4.1 and 4.2). E. coli RecA, S. cerevisiae Rad51, or S. cerevisiae Dmc1 pre-synaptic complexes
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were assembled onto the ssDNA curtains. The fluorescent dsDNA substrates were then
injected into the sample chamber and incubated for 10 min at 30 ◦C, and the unbound
DNA was then flushed away while collecting data. Dissociation rates were then obtained
from survival probability analysis of the bound dsDNA fragments (Fig. 4.3) [306, 363].
These experiments revealed that extension of the internal tract of microhomology in the 3’→
5’direction yielded changes in dissociation rates for RecA, Rad51, and Dmc1, similar to our
previously reported results for 5’→ 3’extension (Fig. 4.2B-D) [306, 363]. In addition, each
step coincided with a ￿30% change in relative dissociation rates, corresponding to change in
free energy (∆∆G‡) of ∼ 0.3kBT (Fig. 4.2B-D). From these results, we concluded that 3’→
5’extension of an internal tract of microhomology gave rise to periodic changes in dsDNA
dissociation rates for RecA, Rad51, and Dmc1. These findings are consistent with our
previous experimental observations using substrates in which we incrementally extended the
microhomology length in the 5’→ 3’, as anticipated [306, 363]. We were careful to note that
although we obtained similar results for these two sets of substrates, the findings themselves
do directly report upon the polarity of strand exchange because we are only assessing the
stability of the reaction intermediates after they have already formed.
4.3.3 Mismatch discrimination at the 5￿ terminus of
microhomology
We next asked whether RecA, Rad51, and Dmc1 could discriminate against mis-
matched bases located within the 5’-terminal triplet of an embedded tract of microhomology.
For these assays, a single mismatch was introduced at each of three possible positions at the
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Figure 4.2: Base triplet stepping observed with incremental extension of the 5’-
microhomology. (A) Schematic illustration of the 70-bp dsDNA substrates with incrementally
lengthened 5’-microhomology. (B) Atto565-dsDNA dissociation rates (mean ± S.D.) for RecA in
the presence of ATP S; (C) S. cerevisiae Rad51 plus ATP; and (D) S. cerevisiae Dmc1 plus ATP.
All data points were calculated from an average of 200 molecules (n = 150 –250); the color-coded
shading highlights each base triplet; magenta coloring indicates the minimum 8 nt necessary for
stable binding, and purple shading corresponds to addition of homologous nucleotides; arrows indi-
cate stepwise reductions in dissociation rates coincident with the third base of each triplet; dashed
lines report the mean rate for each step; and the free energy (∆∆G‡) calculated for each triplet
step are indicated.
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Table 4.1: Oligonucleotide sequences. Lesions near the 3’end of the microhomology.
Table 4.2: Oligonucleotide sequences (cont.). 5’extension of the microhomology.
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Figure 4.3: Survival probability
plots. (A) Examples of survival prob-
ability data for 70-bp oligonucleotide
substrates with 8-, 9-, 12-, or 15-nt
of microhomology, as indicated. (B)
Survival probability data for the 9-,
10-, and 11-nt substrates and (C) 12-,
13-, and 14-nt substrates are presented
separately, for clarity. All plots are
for reactions with S. cerevisiae Rad51
in the presence of ATP. Error bars
represent 70% confidence intervals
obtained through bootstrap analysis,
providing a close approximation to
expectations for one standard deviation
from the mean, as previously described
from Qi, Z. et al. (2015) DNA sequence
alignment by microhomology sampling
during homologous recombination. Cell
160, 856-869. Lee, J.Y. et al. (2015)
DNA recombination. Base triplet
stepping by the Rad51/RecA family of
recombinases. Science 349, 977–981.
5’end of a 12-nt tract of microhomology (Fig. 4.4A). These results revealed that a single
mismatch at any position within the 5’-terminal triplet abolishes detectable binding of the
mismatched triplet by the RecA, Rad51, and Dmc1 (Fig. 4.4B-D). These findings are simi-
lar to our previous observations for mismatches located at the 3’end of the internal tract of
microhomology [363]. Taken together, our results support the conclusion that RecA, Rad51,
and Dmc1 are all intolerant of single nucleotide mismatches within terminal base triplets
located at either the 5’or 3’end of an internal tract of sequence homology.
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Figure 4.4: Effect of single nucleotide mismatches on 5’-base triplet recognition. (A)
Schematic illustration of dsDNA substrates bearing single nucleotide mismatches within the termi-
nal triplet at the 5’end of a 12-nt tract of microhomology. Each mutated nucleotide is highlighted
in magenta and underlined, and the corresponding sequence of the pre-synaptic ssDNA is indicated.
Mismatch substrate-binding data for RecA (B), Rad51 (C), and Dmc1 (D) are as indicated. All
indicated (∆∆G‡) values are relative to the step 1 binding data for the substrate bearing 9 nt of
microhomology (see Fig. 4.2). The green and blue dashed lines correspond to the average binding
stability for data obtained from the non-mismatched 9 –11-nt substrates (reflecting stable associa-
tion equivalent to three complete triplets) and the 12–14-nt substrates (reflecting stable association
equivalent to four complete triplets), respectively. (E) Schematic illustration of dsDNA substrates
bearing single nucleotide mismatches within the penultimate triplet at the 5 end of a 15-nt tract
of microhomology. Corresponding binding data for RecA (F), Rad51 (G), and Dmc1 (H)are as
indicated. Green, blue, and purple dashed lines correspond to the averaged binding stability for
data obtained from the non-mismatched 9 –11-nt substrates (reflecting stable association equiva-
lent to three complete triplets); the 12–14-nt substrates (reflecting stable association equivalent to
four complete triplets); and 15-nt substrates (reflecting stable association of 5 complete triplets),
respectively, reflecting steps 1–3 in A.
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4.3.4 Internal triplets are destabilized within RecA and Rad51
complexes
RecA and Rad51 can step over mismatches located within the penultimate base triplet
near the 3’end of an internal tract of microhomology, but the reduced stability of the resulting
intermediates suggests that the mismatched triplet may remain unpaired [363]. Dmc1 can
also step over internal triplets near the 3’end of an internal tract of microhomology, but these
mismatched triplets still contribute to binding free energy of the resulting intermediate [363].
As an extension of these previous findings, we next asked whether RecA, Rad51, and Dmc1
could step over mismatches positioned within the penultimate base triplet near the 5’end of
an internal tract of microhomology (Fig. 4.4E). Here, a single mismatch was introduced at
each of three possible positions within the penultimate base triplet within a 15-nt tract of
microhomology (Fig. 4.4E). For both RecA and Rad51, the binding stability of the resulting
intermediate was most consistent with destabilization of the mismatch-bearing base triplet
(Fig. 4.4F,G). In contrast, the stability of the mismatched intermediates generated by Dmc1
was comparable with the fully paired intermediate (Fig. 4.4H). We conclude that Dmc1 can
stabilize single mismatches located in the penultimate base triplet near either the 5’or 3’end
of an embedded tract of microhomology. In contrast, RecA and Rad51 were unable to
stabilize these mismatched triplets, but both were able to step over the mismatch-bearing
triplets to stabilize an adjacent base triplet that is fully homologous to the pre-synaptic
ssDNA.
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4.3.5 Dmc1 can stabilize triplets bearing multiple mismatches
To explore the potential mechanism of mismatch stabilization by Dmc1 we next sought
to determine whether Dmc1 could stabilize base triplets bearing more than one mismatch.
For these assays, we utilized a 70-bp dsDNA substrate bearing a 15-nt tract of microhomology
in which the penultimate 3’-triplet harbored either two or three nucleotide mismatches with
the pre-synaptic ssDNA (Fig. 4.5A and 4.6). Consistent with the observation that RecA and
Rad51 are intolerant of even a single mismatch, neither protein was capable of stabilizing
substrates bearing either two or three mismatches (Fig. 4.5B,C and 4.6). In contrast, Dmc1
was able to stabilize each mismatched substrate such that the relative binding energy of the
mismatch-bearing substrates was comparable with the fully paired substrate (Fig. 4.5B).
Interestingly, RecA and Rad51 can both step over triplets bearing single mismatches,
but only Rad51 appears to be capable of stepping over triplets bearing either two or three
mismatches (Fig. 4.5B,C and Fig. 4.6). Based upon the observed changes in binding free
energy, RecA appears to be incapable of stabilizing a homologous triplet that lies beyond a
triplet bearing either two or three mismatches in reactions using ATPγS. This differential
response to substrates harboring multiple mismatches is the only substantive difference we
have found between RecA and Rad51 in response to base triplet imperfections. Bulk bio-
chemical assays have revealed that RecA is unable to bypass longer (≥50 bp) heterologous
insertions during strand invasion when ATPγS is used as the nucleotide cofactor, but it can
bypass these insertions in reactions with ATP [366, 367]. Therefore, we sought to determine
whether RecA might be able to stabilize the substrates with multiple mismatches in the
presence of ATP. These experiments revealed that in the presence of ATP, RecA is capa-
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Figure 4.5: Impact of multiple mismatches on base triplet recognition. (A) Schematic
illustration of dsDNA substrates bearing either two or three nucleotide mismatches within the
penultimate triplet at the 3’end of a 15-nt tract of microhomology. Corresponding binding data
for RecA (B), Rad51 (C), and Dmc1 (D) are as indicated. Green, blue, and purple dashed lines
correspond to the averaged binding stability for data obtained from the non-mismatched 9–11-
nt substrates; the 12–14-nt substrates; and 15-nt substrates, respectively, reflecting steps 1–3 in
A. Previously reported data for substrates bearing single mismatches are shown (open circles)
for comparison see Lee, J.Y. et al. (2015) DNA recombination. Base triplet stepping by the
Rad51/RecA family of recombinases. Science 349, 977–981.
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Figure 4.6: RecA plus ATP with
substrates bearing multiple mis-
matches. (A) Schematic illustration
of the substrates bearing multiple mis-
matches in the penultimate triplet near
the 3’end of the 15-nt tract of micro-
homology. The position and identity
of the mismatches are highlighted in
magenta underlined text. (B) Corre-
sponding data for each of the different
DNA substrates. Data for the com-
plementary triplet is shown as a refer-
ence (open square), previously reported
data for substrates bearing single mis-
matches are also shown (open circles) for
comparison see Lee, J.Y. et al. (2015)
DNA recombination. Base triplet step-
ping by the Rad51/RecA family of re-
combinases. Science 349, 977–981, along
with the data for the multiple mismatch
substrates (closed circles).
ble of stabilizing a homologous triplet that lies beyond an internal triplet bearing multiple
mismatches (Fig. 4.7). We conclude that in the presence of ATP, RecA and Rad51 respond
similarly to internal base triplets bearing multiple mismatches.
4.3.6 Dmc1 can stabilize triplets bearing abasic sites
We next tested substrates bearing a single abasic site at each of the three possible
positions within the penultimate base triplet near the 3’or 5’end of the microhomology (Fig.
4.8). Neither RecA nor Rad51 was able to stabilize internal triplets bearing an abasic
site, consistent with their intolerance for single base mismatches (Fig. 4.8B,C,F,G). In
contrast, Dmc1 was able to stabilize these substrates regardless of the location of the abasic
site within the triplet, and similar findings were obtained for abasic sites located near the
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Figure 4.7: Reactions with multiple mismatches near the 5’end of the microhomology.
(A) Schematic illustration of the substrates bearing multiple mismatches in the penultimate triplet
near the 5’end of the 15-nt tract of microhomology. The position and identity of the mismatches
are highlighted in magenta underlined text. Corresponding data for each of the different DNA
substrates with (B) RecA and ATPγS, (C) RecA and ATP, (D) S. cerevisiae Rad51 and ATP,
and (E) S. cerevisiae Dmc1 and ATP. Data for the complementary triplet is shown as a reference
(open square), along with the data for the multiple mismatch substrates (closed circles).
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3’or 5’ends of the internal tract of microhomology (Fig. 4.8D,H). These findings provide
further support for the hypothesis that Dmc1 does not stabilize mismatched intermediates
through a mechanism involving protein-enhanced pairing of non-Watson-Crick interactions,
because abasic sites cannot form any type of non-canonical pairing interaction. The finding
that Dmc1 can stabilize substrates bearing abasic sites also suggests that the stabilization
mechanism likely does not involve direct protein contacts with the nucleotide bases of the
suboptimal triplet, but instead it may involve contacts with the ribose-phosphate backbone
of the DNA.
4.3.7 Non-bridging oxygen modifications do not prevent
mismatch stabilization by Dmc1
We next tested whether Dmc1-mediated mismatch stabilization might involve recombi-
nase contacts with the phosphate backbone. To address this possibility, we conducted assays
with Dmc1 using mismatched substrates harboring either methylphosphonate or phospho-
rothioate substitutions within the phosphate backbone of the mismatched triplet (Fig. 4.9).
Surprisingly, the methylphosphonate substitutions had no appreciable impact upon the abil-
ity of Dmc1 to stabilize the mismatched base triplets. These findings suggest that if Dmc1
contacts the phosphate backbone of incoming complementary strand during mismatch stabi-
lization, then these protein-DNA contacts may not involve the non-bridging oxygen atoms,
but it would more likely involve other contacts with the ribose-phosphate backbone. Future
work will be essential to determine the structural basis for mismatch stabilization by Dmc1.
137
Figure 4.8: Dmc1 can stabilize triplets bearing abasic sites. (A) Schematic illustration
of dsDNA substrates bearing single abasic sites within the penultimate triplet at the 3’end of
a 15-nt tract of microhomology. Open magenta boxes signify the locations of the abasic sites.
Corresponding to binding data for RecA (B), Rad51 (C), and Dmc1 (D) are as indicated. Green,
blue, and purple dashed lines correspond to the averaged binding stability for data obtained from
the non-mismatched 9-nt substrates; the 12–14-nt substrates; and 15-nt substrates, respectively,
reflecting steps 1–3 in A. (E) Schematic illustration of dsDNA substrates bearing single abasic sites
within the penultimate triplet at the 3’end of a 15-nt tract of microhomology. Open magenta boxes
signify the locations of the abasic sites. Corresponding binding data for RecA (F), Rad51 (G), and
Dmc1 (H) are as indicated. Green, blue, and purple dashed lines correspond the averaged binding
stability for data obtained from the non-mismatched 9 –11-nt substrates; the 12–14-nt substrates;
and 15-nt substrates, respectively, reflecting steps 1–3 in A.
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Figure 4.9: Substitutions of the non-bridging oxygens do not affect mismatch stabi-
lization by Dmc1. Illustrations of (A) methylphosphonate and (B) phosphothioate backbone
substitutions. (C) Schematic of dsDNA substrates bearing either methylphosphonate or phos-
phorothionate substitutions within the penultimate triplet at the 3’end of a 15-nt tract of micro-
homology. The locations of the backbone modifications are indicated with a magenta asterisk.
(D) Binding data for the methyl phosphonate and phosphorothionate substituted substrates (as
indicated) in reactions with Dmc1.
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4.3.8 Single nucleotide insertions disrupt triplet stabilization
We next sought to establish whether RecA, Rad51, or Dmc1 could tolerate single
nucleotide insertions. For this purpose, we designed a dsDNA substrate harboring a single
base insertion between the penultimate and terminal triplet at either the 3’or 5’end of an
internal tract of microhomology, which is anticipated to position the terminal base triplets
just 1-nucleotide out of register with the pre-synaptic ssDNA (Fig. 4.10A,C). Surprisingly,
the results revealed that a single base insertion results in a change in binding free energy
consistent with the loss of stabilizing interactions involving the terminal base triplets for
each of the three recombinases (Fig. 4.10B,D). We conclude that RecA, Rad51, and Dmc1
cannot stabilize a homologous 3’- or 5’-terminal base triplet that is moved out of register by
the presence of a single nucleotide insertion.
We have established that the eukaryotic meiosis-specific recombinase Dmc1 is more
tolerant of imperfect base triplet-pairing interactions relative to Rad51 and RecA. As dis-
cussed below, our findings suggest a model in which Dmc1 stabilizes imperfectly paired
triplets through a mechanism involving protein-mediated contacts that compensate for the
binding energy that would otherwise be lost due to the unpaired triplet.
4.3.9 Strand exchange takes place in 3-nt steps
Our work suggests that incrementally increasing the length of homology in either the
5’→ → 3’or 3’→ 5’around a central 8-nt tract of microhomology gives rise to stepwise changes
in binding free energy that follow a highly predictable base triplet pattern. In addition, the
free energy changes associated with base triplet stabilization appear to be indistinguishable
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Figure 4.10: Single base insertion can disrupt triplet stabilization. (A) Schematic illustra-
tion of dsDNA substrates bearing a single nucleotide insertion adjacent to the penultimate triplet
at the 3’end of a 15-nt tract of microhomology. (B) Corresponding binding data for Rad51, RecA,
and Dmc1 for dsDNA substrates with (closed circles) and without (open squares) the nucleotide
insertion. (C) Schematic illustration of dsDNA substrates bearing a single nucleotide insertion
adjacent to the penultimate triplet at the 5’end of a 15-nt tract of microhomology. (D) Corre-
sponding binding data for Rad51, RecA, and Dmc1 for dsDNA substrates with (closed circles) and
without (open squares) the nucleotide insertion.
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for base triplets located at either end of the internal tract of microhomology. These ob-
servations, together with the finding that the recombinases can all step over mismatches or
abasic sites positioned within the penultimate triplet at either the 5’or 3’ends of the internal
tract of microhomology, support a model in which strand exchange might proceed in either
the 5’→ 3’or 3’→ 5’directions, and they suggest that bidirectional strand exchange may
be conserved across the Rad51/RecA family of recombinases (Fig. 4.11A). Several stud-
ies have suggested that strand exchange can take place with a defined polarity [368–371],
whereas others have reported that strand exchange can occur in either direction [372, 373].
We note that our assays do not directly observe strand exchange steps as they are taking
place, but rather assess the stability of these early recombination intermediates only after
they have already formed. Therefore, we do not rule out the possibility that there may exist
polarity-dependent differences in the rates of strand exchange that cannot be assessed in our
experimental system.
4.3.10 Responses of RecA, Rad51, and Dmc1 to sequence
imperfections
Single mismatches within the terminal base triplet at either the 5’or 3’end of the mi-
crohomology prevent stabilization of these terminal triplets by RecA, Rad51, and Dmc1,
suggesting that this may be a universal response of Rad51/RecA family members to imper-
fectly paired terminal base triplets (Fig. 4.11A). This result is surprising for Dmc1 because
this recombinase can stabilize all other tested imperfections (i.e.single, double, and triple
mismatches, and abasic sites), with the exception of single nucleotide insertions, so long as
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Figure 4.11: Effects of lesions on base triplet recognition by RecA, Rad51, and Dmc1.
Details of these models are presented under “Discussion.”
the imperfections are flanked by at least one fully homologous base triplet (Fig. 4.11B).
These findings raise the question of whether the inability of Rad51/RecA recombinases to
stabilize imperfect terminal triplets provides some specific biological advantage for homolo-
gous recombination or whether it might be a reflection of the thermodynamic properties of
RS-DNA or both. One possibility is that imperfect terminal triplets play an important role
in ensuring accurate recombination, perhaps by providing a kinetic barrier to slow the pro-
gression of stand invasion, and providing a decision point for the pre-synaptic complex (and
associated factors) to either continue strand invasion or dissociate to sample other regions
of the genome for a more perfectly matched donor sequence.
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4.3.11 Triplet pairing requires perfect alignment
Single base insertions abolish recognition of the adjacent triplet by all three recom-
binases, suggesting that this may be a conserved feature of base triplet recognition by the
Rad51/RecA family of DNA recombinases (Fig. 4.11A). This finding highlights intolerance
of the pre-synaptic complex to what might have been considered a relatively minor structural
defect. For instance, one might have assumed that a single base insertion would simply have
been accommodated between the two homologous triplets, which would in principle eliminate
the need to fully extend the phosphodiester linkage between these two triplets. Instead, the
inserted base appears to abolish interactions with the downstream triplet, suggesting that
amino acids within the pre-synaptic complex may be positioned to prevent accommodation
of extra nucleotides. Indeed, inspection of the RecA crystal structure reveals that the L2
DNA-binding loop lies between adjacent base triplets, suggesting that steric hindrance by L2
may be responsible for preventing accommodation of base insertions [36]. Our experiments
cannot yet address whether the presence of additional homologous base triplets beyond the
nucleotide insertion would eventually allow stabilization, although we favor the idea that
they would, given that homologous recombination can take place between longer nucleic
acid substrates bearing either nucleotide insertions or deletions. Future work will be neces-
sary to determine how much sequence homology is necessary on either side of a base insertion
to allow triplet pairing interactions with both flanking sequences.
Interestingly, RecA and Rad51 can both step over triplets bearing single mismatches
at either the 5’or 3’ends of the microhomology, but neither Rad51 nor RecA can stabilize
the resulting mismatched triplets (Fig. 4.11B). This finding contrasts with results for Dmc1,
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which can both step over and stabilize single mismatches at either the 5’or 3’ends of the
microhomology (Fig. 4.11B). RecA and Rad51 can also step over abasic sites, but cannot
stabilize the resulting triplets bearing the abasic residues. This finding is again in striking
contrast with Dmc1, which can step over and stabilize base triplets bearing abasic sites
regardless of the location of the abasic site within the base triplet (Fig. 4.7C). These re-
sults have important implications for understanding the mechanistic basis by which Dmc1
stabilizes substrates bearing imperfect triplets (see below).
4.3.12 Effects of multiple mismatches
Experiments looking at multiple mismatches yielded several important findings. First,
RecA can step over triplets bearing a single mismatched nucleotide but not two or three
mismatches in reactions with ATPγS (Fig 4.11D). This contrasts with the findings for Rad51,
which is able to step over base triplets bearing two or even three mismatches (Fig. 4.11D).
We speculate that in the presence of ATPγS, RecA might be capable of stepping over
these tandem mismatches if there were additional sequence homology beyond the tandem
mismatches, perhaps by initiating an independent strand invasion reaction downstream of
the mismatches. Interestingly, RecA can step over multiple mismatches in reactions with
ATP (Fig. 4.11D), which is consistent with prior biochemical assays demonstrating that
RecA can bypass larger sequence heterologies only in the presence of ATP [366, 367]. This
requirement for ATP has led to the hypothesis that RecA may have an ATP-dependent
motor activity that is coupled to heterology bypass [374]. An alternative possibility is that
ATP hydrolysis-dependent protein turnover may be necessary to reduce the stiffness of the
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RecA filament, allowing a separate segment of the pre-synaptic complex to more readily
re-engage the dsDNA substrate beyond tandem mismatches.
These experiments also revealed that Dmc1 can stabilize base triplets bearing either
one, two, or three mismatches, so long as those triplets are flanked by at least one homologous
triplet (Fig. 4.11D). This finding highlights the marked tolerance of Dmc1 to sequence
imperfections at the level of a single base triplet, and it also has crucial implications for
understanding how Dmc1 stabilizes imperfectly matched RS-DNA triplets (see below).
4.3.13 Models for base triplet stability
Our results can be considered within the context of two contrasting models describing
the physical stability of mismatched RS-DNA base triplets. The first model is that im-
perfectly matched RS-DNA base triplets are themselves inherently unstable (Fig. 4.11E).
This unstable triplet model would account for all of our observations with RecA and Rad51,
indicating that the inability of these two proteins to stabilize imperfect triplets stems from
the lesion-bearing triplets themselves being unstable relative to a perfectly paired triplet.
The unstable triplet model is also supported by the previous reports that RecA makes very
limited contact with the incoming complementary DNA strand, which is instead held in
place primarily by Watson-Crick hydrogen bond pairing interactions with the pre-synaptic
ssDNA [36]. However, if the unstable triplet model is correct, then Dmc1 must somehow
stabilize the imperfect triplet, or otherwise compensate for the loss of binding free energy
that would be expected if the imperfect triplets were not paired within the Dmc1-dsDNA
postsynaptic complex.
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An alternative model, which we do not favor, is that imperfect RS-DNA base triplets
are themselves inherently stable (Fig. 4.11E). This model could explain all of our results
with Dmc1, but it would then require that RecA and Rad51 have built-in mechanisms for
sensing and actively destabilizing imperfect base triplets. Moreover, it is difficult to envision
how an RS-DNA base triplet would tolerate single, double, and triple mismatches and even
abasic sites without any loss of triplet pairing stability. Indeed, molecular dynamics (MD)
simulations of either RS-DNA or isolated base triplets reveal that RS-DNA is highly dynamic
relative to B-DNA, and single base mismatches cause rapid destabilization of triplet pairing
interactions.2 Recent reports suggest that non-complementary sequences are stable within
RecA filaments during a 10-ns MD simulation [375], so future work will be required to more
fully understand how mismatched sequences behave during recombination. However, our
experimental results seem to argue against a model where mismatched triplets are inherently
stable and must be actively destabilized by RecA and Rad51. Specifically, Dmc1 can stabilize
base triplets bearing single abasic sites at any of the three possible positions, and it is again
difficult to envision that a base triplet harboring an abasic site could be inherently stable
within an RS-DNA triplet. Together, we consider our findings to be most consistent with
the unstable triplet model, suggesting that RecA and Rad51 need not actively destabilize
imperfect RS-DNA base triplets, but instead Dmc1 must somehow compensate for the loss
of Watson-Crick binding free energy due to mismatched base triplets.
2T. Terawaka and E. C. Greene, unpublished data.
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4.3.14 Possible implications for homologous recombination
Our results suggest that RecA and Rad51 require perfect Watson-Crick pairing to
allow stabilization of RS-DNA base triplets, whereas Dmc1 can stabilize non-complementary
triplets embedded with longer tracts of homology. We emphasize that we do not yet know
the biological implications of these findings. One possibility is that this biophysical difference
may reflect the biological specialization of the meiosis-specific recombinase Dmc1, namely
the requirement for Dmc1 to promote recombination between polymorphic alleles of different
parental origins (see below). Future work will therefore be essential to determine whether
or not the differences we observe between Rad51 and Dmc1 in response to mismatches and
abasic sites reflect some broader biological difference between these two proteins.
Importantly, our work only reflects the effects of mutations within individual base
triplets. The overall pairing interactions are highly stable, with half-lives still exceeding tens
of minutes, even when mismatches or basic sites are present. Furthermore, we anticipate that
the relative differences in stability for longer strand-exchange products will be very small. A
single unpaired triplet within a paired intermediate that is tens or perhaps hundreds of base
triplets in length will not in and of itself destabilize pairing interactions. Indeed, experimen-
tal and theoretical studies of RecA have recently shown that after initial recognition of an
8-nt homologous sequence, the presence of mismatches outside this region has little impact
on overall stability [375]. The previous work with RecA by Prentiss and co-workers [375]
is in good general agreement with our findings. At this stage, we can only infer that the
differential stabilization of imperfectly matched RS-DNA triplets might reflect some broader
difference in the overall stability of a complete strand-exchange product, which in turn may
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manifest as a recombinase- and mismatch-dependent difference in recombination efficiency.
Future work will be essential to continue testing for potential relationships between triplet
pairing, or mispairing, and recombination efficiencies.
Finally, the results reported here reflect the basal activities of E. coli RecA, S. cere-
visiae Rad51, and S. cerevisiae Dmc1. These recombinases acts in concert with many other
proteins; for example, a total of ∼20 proteins or protein complex participate in recombina-
tion in E. coli [356, 376, 377], and ￿45 distinct proteins or protein complexes participate in
recombination in S. cerevisiae [27, 293]. Interestingly, recent in vivo studies have shown that
Rad51-mediated recombination is unexpectedly tolerant of mismatches [378]. Therefore, the
crucial next step will be to start understanding how recombination accessory proteins aug-
ment the basal base triplet recognition activities of the recombinases during strand invasion.
4.4 Experimental Procedures
4.4.1 DNA curtains
Single-stranded DNA substrates were generated using M13mp18 (7,249-nt; New Eng-
land Biolabs) as a template for rolling circle replication (RCR), as described [81, 306]. In
brief, a biotinylated primer was annealed to the M13mp18 template (∼30 nM) at a 1:1.2
molar ratio (primer, M13mp18) in buffer containing 40 mM Tris-HCl (pH 8.0), 50 mM NaCl,
and 10 mM MgCl2. The annealing mixture was heated for 5 min at ∼90 ◦C and then cooled
slowly to room temperature. Annealed products were diluted to a final concentration of 15
nM and stored at 4 ◦C until use. Replication reactions were prepared in RCR buffer (50 mM
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Tris-HCl (pH 7.5), 4 mM DTT, 10 mM ammonium sulfate, and 10 mM MgCl2), containing
annealed primer/M13mp18 mixture (350 pM), 150 nM ϕ29 DNA polymerase, and dNTP
mixture (200 µM each). Reactions were incubated at 30 ◦C for 25 min and then diluted
10-fold into buffer containing 40 mM Tris-HCl (pH 7.5), 2 mM MgCl2, 50 mM NaCl, 1mM
DTT, and 0.2 mg/ml BSA prior to use.
Flow cells were made by depositing chromium barriers onto the surface of a fused
silica slide by electron beam lithography and then assembled into a sample chamber
using double-sided tape and a borosilicate cover slide, as described [312]. Bilayers
were prepared with 91.5% 1,2-dioleoyl-sn-glycero-3-phosphocholine, 0.5% biotinylated 1,2-
dioleoyl-sn-glycero-3-phosphoethanolamine-N-(biotinyl), and 8% mPEG 2000–1,2-dioleoyl-
sn-glycero-3-phosphoethanolamine, and the biotinylated ssDNA molecules were attached to
the bilayer through a biotin-streptavidin linkage. Anchored ssDNA molecules were then
aligned at the barriers by application of flow in buffer containing 40 mM Tris-HCl (pH 7.5),
2 mM MgCl2, 50 mM NaCl, 1 mM DTT, 0.2 mg/ml BSA, and 0.1 nM RPA-eGFP for 15 min
at 1 ml/min. All experiments were conducted with a custom-built prism-type total inter-
nal reflection fluorescence microscope (Nikon) equipped with a 488-nm blue laser (Coherent
Sapphine, 200 milliwatt) and a 561-nm yellow laser (Coherent Sapphine, 200 milliwatt).
4.4.2 Reaction conditions and data analysis
E. coli RecA, S. cerevisiae Rad51, and S. cerevisiae Dmc1 were prepared as described
[306, 363]. Rad51/RecA pre-synaptic complexes were assembled as described previously
[306, 363], using the following reaction buffers: E. coli RecA buffer, 25 mM Tris acetate
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(pH 7.5), 4 mM magnesium acetate, 10 mM sodium acetate, 1 mM ATPγS, or 2.5 mM
ATP plus an ATP-regenerating system (20 mM creatine and 0.04 mg/ml creatine kinase),
1 mM DTT, and 0.2 mg ml−1 BSA; S. cerevisiae Rad51 buffer, 30 mM Tris acetate (pH
7.5), 20 mM magnesium acetate, 50 mM KCl, 1 mM DTT, 2.5 mM ATP, and 0.2 mg ml−1
BSA; S. cerevisiae Dmc1, 40 mM Tris-HCl (pH 7.5), 2 mM MgCl2, 1.5 mM CaCl2, 100
mM KCl, 2.5 mM ATP, 1 mM DTT, and 0.2 mg ml−1 BSA. Note that the identity of the
nucleotide cofactor used in each different experiment is specified in each of the corresponding
figure panels. All data were collected at 30 ◦C. All dsDNA binding data were collected and
analyzed as described previously [306, 363]. In brief, Atto565-tagged dsDNA oligonucleotides
(2–10 nM; Table 4.1 and 4.2) were injected into the sample chamber in the same buffers (see
above), and reactions were incubated for 10 min at 30 ◦C in the absence of buffer flow.
Flow cells were quickly flushed (40 s at 1.0 ml min−1) with fresh buffer to remove unbound
Atto565-dsDNA, and the flow rate was then reduced (0.2 ml min−1) to remove dissociated
dsDNA and to replenish free nucleotide cofactor. Data were obtained by acquiring 100-ms
frames at 30- or 60-s intervals; collection intervals were optimized relative to the overall
lifetime of each dsDNA substrate, and the laser was shuttered between acquired images
to minimize photobleaching. Kymographs were generated using Fiji and were analyzed by
measuring the time that each Atto565-dsDNA molecule remained bound to the pre-synaptic
complexes after flushing unbound DNA from the sample chamber. The probability that a
bound molecule survived to a particular time point (t) was determined as the fraction of
Atto565-dsDNA molecules that remained bound at time t, and survival probability graphs
were constructed from the resulting data. All data points were calculated from an average
of ∼200 molecules (n = 150–250). The dissociation kinetics for all dsDNA substrates were
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well described by single exponential fits to the survival probability data (Fig. 4.2). Free
energy calculations were performed as described previously [306, 363]. In brief, for dsDNA
substrates harboring ≥8-nt of microhomology, the free energy barrier, ΔG‡, for escape from





where A is the jump frequency, kb is the Boltzmann constant, and T is temperature
[306]. The difference in the barrier heights between two different dsDNA substrates can be
compared , leading to Equation 4.2,
∆∆G‡ = ∆G‡2 −∆G
‡




All reported ∆∆G‡ values were normalized such that ∆G‡ for the dsDNA containing
a single 8-nt tract of microhomology is zero, and the experimentally measured data used




Rad51 and Dmc1 lineage–specific amino acids influence the
fidelity of genetic recombination
This chapter is adapted from a manuscript in submission as: “Rad51 and Dmc1 lineage-
specific amino acids regulate the fidelity of genetic recombination,” Justin B. Steinfeld,
Ondrej Belan, YoungHo Kwon, Tsuyoshi Terakawa, Amr Al-Zain, Michael J. Smith, Zhi Qi,
Weixing Zhao, Rodney Rothstein, Lorraine S. Symington, Patrick Sung, Simon J. Boulton,
Eric C. Greene. Manuscript in submission to Molecular Cell (2018). I did everything in this
paper except single molecule experiments for CeRad51-WT by ZQ, Rad54 foci experiments
by MJS, MD simulations by TT, bulk biochemistry assays for yeast and human proteins by
YK and for C. elegans by OB, and zeocin and MMS plating by AA.
5.1 Summary
The vast majority of eukaryotes possess two DNA recombinases, Rad51, which is ubiq-
uitously expressed, and the meiosis–specific recombinase Dmc1. The evolutionary origins
and potential benefits of this two–recombinase system remain poorly understood. Interest-
ingly, Dmc1 can stabilize heteroduplex recombination intermediates bearing mismatches,
whereas Rad51 cannot. Here, we demonstrate that this difference can be attributed to three
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amino acids conserved within the Dmc1 lineage of the Rad51/RecA family, but absent from
Rad51. Chimeric Rad51 mutants harboring Dmc1 lineage–specific amino acids gain the
ability to stabilize mismatches in vitro and exhibit higher mismatch tolerance in vivo. We
also show that RAD–51 from Caenorhabditis elegans, an organism that lacks Dmc1, has
acquired “Dmc1–like” characteristics. We propose that the ability to stabilize imperfectly
paired recombination intermediates reflects a fundamental distinction between Dmc1 and
Rad51 that may have been established early in the evolutionary history of the Rad51/RecA
family of recombinases.
5.2 Introduction
Homologous recombination (HR) enables the exchange of genetic information between
DNA molecules and is a major driving force in evolution. HR plays essential roles in double–
strand DNA break (DSB) repair [379], the rescue of stalled or collapsed replication forks [327,
379], and meiosis [141, 380]. During HR, a presynaptic single–stranded DNA (ssDNA) is
paired with the complementary strand of a homologous double stranded DNA (dsDNA),
resulting in displacement of the non–complementary strand [295, 356], and the resulting
D–loop intermediates can then be channeled through several mechanistically distinct path-
ways to complete repair [292, 379]. The DNA pairing reactions that take place during HR
are promoted by the Rad51/RecA family of DNA recombinases, which are ATP–dependent
proteins that form extended helical filaments on DNA, referred to as presynaptic complexes
[295, 356, 359]. Crystal structures of RecA–ssDNA presynaptic and RecA–dsDNA postsy-
naptic complexes reveal that the DNA is organized into near B–form base triplets separated
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by 8 Å between adjacent triplets [36, 359]. This structural organization likely underpins
homology recognition mechanisms and the ability of the Rad51/RecA family of recombinases
to promote DNA strand invasion in 3–nt steps [306, 330, 359, 363, 381].
In mitotic cells, HR is primarily used for the repair of spontaneous DNA breaks, such
as those associated with DNA replication errors [292, 327, 379]. Mitotic HR is strongly
biased towards inter–sister recombination, and the resulting intermediates are preferentially
channeled through the synthesis–dependent strand annealing pathway (SDSA), and double
Holliday junction (dHJ) dissolution pathways, which yield only noncrossover recombinants
and thus help avoid chromosome arm translocations that may stem from crossover recom-
bination [379]. Meiotic HR is used to repair programmed DSBs generated by the Spo11
complex and is biased towards inter–homolog recombination to allow for the formation of
crossovers necessary for accurate chromosome segregation in the first meiotic division [141,
355, 380].
Rad51 is the only recombinase in mitotic cells, whereas Rad51 and Dmc1 are both
expressed during meiosis in the vast majority of eukaryotes [141, 355, 380]. Dmc1 is re-
sponsible for catalyzing inter–homolog recombination during meiosis, while Rad51 promotes
Dmc1 presynaptic filament assembly and as participates in inter–sister repair that give rise
to noncrossover outcomes[141, 155, 380]. Although Rad51 and Dmc1 interact with different
subsets of accessory factors, there are few other biochemical differences between them that
might explain the evolutionary advantages of using different recombinases during mitosis and
meiosis [141, 380]. Biophysical studies have shown that Rad51–ssDNA filaments can bind to
dsDNA fragments containing short tracts of sequence microhomology, but the introduction
of a single nucleotide mismatch causes a reduction in binding lifetime commensurate with
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the loss of one base triplet pairing interaction [363, 381]. In contrast, Dmc1–ssDNA can
tolerate base triplets bearing single, double, or triple mismatches and even abasic sites with
no change in the binding lifetimes of the heteroduplex DNA intermediates [363, 381]. These
findings suggest that Dmc1 can stabilize heteroduplex DNA joints containing mismatched
base triplets, whereas Rad51 cannot [363, 381, 382]. We have hypothesized that the ability
of Dmc1 to stabilize imperfectly paired recombination intermediates might reflect an intrin-
sic difference in fidelity between the two eukaryotic recombinases [363, 381]. However, the
molecular basis for these biophysical differences, and their biological implications remained
unexplored.
Here, we use structural analysis and bioinformatics to identify Rad51 lineage–specific
amino acid residues and Dmc1 lineage–specific amino acid residues that might contribute to
their unique responses to mismatched base triplets. Based upon these analyses, we swapped
Rad51 lineage–specific amino acid residues present at the putative DNA–binding interfaces
with their lineage–specific counterparts from Dmc1, and vice versa. Single molecule bio-
physical analysis of these chimeric recombinases reveals that the differential responses of S.
cerevisiae and human Rad51 and Dmc1 to mismatches can be attributed to three lineage–
specific amino acid residues within DNA–binding loop L1. MAT switching analysis provides
genetic evidence that these L1 residues affect recombination between divergent sequences in
vivo. Remarkably, C. elegans RAD–51 L1 amino acid residues more closely resemble Dmc1.
Accordingly, wild–type C. elegans RAD–51 stabilizes mismatched substrates, as is observed
for yeast and human Dmc1, whereas mutation of C. elegans L1 residues to their “canoni-
cal” Rad51 counterparts abolishes mismatch stabilization. Together, our results show that
lineage–specific amino acid residues in the L1 DNA–binding domain are responsible for the
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differential response of Rad51 and Dmc1 to mismatched sequences and suggest that the
functions of these amino acid residues in regulating recombination fidelity may be broadly
conserved among eukaryotes.
5.3 Results
5.3.1 Identification of Rad51 and Dmc1 lineage-specific amino
acids
The Rad51 and Dmc1 lineages within the Rad51/RecA family of recombinases arose
early in the evolutionary history of eukaryotes [358, 380, 383, 384]. These proteins remain
closely related, for instance, S. cerevisiae Rad51 (ScRad51) and Dmc1 (ScDmc1) share 56%
sequence similarity and 45% sequence identity [141, 380]; for brevity, we use the nomenclature
Rad51 and Dmc1 as general designations, and we use ScRad51, ScDmc1, hRAD51 (human
RAD51) and hDMC1 (human DMC1) when referring to specific recombinases. Rad51 and
Dmc1 form similar filaments on ssDNA, and both promote DNA strand invasion [141, 380].
However, Dmc1 can stabilize imperfectly paired base triplets, whereas Rad51 cannot [363,
381]. We speculated that Dmc1–specific amino acid residues might be responsible for this
differential response to mismatches. Furthermore, we presumed that residues responsible for
this effect might fulfill three criteria: (i) they should be conserved within the Dmc1 lineage
of the recombinase family; (ii) they should be absent from the Rad51 lineage; and (iii) they
would likely be within one of the two known DNA binding motifs, DNA–binding loop 1
(L1) or DNA–binding loop 2 (L2), which are present in all recombinase family members
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[36, 384]. Given these criteria, we sought to determine whether Rad51 and Dmc1 harbor
lineage–specific residues within the L1 and L2 DNA–binding loops.
L1 and L2 were originally identified from examination of the crystal structure of E. coli
RecA [384]. Therefore, we utilized E. coli RecA as a model to verify the boundaries of the L1
and L2 motifs (Fig. 5.1A) [36]. E. coli RecA shares 26.5 and 25.6% sequence identity with
ScRad51 and ScDmc1, respectively, and the core domain of E. coli RecA co–aligns with the
core domain of ScRad51 with root mean square deviation of 1.5 Å [37]. We then mapped
these regions onto a primary structure alignment of Rad51 and Dmc1 from S. cerevisiae,
H. sapiens, P. carinii, O. sativa, M. musculus, E. histolytica, T. gondii, and S. scrofa (Fig.
5.2). From this initial comparison, we identified four amino acid residues within L1 and five
amino acid residues within L2 that are conserved within either the Rad51 lineage, or the
Dmc1 lineage, but are divergent between the two recombinases (Fig. 5.2A). For ScRad51,
these lineage–specific amino acid residues correspond to L1 residues T288, A298, M301, and
H302; and L2 residues V328V, Q330, V331, D332, and N348. The ScDmc1 lineage–specific
amino acids include L1 residues V224, E234, Q237, and K238; and L2 residues Q264, D266,
P267, G268, and H285. We validated this initial assignment by analysis of 600 Rad51 protein
sequences and 270 Dmc1 sequences (Fig. 5.2B,C and Table 5.1 and 5.2).
5.3.2 Biochemical characterization of Rad51 and Dmc1 chimeras
If Dmc1 lineage–specific residues present within L1, L2, or both are responsible for
mismatch tolerance, then mutation of these residues to those present in Rad51 might abolish
this property. Conversely, mutation of the Rad51 lineage–specific residues to their Dmc1
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Table 5.1: Rad51 and Dmc1 L1 amino acid conservation.
Table 5.2: Rad51 and Dmc1 L2 amino acid conservation.
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Figure 5.1: Structural align-
ments of L1 and L2
DNA binding loops for
Rad51/RecA family mem-
bers. (A) Crystal structure
of E. coli RecA (PDB: 1CMX)
highlighting the L1 and L2 DNA
binding loops. L1 and L2 are
shown in magenta, the remainder
of the protein is in dark gray,
the presynaptic DNA strand and
its complementary strand are
labeled, and the number desig-
nations highlight one of the base
triplets. Structure of E. coli RecA
aligned with (B) ScRad51 (PDB:
1SZP), (C) hRAD51 (PDB:
5HB1), and (D) hDMC1 (PDB:
4HYY). In (B-D), the RecA color
coding is as shown in panel (A),
the eukaryotic protein ribbon
diagrams are light gray, and the
eukaryotic L1 and L2 domains are
shown in cyan.
counterparts might enable Rad51 to stabilize mismatched recombination intermediates. To
test these hypotheses, we designed chimeric recombinases by swapping the entire L1 and L2
motifs (Table 5.3). For brevity, we assigned names to the mutants based on the identity of
the altered residues (e.g. ScDmc1–RL1 refers to S. cerevisiae Dmc1 harboring the ScRad51
L1; hRAD51–DL12 refers to human RAD51 with the amino acid residues from hDMC1
L1 and L2; etc.; Table 5.3). All mutants behaved like their wild–type (wt) counterparts
during expression and purification, with the exception of the hDMC1 chimeras, which were
significantly less soluble than the wt protein (not shown); therefore, we were unable to
analyze these hDMC1 mutants.
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Figure 5.2: Identification of Rad51 and Dmc1 L1 and L2 lineage-specific amino acids.
(A) Location and sequences of the L1 and L2 DNA-binding loops from RecA, Rad51, and Dmc1.
Amino acids conserved in all three lineages are highlighted in red, Rad51– lineage specific amino
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Figure 5.2: (cont.) acids are highlight in blue, and Dmc1-lineage specific amino acids are high-
lighted in green. Included in the alignments are recombinases from S. cerevisiae, Homo sapiens,
Pneumocystis carinii, Oryza sativa, Mus musculus, Entamoebe histolytica, Toxoplasma gondii, Sus
scrofa and Anguilla japonica. (B) Conservation and identity of L1 amino acids based upon analy-
sis of 600 Rad51 and 270 Dmc1 sequences. The analyzed positions correspond to ScRad51 amino
acids T288, A298, M301 and H302, and ScDmc1 amino acids V224, E234, Q237 and K238. Color-
coding indicates Rad51-like, Dmc1-like and other amino acids (see also Tables 5.1 and 5.2). (C)
Conservation and identity of L2 amino acids.
Table 5.3: Chimeric recombination design at L1 and L2.
Each chimeric protein was tested for ATP hydrolysis and DNA strand exchange activ-
ity (Figure 5.3A). Most of the chimeras retained DNA–dependent ATPase activity, albeit
typically at a lower level relative to the wt recombinases, and the single loop swaps exhibited
greater ATP hydrolysis activity than the double loop swaps (Figure 5.3A). DNA strand ex-
change assays revealed that the mutant proteins with a single chimeric loop swap exhibited
activity comparable to that of their wt counterparts (Figure 5.3B,C). However, chimeric
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recombinases in which both loops were swapped, were deficient in strand exchange activ-
ity, in particular, ScDmc1–RL12, was significantly compromised for both strand exchange
and ATP hydrolysis (Figure 5.3). Interestingly, ScDmc1–RL1 exhibited 3–fold more strand
exchange activity compared to wt Dmc1 (Figure 5.3B,C). These findings indicate that the
identity of the lineage–specific amino acid residues contribute to recombinase interactions
with DNA substrates, and also show that it is possible to swap the Rad51 and Dmc1 L1 or
L2 regions without abolishing basic protein activities in vitro.
5.3.3 Assembly of presynaptic filaments with chimeric
recombinases
The chimeric recombinases were tested for the ability to assemble into stable presy-
naptic complexes using ssDNA curtain assays (Fig. 5.4). As reported, the addition of wt
(unlabeled) Rad51 or Dmc1 results in ATP–dependent displacement of RPA–GFP from the
ssDNA, reflecting the assembly of the presynaptic complexes (Fig. 5.4)[385]. The RPA–GFP
reappears when ATP, or both ATP and Ca2+ in the case of ScDmc1 and hRAD51, is flushed
from the sample chamber, reflecting presynaptic complex disassembly (Fig. 5.4)[385]. Most
of the chimeras assembled into presynaptic filaments, which remained stable for ≥30 minutes
so long as ATP (and Ca2+ when appropriate) was maintained in the reaction buffer (Fig.
5.4 and Table 5.4). One exception was ScDmc1–RL12, which failed to assemble into stable
filaments (not shown) and was not characterized further.
163
Figure 5.3: Biochemical characterization of human and yeast recombinases. (A) ATP
hydrolysis assays, (B) D-loop formation assays, and (C) quantitation of D-loop formation for
each of the yeast and human chimeric recombinases. Lane designations in (B) correspond to the
quantitation in panel (C). Error bars in (A) and (C) represent the mean ± s.d. from three separate
experiments.
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Figure 5.4: Characterization of presynaptic complexes. These ssDNA curtain assays use
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Figure 5.4: (cont.) fluorescent GFP-tagged RPA (replication protein A) as a proxy for Rad51 or
Dmc1 binding. In brief, ssDNA was generated using M13mp18 (7,249-nt) as a template for rolling
circle replication, anchored to a lipid bilayer within a microfluidic chamber through a biotin-
streptavidin linkage, and aligned along chromium (Cr) barriers, as described. The ssDNA unravels
when incubated with RPA-GFP, and the downstream ends of the RPA-ssDNA are anchored to Cr
pedestals, and these nucleoproteins complexes can be visualized by total internal reflection fluo-
rescence microscopy (TIRFM). (A) Kymographs showing typical examples of presynaptic complex
assembly, stability and disassembly assays for the yeast and human chimeric recombinases. These
assays use GFP-RPA (green) as a read out for protein occupancy on the ssDNA. The ssDNA is
bound by GFP-RPA at the outset of the measurements, and filament assembly is initiated by
injection of the appropriate recombinase and ATP at the indicated time point (first dashed white
line). Filament assembly is revealed as the loss of GFP-RPA signal. Unbound recombinase is then
flushed from the sample chamber (second dashed white line) and the filaments are observed for
≥30 minutes to verify that they remain intact. Filament disassembly is then triggered by flush-
ing free ATP from the sample chamber (third dashed white line) while monitoring the rebinding
of GFP-RPA. (B-D) Filament assembly kinetics for each of the indictated recombinases. (E-G)
Filament disassembly kinetics for each indicated recombinase. Error bars in (B-G) represent mean
± s.d. Assembly and disassembly lifetimes are presented in Table 5.4.
5.3.4 Chimeric recombinases exhibit base triplet stepping
We have developed a ssDNA curtain assay for visualizing DNA strand exchange inter-
mediates at the single–molecule level [306, 363, 381]. In brief, a series of Atto565–labeled
dsDNA substrates (70–bp), harboring 8– to 15–nt tracts of microhomology targeted towards
unique sequences in the M13 ssDNA, are incubated with the presynaptic complexes, and
unbound dsDNA is flushed away (Fig. 5.5A,B). The resulting intermediates are visualized
by total internal reflection fluorescence microscopy (TIRFM), and dsDNA dissociation rates
are obtained from the survival probabilities of the bound dsDNA fragments [306, 363]. Us-
ing this assay, we have shown that RecA, Rad51 and Dmc1 stabilize paired heteroduplex
intermediates in 3–nt increments, each base triplet “step” coincides with an energetic sig-
nature (∆∆G‡) of ∼ 0.3kBT , corresponding to an ∼30% change in the dissociation rates
[306, 363, 381]. Importantly, presynaptic complexes prepared with the chimeric recombi-
nases could bind the Atto565–labeled dsDNA, the resulting dsDNA dissociation rates were
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Table 5.4: Presynaptic complex assembly and disassembly kinetics.
comparable to those measured for the wt proteins, and the dissociation rates also varied
in 3–nt increments (Fig. 5.5C-J, 5.6, and 5.7). We conclude that the chimeric Rad51 and
Dmc1 recombinases possess dsDNA–binding and base triplet stepping attributes similar to
those determined for their wt counterparts.
5.3.5 Dmc1 L1 lineage–specific amino acid residues regulate
mismatch stabilization
We next asked how the chimeric recombinases responded to DNA mismatches. Rad51,
RecA, and Dmc1 require perfect Watson–Crick pairing interactions to stabilize base triplets
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Figure 5.5: Chimeric recombinases undergo base triplet stepping. (A) Schematic of dsDNA
capture assay. (B) Illustration of dsDNA substrates used for testing base triplet stepping.
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Figure 5.5: (cont.) The 8-nt tract of microhomology highlighted in green is required for efficient
binding, and the nucleotides highlighted in blue represent incremental increases in the microhomol-
ogy length. (C) Survival probabilities and (D) dissociation rate data obtained from the survival
probability plots for wt ScRad51. (E) Survival probabilities and (F) dissociation rate data for
ScRad51-DL1. (G) Survival probabilities and (H) dissociation rate data for ScRad51-DL2. (I)
Survival probabilities and (J) dissociation rate data for ScRad51-DL12. For all dissociation rate
graphs, arrows indicate stepwise reductions in dissociation rates coincident with recognition of the
third base of each triplet, dashed lines report the mean rate for each step, and the free energy
changes (∆∆G‡) associated with each triplet step are indicated. Here and throughout, error bars
for survival probability plots represent 70% confidence intervals obtained through bootstrap anal-
ysis, error bars for the dissociation rate data represent mean ± s.d., the number of events used to
calculate these values are shown the survival probability panels.
located at the terminal positions of tracts of microhomology tracts embedded within the
dsDNA (Fig. 5.8Ai)[363, 381]. Rad51 and RecA also require perfect Watson–Crick base
pairing interactions to stabilize base triplets located at internal positions (Fig. 5.8Aii)[363,
381]. In contrast, Dmc1 can stabilize mismatches at internal positions (Fig. 5.8Aiii)[363,
381]. Indeed, Dmc1 can stabilize single, double and triple mismatches and even abasic sites,
so long as these imperfect triplets are flanked by homologous sequences [381].
Consistent with previous results, none of the recombinases was capable of stabilizing a
base triplet located at the terminal position of a 12–nt tract of microhomology (Fig. 5.8B),
and the resulting substrates exhibited dissociation rates similar to those measured for a
substrate with only 9–nts of microhomology (Fig. 5.8D–F). We next tested the chimeric
recombinases with mismatched triplets that were juxtaposed to a single perfectly paired
triplet with a 15–nt tract of microhomology (Fig. 5.8C). As previously shown, ScRad51
and hRAD51 could step over internal mismatches, but could not stabilize the internal mis-
matched triplet, instead yielding dissociation rates comparable to a substrate bearing only
12–nts of microhomology (Fig. 5.8H,I)[363, 381]. In contrast, ScDmc1 and hDMC1 yielded
dissociation rates comparable to the corresponding substrate bearing 15–nts of perfect mi-
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Figure 5.6: dsDNA binding characteristics of presynaptic complexes prepared with
ScDmc1 chimeric proteins. (A) Survival probabilities and (B) dissociation rate data for wt
ScDmc1. (C) Survival probabilities and (D) dissociation rate data for ScDmc1-RL1. (E) Survival
probabilities and (F) dissociation rate data for ScDmc1-RL2. As in the main text figures, error bars
for survival probability plots represent 70% confidence intervals calculated by bootstrap analysis,
error bars for the dissociation rate data represent mean ± s.d., the number of events used to
calculate these values are shown the survival probability panels.
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Figure 5.7: dsDNA binding characteristics of presynaptic complexes prepared with
hRAD51 chimeric proteins. (A) Survival probabilities and (B) dissociation rate data for wt
hRAD51. (C) Survival probabilities and (D) dissociation rate data for hRAD51-RL1. (E) Survival
probabilities and (F) dissociation rate data for hRAD51-RL2. (G) Survival probabilities and (H)
dissociation rate data for hRAD51-RL12.
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Figure 5.8: The Dmc1 L1 DNA-binding loops allows for mismatch stabilization. (A)
Schematic illustration of a dsDNA substrate (shown in blue; non-complementary strand is omitted
for clarity) bound to a presynaptic ssDNA (in red). A single mismatch is highlighted and is
positioned either in the (i) terminal base triplet, (ii) an internal base triplet that is not stabilized
(as with Rad51), or (iii) an internal triplet that is stabilized (as with Dmc1). The binding steps
relative to triplet length are highlighted, where step 1 corresponds to the initial binding interaction,
whereas steps 2 and 3 reflect the changes in dissociation rates that occur for each 3-nt increase
in length. (B) Schematic of dsDNA substrates with mismatches positioned within the terminal
base triplet. The location of the mismatches are highlighted as an underlined, magenta X. (C)
Schematic of dsDNA substrates with mismatches positioned within the internal triplet. Assays with
terminal mismatch substrates for wild type and chimeric versions of (D) ScRad51, (E) hRAD51,
and ScDmc1. Assays with internal mismatch substrates for wild type and chimeric versions of
(D) ScRad51, (E) hRAD51, and ScDmc1. In (D-J), the location and identity of the mismatched
nucleotide is highlighted in red and underlined, and the error bars represent mean ± s.d.
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crohomology (Figure 3J)[363]. Remarkably, ScRad51–DL1, ScRad51–DL12, hRAD51–DL1,
and hRAD51–DL12 could stabilize the mismatched substrates similar to wt Dmc1 (Fig.
5.8H,I). In contrast, ScRad51–DL2 and hRAD51–DL2 were unable to stabilize internal mis-
matches, and instead exhibited behaviors more comparable to wt Rad51 (Fig. 5.8H,I).
Moreover, ScDmc1–RL1 was unable to stabilize the mismatched substrates, and instead
exhibited behavior similar to ScRad51 (Fig. 5.8J). Finally, ScRad51–DL2, ScDmc1–DL2,
and hRAD51–DL2 all exhibited responses to the mismatched triplets comparable to their
wt counterparts (e.g. ScRad51 and ScRad51–DL2 behaved similarly, ScDmc1 and ScDmc1–
RL2 behaved similarly, as did hRAD51 and hRAD51–DL2; Fig. 5.8H–J). These findings
demonstrate that Rad51 chimeras harboring L1 amino acid residues from Dmc1 attain the
ability to stabilize mismatched base triplets, whereas Dmc1 chimeras harboring L1 residues
from Rad51 lose the ability to stabilize mismatched triplets.
5.3.6 C. elegans RAD–51 behaves like “canonical” Dmc1
Some eukaryotes, such as Caenorhabditis sp., have lost the DMC1 gene, although the
reasons for this loss remain uncertain [380]. Inspection of RAD–51 from Caenorhabditis sp.
revealed that the lineage–specific residues present in L1 were not the same as “canonical”
Rad51 (we use the term “canonical” to identify Rad51 from species that have both recom-
binases), but instead more closely resembled Dmc1 (Fig. 5.9A). If our hypothesis regarding
the role of L1 in mismatch stabilization is correct, then C. elegans RAD–51 (CeRAD–51)
may stabilize mismatches. Whereas, a RAD–51 mutant, in which the “Dmc1–like” amino
acids were converted to the Rad51 lineage–specific residues, might lose the ability to stabilize
173
Figure 5.9: C. elegans Rad51 has Dmc1-like amino acids and dsDNA-binding properties.
(A) Comparison of Caenorhabditis sp. Rad51 sequences (C. elegans, C. remanei and C. brenneri)
with Rad51 and Dmc1 sequences from organisms with both recombinases. Color coding is the same
as shown in Figure 5.2A. Base triplet stepping data for (B) wt CeRad51 and (C) the CeRad51
triple mutant. (D) Terminal mismatch triplet assays for CeRad51 and CeRad51-TM. Data for wt
ScRad51 and ScDmc1 are shown for comparison and are reproduced from Figures 5.8D and F.
(E) Internal mismatch triplet assays for CeRad51 and CeRad51-TM. Data for wt ScRad51 and
ScDmc1 are shown for comparison and are reproduced from Figures 5.8H and J.
mismatches.
To test this hypothesis, we made a CeRAD–51 N251T, E261A, K265H triple mu-
tant protein, which we refer to as CeRAD–51–TM, for brevity. Both CeRAD–51 [386] and
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CeRAD–51–TM form presynaptic complexes in the ssDNA curtains with similar assem-
bly and disassembly kinetics (Fig. 5.10C,D and Table 5.2). Assays with Atto565–dsDNA
fragments confirmed that both CeRAD–51 proteins exhibited base triplet stepping (Figure
5.9B,C and 5.10E,F), and as with the other recombinases, wt and triple mutant RAD–51
were unable to stabilize mismatches present at the end of an embedded tract of microho-
mology (Fig. 5.9D). However, in contrast to ScRad51 and hRAD51, wt CeRAD–51 could
stabilize mismatches located at an internal position within the embedded tract of micro-
homology (Fig. 5.9E). This finding demonstrates that CeRAD–51 does not behave like
“canonical” Rad51 when presented with a mismatched substrate, rather it responds sim-
ilarly to Dmc1. However, the ability to stabilize mismatched base triplets was abolished
for the CeRAD–51–TM (Fig. 5.9E). Remarkably, CeRAD–51 could also promote D–loop
formation with mismatched substrates (32% sequence divergence), albeit at low efficiency,
whereas CeRAD–51–TM lacks this activity (Fig. 5.10G,H). Together, these findings pro-
vide additional support for the premise that lineage–specific L1 residues in Dmc1 confer the
ability to stabilize mismatched base triplets during DNA strand exchange.
5.3.7 Three Dmc1 L1 amino acid residues contribute to DNA
mismatch stabilization
ScRad51–DL1 has a total of six amino acid residues from ScDmc1 (Tables 5.1, 5.2, and
5.3), and we sought to determine whether a smaller subset of these residues could confer the
ability to stabilize mismatches. We focused on the ScRad51 chimeric point mutants T288V,
A298E, M301Q, and H302K because these residues were most conserved across the Rad51
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Figure 5.10: Biochemical and single molecule analysis of CeRad51 proteins. (A) ssDNA
and dsDNA binding assays an quantitation for wt CeRad51 and CeRad51-TM; error bars represent
s.d. from three separate measurements. (B) D-loop formation assays and quantitation for wt
CeRad51 and CeRad51-TM; error bars represent s.d. from three separate measurements. (C)
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Figure 5.10: (cont.) Assembly and (D) disassembly kinetics for CeRad51 and CeRad51-TM fila-
ments obtained from ssDNA curtain assays; error bars represent s.d. cacluated from the indicated
number of single ssDNA molecules. Corresponding rate data are presented in Table 5.3. Survival
probability plots from base triplet stepping assays for (E) wt CeRad51 and (F) CeRad51-TM. (G)
D-loop formation assay and (H) corresponding quantitation for a 90-nt D-loop substrate harboring
29 mutations, corresponding to 32% sequence divergence with the dsDNA plasmid substrate. Error
bars in (H) represent s.d. from three separate measurements.
or Dmc1 lineages (Fig. 5.2A). The resulting mutants displayed filament assembly and dis-
assembly kinetics that closely resembled the wt protein (Table 5.4). Each mutant exhibited
dissociation rates for the Atto565–dsDNA fragments harboring the 9–nt, 12–nt, and 15–nt
tracts of microhomology, which were essentially indistinguishable from wt ScRad51 (not
shown). As with all recombinases, the point mutants were unable to stabilize mismatches
present at the terminal position of an embedded tract of microhomology (Fig. 5.11A–C).
ScRad51 T288V behaved like wt ScRad51 as it was able to step–over the internal mismatches
but did not stabilize the mismatch (Fig. 5.11B,D). However, ScRad51 M301Q stabilized mis-
matches, regardless of the relative position of the mismatch within the base triplet, exhibiting
behavior comparable to wt ScDmc1 (Fig. 5.11D). Interestingly, both ScRad51 A298E and
ScRad51 H302K mutants were able to stabilize an internal mismatch located at the edge of
a base triplet (nt position 12 in Fig. 5.11B), but neither mutant could stabilize an internal
mismatch located at the center of the triplet (nt position 11 in Fig. 5.11B; Fig. 5.11D);
these properties were confirmed using an alternative set of dsDNA substrates targeted to
a different region of the presynaptic ssDNA (not shown)[363]. However, a ScRad51 A298
H302K double mutant (Table 5.4) could stabilize internal mismatched base triplets regard-
less of whether the mismatch was located at the center or edge of the triplet (Fig. 5.11F).
These results suggest that ScRad51 L1 amino acids E298, Q301, H302, when mutated to the
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corresponding Dmc1 L1 residues, can all contribute to mismatch stabilization.
5.3.8 Genetic characteristics of ScRad51 chimeras
A major challenge in understanding why eukaryotes have two recombinases is that
Rad51 and Dmc1 cannot simply be replaced for one another because of the many mitotic–
and meiotic–specific cofactors necessary for each of their in vivo functions, respectively [141,
380]. However, the chimeric proteins described here offer the opportunity to examine po-
tential benefits of the dual recombinase system within the context of mutants that have
a well–defined biochemical characteristic, namely, the ability or inability to stabilize mis-
matched recombination intermediates.
For genetic testing of the chimeric ScRad51 proteins, we constructed S. cerevisiae
strains wherein the chromosomal RAD51 gene was replaced with rad51 mutants containing
Dmc1 lineage–specific amino acids. Western blot analysis confirmed that all proteins were
expressed at similar levels (not shown). In addition, wt ScRad51, ScRad51–DL1, ScRad51
A298E and ScRad51 M301Q all supported YFP–Rad54 DNA repair focus formation upon
exposure to ionizing radiation (Fig. 5.12A,B). Since the assembly of DNA repair–specific
Rad54 foci is known to be dependent upon Rad51–ssDNA filaments [103], these results pro-
vide evidence that the mutant Rad51 proteins could form presynaptic filaments in vivo. In
contrast, ScRad51 H302K and the ScRad51 A298E H302K double mutant were unable to
support YFP–Rad54 focus formation, suggesting that these mutants were defective in presy-
naptic filament assembly in cells (Fig. 5.12B). We next asked whether ScRad51 chimeras
could support cell growth on media containing the DNA–damaging agents methyl methane-
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Figure 5.11: Identification of Dmc1 lineage-specific amino acids involved in stabilizing
mismatches. Schematic illustrations of dsDNA sequences used to analyze the effects of (A)
terminal and (B) internal mismatched triplets. (C)Terminal mismatch assays for the ScRad51
point mutants (V288T, A298E, M301Q and H302K). (D) Internal mismatch assays for the ScRad51
point mutants. (E) Terminal mismatch assays and (F) internal mismatch assays for the ScRad51
double mutant A298E H302K. In (C-D), data for wt ScRad51 and ScDmc1 are reproduced from
Figures 5.8D and F, and in (E-F) Data for wt ScRad51 and ScDmc1 are shown for comparison and
are reproduced from Figures 5.8H and J, for comparison.
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sulfonate (MMS) or zeocin (Fig. 5.12C). Importantly, strains expressing either ScRad51
A298E or ScRad51 M301Q exhibited near wild–type levels of cell growth in the presence
of MMS or zeocin (Fig. 5.12B), demonstrating that these point mutants retain function
in vivo. As expected, ScRad51 H302K and ScRad51 A298E H302K were compromised for
growth on plates with MMS or zeocin (Fig. 5.12C). Interestingly, ScRad51–DL1 was also
compromised for growth on MMS or zeocin plates, even though this chimera was functional
in vitro and supported Rad54 focus formation (Fig. 5.12B). We speculate that swapping the
entire Rad51 L1 motif may hinder some downstream step in the HR pathway.
5.3.9 Lineage–specific amino acid residues contribute to
recombination fidelity
We used a modified version of the mating¬ type (MAT) switching assay to determine
whether lineage–specific L1 residues might contribute to recombination fidelity. In this as-
say, the mating type locus (MAT) is cleaved by the HO endonuclease, and Rad51–mediated
recombination takes place between the cleaved mating type locus and either the HMRa or
HMLα donor locus [291]. Strand invasion initiates from the Z box within the MAT locus,
which is homologous to sequences in the donor loci (Fig. 5.13A)[291]. The cleaved interme-
diates can be repaired by HR or non–homologous end–joining (NHEJ), and the identity of
the resulting products can be defined by Southern Blot analysis (Fig.5.13A,B). To examine
the effects of mismatches on recombination, we introduced point mutations at every 8th,
7th, 6th, 5th or 4th position within the Z box, corresponding to 12.5, 14.2, 16.7, 20 or 25%
sequence divergence between donor and acceptor loci, respectively (Fig. 5.13A and Table
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Figure 5.12: In vivo characterization of chimeric S. cerevisiae Rad51 mutants. (A)
Rad54–YFP focus formation assays; white arrowheads highlight examples of Rad54–YFP; and (B)
focus quantitation, (C) MMS and zeocin resistance assays, and MAT switching assays for (D)
ScRad51–DL1, (E) ScRad51 A298E, (F) ScRad51 H302K and (G) the ScRad51 A298E H302K
double mutant (abbreviated as DM), as indicated. Each bar in panels D–G represents the mean ±
s.d. from n independent experiments, as indicated.
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5.5).
For the strain expressing wt ScRad51, MAT switching was remarkably tolerant of
mismatches (Fig. 5.13C). For instance, with the wt templates (0% divergence) 75.1 ± 1.33%
of the repair products could be attributed to HR–mediated repair, while 66.1 ± 4.75% of
the repair products could be attributed to HR for templates with 16.7% sequence divergence
(Fig. 5.13C). However, HR efficiency drops markedly for templates with mismatches at every
5th (20% divergence) and 4th position (25% divergence), yielding values of 35.0 ± 4.75%
and 5.52 ± 1.46%, respectively (Fig. 5.13C). These observations are in good agreement with
previous reports indicating that wt ScRad51 supports efficient break–induced replication
(BIR) for templates with similar levels of sequence divergence [378].
Consistent with the MMS and zeocin resistance assays, ScRad51–DL1, ScRad51
H302K, and the ScRad51 A298E H302K double mutant were all compromised for MAT
switching even at 0% divergence, and these defects were exacerbated at higher levels of
sequence divergence (Fig. 5.12D,F,G). In contrast, the ScRad51 M301Q point mutant sup-
ported levels of HR–mediated repair comparable to wt ScRad51 for the substrates with up
to 16.7% divergence. Remarkably, at 20% sequence divergence, representing the midpoint of
the curve for wt ScRad51 (Fig. 5.13B), there was a 26.7 ± 5.00% (Student t–test, p<0.001)
increase in HR–mediated repair by ScRad51 M301Q relative to wt ScRad51, and there was
a 22.2 ± 10.2% (Student t–test, p<0.05) increase in HR for the template with 25% sequence
divergence (Fig. 5.13B,C). These findings, together with our biophysical data, demonstrate
that ScRad51 M301Q, which can stabilize mismatched HR intermediates in vitro, also sup-
ports a higher recombination frequency for mismatched substrates in vivo. Interestingly,
although ScRad51 A298E was functional for MAT switching, this mutant showed no dif-
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ferences in HR efficiency compared to wt ScRad51 for templates with increasing sequence
divergence (Fig. 5.12E). Given this outcome, it is notable that ScRad51 A298E could only
stabilize mismatches located at the edge of a base triplet (Fig. 5.11B,D), and the divergent
Z box sequences will always have mismatches at both the center and edge positions of the
mismatched base triplets (irrespective of the frame of reference) (Table 5.5). The inability of
ScRad51 A298E to stabilize mismatches located in the center of a base triplet could explain
why this particular mutant does not behave like ScRad51 M301Q in the MAT switching
assays.
5.4 Discussion
We have defined the structural elements that are responsible for the differential re-
sponse of Rad51 and Dmc1 to mismatched base triplets. We propose that these structural
and functional differences represent a fundamental distinction between the Rad51 and Dmc1
lineages of the Rad51/RecA family of DNA recombinases. Here, we discuss possible impli-
cations of these findings with respect to recombinase structures, recombination fidelity and
mechanisms, and the evolution of Rad51/RecA family members.
5.4.1 Lineage–specific amino acid residues help determine
recombinase behaviors
L1 and L2 DNA–binding loops of the Rad51/RecA family of DNA recombinases con-
tain amino acids that are specifically conserved within either the Rad51 lineage, or the Dmc1
lineage, but not both. Our data demonstrate that three amino acid residues within the L1
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Figure 5.13: L1 amino acid identity influences recombination between divergent DNA
sequences. (A) Schematic illustration of the MAT switching assay highlighting the products that
arise from NHEJ and HR. (B) Example of a southern blot analysis of StyI–digested DNA after
galactose induction of HO endonuclease. (C) Bar graph showing the fraction of repair products
attributed to HR for strains expressing either wt Rad51 or Rad51 M301Q for templates with
varying levels of sequence divergence. Each bar represents the mean ± s.d. from n independent
experiments, as indicated. The statistical significance for the observed differences between wt and
mutant for the 20 and 25% sequence divergence data sets are indicted (p values from an unpaired
two–tailed Student’s t test are indicated). (D) Bar graph illustration the percent difference for
HR–mediated MAT switching between Rad51 M301Q and wt Rad51. Each bar represents the
mean ± s.e.m. calculated from data in panel C.
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Table 5.5: MAT switching Z box templates.
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DNA–binding loop regulate the response of Rad51 and Dmc1 to mismatched base triplets.
Mutations that swap the identity of these residues alter the response of the respective re-
combinase to match that of its paralog, and this behavior appears to be conserved between
recombinases from both S. cerevisiae and humans. We speculate that within the Rad51
lineage, these residues may help enhance recombination fidelity, whereas identity of these
residues within the Dmc1 lineage may contribute meiosis, perhaps by allowing for more
favorable recombination between polymorphic parental alleles. Indeed, a single point mu-
tation in Rad51 (M301Q) is sufficient to recapitulate Dmc1–like mismatch stabilization in
vitro and also enhances recombination between divergent sequence in vivo. However, we also
note that the precise spatial geometry of the L1 DNA–binding loop is likely to be influenced
by its native context, in particular its connectivity to rest of the recombinase core domain.
Thus, it is possible, that the mismatch tolerance observed for Rad51 M301Q may not exactly
match that of Dmc1. Indeed, Dmc1 itself may prove to be even more mismatch–tolerant in
vivo than the Rad51 chimeras harboring Dmc1 residues. Although the natural prevalence of
sequence polymorphisms between parental alleles would not approach the high levels of se-
quence divergence in our MAT switching assays, we anticipate that more subtle differences in
recombination efficiency involving templates with lower divergence may be important when
considered over long evolutionary time scales. Moreover, MAT switching is a highly efficient
HR–dependent process that is greatly facilitated by local chromosomal architecture [291],
which may make MAT switching inherently more tolerant to mismatches. It is possible that
less efficient HR–mediated repair events could exhibit even more pronounced effects at lower
levels of sequence divergence.
Interestingly, ScRad51–DL2 retains basic biochemical functions (Fig. 5.3, 5.4, 5.5, and
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5.8 and Table 5.4), but does not support Rad54 focus formation or allow for growth on MMS
or zeocin plates (not shown). The disparity between the in vivo and in vitro activities of this
chimera suggest that lineage–specific amino acids in L2 may be important for assembly of
the native presynaptic complex. Finally, in addition to the L1 and L2 amino acids described
in this study, we have also identified ∼19 lineage–specific amino acid residues present in
other regions of recombinases (not shown). We anticipate that some of these residues may
mediate Rad51– and Dmc1–specific protein–protein contacts. Exploring the roles of these
lineage–specific amino acids may yield further insights into the differential properties of the
two eukaryotic recombinases.
5.4.2 Recombination between divergent sequences
Rad51/RecA family recombinases require at least consecutive 8 nucleotides of micro-
homology for efficient recognition of short dsDNA substrates in vitro [306, 330, 375, 387].
However, the efficiency of BIR [378] and MAT switching (this study) indicate that the in vivo
requirements for donor DNA recognition and strand invasion are significantly less stringent.
Two factors may account for these differences. First, in vivo recombination requires many
other proteins, a number of which may influence the activities of Rad51 [356, 379]. Second,
long substrates likely allow for multiple, simultaneous interactions, the cumulative effects of
which may circumvent the kinetic benefits observed in vitro for shorter substrates bearing a
single contiguous tract of homology. For example, the Z box with mismatches at every 8th
position has 40 adjacent 7–nt tracts of microhomology separated from one another by single
mismatches, and the Z box with mismatches at every 6th position has 52 adjacent 5–nt tracts
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of microhomology (Table 5.5). At present, the length and complex sequence composition of
these substrates preclude detailed biophysical analysis in ssDNA curtain assays, nor can we
recapitulate the protein composition of a native presynaptic complex in vitro. Future work
will be necessary to understand how these parameters influence the efficiency and kinetics
of HR reaction mechanisms.
Our data reveal that the chimeric ScRad51 M301Q mutant, which stabilizes mis-
matches in biophysical assays, can also support more efficient HR–mediated repair during
MAT switching for a Z box bearing ≥20% sequence divergence. It is interesting to note
that for wt ScRad51, we observe the largest decline in HR efficiency only for templates with
≥20% divergence (Fig. 5.13C). Inspection of these DNA sequences reveals an interesting
feature that coincides with this dramatic change in HR efficiency. Namely, for templates
ranging up to 16.7% sequence divergence, the mismatched base triplets are never adjacent
to one another, but this is not true for the templates with ≥20% sequence divergence, which
instead are comprised of repeating patterns where there are always two or three mismatched
triplets adjacent to one another (Table 5.5). One possible explanation for marked decline in
HR efficiency at ≥20% sequence divergence is that Rad51 may have particular difficulties
in promoting recombination when two or more adjacent base triplets contain mismatches,
whereas Dmc1, or ScRad51 harboring Dmc1 L1 amino acids, may be more tolerant of these
substrates.
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5.4.3 Potential mechanisms of DNA mismatch stabilization
Three lineage–specific residues clustered together within L1 DNA–binding loop con-
tribute mismatch stabilization by Dmc1. We proposed that these amino acids may allow
Dmc1 to make compensatory DNA contacts that are independent of Watson–Crick pairing
interactions (Fig. 5.14A). Consistent with this hypothesis, molecular dynamics (MD) simu-
lations of wt hRAD51 and an hRAD51 chimeric mutant bearing three hDMC1 residues in the
L1 domain, corresponding to the mutations A241E, M244K and H245K (numbering based
on hRAD51; Fig. 5.2A) reveal that the introduction of these Dmc1–specific residues results
in more intimate contacts between L1 and the phosphate backbone of the complementary
strand of the postsynaptic complex (Fig. 5.14B,C). The notion that Dmc1 residues contact
the phosphate backbone of the nascent DNA joint is also consistent with the observation
that Dmc1 can stabilize base triplets bearing abasic sites [381]. At present, these simula-
tions must be interpreted with caution, given that they are based upon structural data that
lacks sufficient information to fully describe the relevant protein–nucleic acid interfaces. In
the case of hDMC1, the crystal structures lack DNA [189]. For hRAD51, existing cryo–EM
structures lack sufficient resolution to accurately define the L1 protein–DNA interface [39,
388]. Similarly, although there is a crystal structure of ScRad51 bound to DNA, the L1
and L2 contacts are not visible [37]. Finally, there is as yet no structural information re-
garding how recombinases interact with a DNA joint that harbors mismatches, nor do our
simulations take into account the potential influence of mismatches on recombinase–DNA
interactions. Regardless, the MD simulations, together the observation that Dmc1 can sta-
bilize abasic sites [381], are consistent with the general notion that the lineage–specific amino
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acid residues responsible for the differential responses of Rad51 and Dmc1 to mismatches
are positioned to interact with the phosphate backbone of the complementary DNA strand
within the nascent DNA joint.
5.4.4 What is the mechanistic impact of mismatches on
recombination?
We can envision at least two general mechanisms by which DNA mismatches could
affect recombination: by altering the intrinsic stability of the heteroduplex DNA intermedi-
ates; or by making these intermediates more susceptible to disruption by regulatory enzymes.
Importantly, although a single mismatch impacts the binding lifetimes of dsDNA fragments
in our biophysical assays, on the whole, these are all still relatively long–lived intermediates
(e.g. for ScRad51, a 70–bp dsDNA fragment with 12–nt of microhomolgy has a lifetime of
∼33 minutes, increasing the microhomology length to 15–nts yields a lifetime of ∼47 min-
utes, and introduction of a single mismatch within the 15–nt tract of microhomology reduces
the lifetime to ∼35 minutes). This conclusion is also consistent with studies demonstrating
that bacterial RecA is surprisingly tolerant of mismatches in vitro [375]. We cannot yet
predict how our in vitro observations will scale for the longer in vivo substrates, nor can we
measure the equivalent biophysical parameters in vitro with longer substrates. Nevertheless,
the available biophysical data imply that mismatched HR intermediates are not intrinsically
unstable. Thus, we favor the hypothesis that mismatches may render HR intermediates more
susceptible to disruption by regulatory enzymes. Several proteins are known to dissociate
HR intermediates, including the S. cerevisiae helicases Srs2 and Sgs1 (BLM in humans), and
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Figure 5.14: Potential mechanism of mismatch stabilization and L1 conservation among
different Rad51/RecA family members. (A) Model for differences between Rad51 and Dmc1
interactions involving imperfectly paired HR intermediates. (B) Snapshots taken from MD
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Figure 5.14: (cont.) simulations of hRAD51 and (C) hRAD51 harboring three Dmc1 lineage–
specific amino acids substitutions (A240E M243Q H244K), suggesting that the Dmc1 amino acids
are better positioned to contact the incoming complementary DNA strand. Insets highlight po-
tential protein contacts (red dashed lines) with the ribose ring of the phosphate backbone. (D)
Comparison of L1 and L2 sequences from: E. coli RecA; “canonical” Rad51 and Dmc1, from
organisms harboring both recombinases; Rad51 from four Drosophilia sp. (D. melanogaster, D.
virilis, D. mojavenis and D. simulans); Rad51 sequences designated as “other” from U. maydis,
S. macrospora, and N. crassa; and RadA from H. volcanii, Pyrococcus furiousus, Methanococcus
maripaludis, Methanococcus voltae, and sulfolobus solfataricus. Asterisks denote the amino acids
that contribute to mismatch stabilization for Dmc1.
the post–replicative mismatch repair (MMR) machinery also plays a role in minimizing HR
between divergent sequences [389–393]. One possibility is that these enzymes may recog-
nize some distinct mismatch–dependent structural feature that enables them to more readily
disrupt Rad51–bound intermediates, whereas Dmc1 may shield mismatched intermediates
from these enzymes (Fig. 5.14A).
5.4.5 C. elegans RAD–51 and other “non–canonical”
recombinases
Not all eukaryotes follow the typical two recombinases paradigm. Ecdysozoans, such
as Caenorhabditis sp. and Drosophila sp., possess RAD51 but have lost DMC1 as well
as genes encoding core meiotic proteins necessary for Dmc1 activity (e.g. Hop2/Mnd1)
[355, 358, 383, 394, 395]. It remains unknown why these organisms have lost DMC1, and
the evolutionary implications of this loss remain unexplored. However, Caenorhabditis sp.
and Drosophila sp., have among the highest rates of evolution for the RAD51 genes [358].
Interestingly, the lineage–specific amino acid residues within the L1 DNA–binding loop of
RAD–51 from Caenorhabditis sp. have adapted to more closely match Dmc1, and our
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findings show that CeRAD–51 can stabilize mismatched base triplets in vitro. Thus, the loss
of DMC1 may have caused, or allowed for, adaptation of CeRAD–51 L1 to become more
“Dmc1–like”. Our findings suggest that CeRAD–51 may have inherently lower fidelity than
“canonical” Rad51 proteins from other organisms. Consistent with this idea, recent studies
have shown that recombination can occur in C. elegans meiosis between sequences with very
limited sequence homology [396]. Interestingly, Drosophila sp. Rad51 L1 amino acids closely
match those found in canonical Rad51 (Fig. 5.14C). However, N301 (numbering based on S.
cerevisiae Rad51 for comparison) in Drosophila Rad51 does not match the methionine found
in canonical Rad51 but is instead more similar to the glutamine from Dmc1 (Fig. 5.14C).
Thus, Drosophila Rad51 may also behave like Dmc1 with respect to mismatches.
Among organisms that have Dmc1, chromosome pairing is initiated through
recombination–dependent mechanisms [141, 355, 380]. In contrast, both C. elegans and
D. melanogaster have evolved alternative, recombination–independent mechanisms for ini-
tiating chromosome pairing during meiosis [395, 397]. However, use of alternative pairing
mechanisms is not necessarily the defining attribute of organisms lacking Dmc1. For in-
stance, Ustilago maydis, Sodaria macrospora and Neurospora crassa have all lost the DMC1
gene, but require recombination to initiate chromosome pairing during meiosis [398]. Inter-
estingly, U. maydis, S. macrospora and N. crassa all possess canonical Rad51 lineage–specific
amino acids in the L1 DNA–binding loop (Fig. 5.14C). Finally, it should be noted that the
L1 (and L2) amino acids from bacterial RecA are highly divergent from the eukaryotic re-
combinases (Fig. 5.2A and 5.14C). Therefore, the mechanisms by which RecA interacts
with the DNA intermediates may differ from those that define the action of the eukaryotic
recombinases.
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5.4.6 Potential origins of the dual–recombinase paradigm
Rad51 and Dmc1 arose early in eukaryotic evolution from a gene duplication event
involving an ancestral Archaeal RadA recombinase, and this gene duplication event may
have coincided with or allowed for the emergence of meiosis and sexual reproduction [358,
383, 394]. Some extant Archaea, such as Haloferax volcanii, undergo a conjugation process
involving the exchange of highly divergent genetic information via HR, and this conjugation
processes bears some resemblance to the eukaryotic meiotic program [399–404]. Intrigu-
ingly, RadA L1 DNA–binding loop amino acid residues located at the positions involved in
mismatch stabilization are identical to those found in the Dmc1 lineage of the Rad51/RecA
family (Fig. 5.14E). One speculative possibility is that a “lower–fidelity” recombinase (i.e.
more “Dmc1–like”) may have predated the “higher–fidelity” Rad51 present in modern eu-
karyotic lineages, and the emergence of Rad51 may have allowed eukaryotes to take better
advantage of HR as a high–fidelity DNA repair pathway.
5.5 Experimental Procedures
5.5.1 Sequence and crystal structure alignments
Crystal structures of E. coli RecA (1CMX) [36], ScRad51 (1SZP) [37], hDMC1 [189]
and hRAD51 (5HB1)[39] were obtained from the RCSB PDB and aligned in MacPyMOL
[405]. All protein sequences were obtained from the NCBI database and sequence alignments
were performed using NIH COBALT [406]. Most of the sequenced RAD51 and DMC1 genes
have not been experimentally validated, therefore to help ensure the alignments reflected
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information from bonafide Rad51 and Dmc1 proteins, we restricted our analysis to proteins
that were ￿200 amino acids in length and also contained the highly conserved L1 motif
GRGEL (or GRGDL; corresponding to amino acids 294-298 in ScRad51). Sequences that
did not fulfill these two criteria were excluded from the analysis. Aligned sequences were
further analyzed for common features and annotated using ESPript 3.0 [407].
5.5.2 Single molecule dsDNA binding assays
All single molecule dsDNA binding experiments were performed as previously described
[306, 363, 381]. In brief, presynaptic filaments were assembled, as described above, by in-
jecting 2 µM of the indicated recombinase in the presence of 2 mM ATP, followed by a
20-minute incubation at 30˚C. Free protein was then flushed from the sample chamber,
followed by an injection of HR buffer (as indicated above for each recombinase) containing
10 nM to 10 µM dsDNA oligonucleotide substrate (as indicated), and the reactions were
incubated for an additional 10 minutes. Unbound dsDNA was then quickly flushed from
the sample chamber using a 30 second wash at 1 ml/min, flow was then reduced to 0.2
ml/min and images (90 millisecond integration) were collected at 30- to 160-second inter-
vals for 1 to 2 hours, as previously described [306, 380, 381]. The data collection intervals
were optimized relative to the overall lifetime of each dsDNA substrate and the laser was
shuttered between acquired images to minimize photo-bleaching. Kymographs were then
generated from the resulting movies using Fiji. Survival probabilities were determined from
analysis of the resulting kymographs by measuring the time (dwell time) that each molecule
of Atto565–DNA remained bound to the presynaptic complexes after flushing the unbound
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DNA from the sample chamber. Error bars for the survival probability measurements and
binding distributions represent 70% confidence intervals obtained through bootstrap anal-
ysis, providing a close approximation of expectations for one standard deviation from the
mean [306, 363]. All reported ∆∆G‡ values were calculated from the dissociation rate data
for the Atto565–dsDNA substrates, as described [306, 363].
5.5.3 ScRad51, ScDmc1, hRAD51 and hDMC1 purification and
characterization
All recombinant yeast and human Rad51 proteins were expressed in E. coli and pu-
rified as previously described [342, 408, 409]. For ATPase assays, hRAD51 was assayed as
previously described [410] with some minor modifications. Reactions (10 µl) were performed
with 4 µM hRAD51 incubated with 50 µM ATP supplemented with 0.05 µCi/µl [γ-32P]-
ATP in buffer containing 35 mM Tris-HCl [pH 7.5], 1 mM DTT, 1 mM MgCl2, 100 ng/µl
BSA, 100 mM KCl, and ϕX174 viral DNA [45 µM nucleotides] at 37˚C. Aliquots (2 µl)
were removed at the indicated time points, and terminated by the addition of 2 µl 500 mM
EDTA. Reaction products were spotted onto TLC cellulose PEI plates (Select Scientific) and
developed with 0.5 M LiCl and 0.5 M formic acid. ScRad51 and ScDmc1 were assayed for
ATP hydrolysis as described [342] with minor modifications. Reactions (10 µl) contained 3
µM recombinase and were performed in buffer containing 125 µM ATP supplemented with
0.05 µCi/µl [γ-32P]-ATP in 35 mM Tris-HCl [pH 7.5], 1 mM DTT, 1.5 mM MgCl2, 100
ng/µl BSA, 100 mM KCl, and ϕX174 viral DNA [45 µM nucleotides] at 37˚C. Reactions
were terminated using 500 mM EDTA and products were resolved by TLC chromatography,
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as above. Strand exchange assays with hRAD51 assays were performed as described [411].
Reactions contained 10 nM 150-mer ssDNA, 10 nM [α-32P]-labeled 40- bp dsDNA, and
either 0.43, 0.86, or 1.3 µM hRAD51, as indicated. ScRad51 and ScDmc1 strand exchange
assays were also performed as previously described [342]. Reactions contained 40nM 150-mer
ssDNA, 40-nM [γ-32P]-labeled 40-bp dsDNA; and either 1.4, 2.9, or 5.8 µM recombinase, as
indicted.
5.5.4 CeRad51 expression and purification
Wt CeRad51 and CeRad51-TM were expressed and purified essentially as described
previously [386]. Briefly, CeRad51 was expressed using the Champion pET-SUMO system
(Life Technologies) in BL21(DE3) One Shot E. coli in LB supplemented with 50 µg/ml
kanamycin at 37˚C, before induction for 4 h with 1 mM IPTG at 30˚C. Pellets were
resuspended in 400 ml ice cold Lysis Buffer (50 mM potassium phosphate [pH 7.8], 1 M
KCl, 10% glycerol) supplemented with cOmplete, EDTA-free protease inhibitor cocktail
tablets (Roche). All further steps were carried out at 4˚C. Triton X-100 was added to 0.1%
and cells were sonicated. Lysate was cleared using a Ti45 rotor (Beckman Coulter) at 40,000
rpm for 60 min. Imidazole was added to the supernatant to a final concentration of 25 mM
and applied to Ni-NTA agarose affinity gel (Qiagen, Cat No. 30210) which had been pre-
washed with Binding Buffer (50 mM potassium phosphate [pH 7.8], 1 M KCl, 10% glycerol,
25 mM imidazole [pH 7.5]). The protein was bound to the beads by rotating for 2 h. Beads
were washed with Binding Buffer and Binding Buffer containing 50 mM imidazole. The
protein was eluted with Binding Buffer containing 200 mM imidazole and dialyzed against
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Dialysis Buffer (20 mM Tris- HCl [pH 8.0], 300 mM KCl, 10% glycerol) overnight using 10
kDa MWCO SnakeSkin dialysis tubing (Thermo Scientific). The His-SUMO tag was cleaved
to yield native CeRad51 by addition of His-tagged Ulp1 SUMO protease for 45 min. The
protein was centrifuged and the soluble fraction collected and bound Ni-NTA agarose affinity
gel to remove the SUMO protease and His-SUMO tag. The flowthrough containing native
CeRad51 was collected and diluted at 1:1 ratio with Dilution Buffer (20 mM Tris-HCl [pH
8.0], 10% glycerol, 2 mM EDTA, 1 mM DTT) to reduce salt concentration to 150 mM KCl.
The protein was bound to a 1 ml Mono Q 5/50 GL column (GE Healthcare) at washed with
R buffer supplemented with 150 mM KCl. The protein was eluted with a gradient of 150-640
mM KCl in R buffer. The peak fractions were pooled and concentrated and frozen directly
in the elution buffer.
5.5.5 CeRad51 D-loop formation assay
Proteins were diluted in Dilution Buffer (25 mM Tris-HCl [pH 7.5], 10% (v/v) glycerol,
0.5 mM EDTA [pH 7.5], 100 mM KCl, 1 mM DTT, 0.01% NP40). To start the reaction,
proteins were incubated with a master mix (35 mM Tris, pH 7.5, 50 mM KCl, 1 mM DTT,
2 mM MgCl2, 2 mM ATP) and 30 nM of either 5´-FITC labelled 90mer (AAA TCA ATC
TAA AGT ATA TAT GAG TAA ACT TGG TCT GAC AGT TAC CAA TGC TTA ATC
AGT GAG GCA CCT ATC TCA GCG ATC TGT CTA TTT) or mismatched 5’-FITC
labelled 90mer (TTT TCT TTC TTT TGT TTT TTT GTG TTT TCT TGG TCT GTC
TGT TTC CTT TGC TTT TTC TGT GTG GCT CCT TTC TCT GCG TTC TGT CTT
TTT; mismatches underlined) oligonucleotide at 25˚C for 10 min; pBluescript SK(–) (540
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ng in 2 ￿l) was then added to bring the final reaction volume to 10 ￿l and incubated for
further 10 minutes. The samples were deproteinized with 0.1% SDS and 10 ￿g proteinase
K for 10 min at 37˚C and resolved in 0.8% agarose gels in 1X TAE (90 V, 35 min). Gels
were imaged on a Typhoon FLA 9500 scanner (GE Healthcare) and quantified using ImageJ
software.
5.5.6 CeRad51 ectrophoretic mobility shift assay
Proteins were diluted in Dilution Buffer (25 mM Tris-HCl pH 7.5, 10% (v/v) glycerol,
0.5 mM EDTA, pH 7.5, 100 mM KCl, 1 mM DTT, 0.01% NP40). To start the reaction,
proteins were incubated with M buffer: 20 mM Tris, pH 7.5, 10% (v/v) glycerol, 50 mM
sodium acetate, 1 mM DTT, 2 mM MgCl2, 2 mM ATP and 25 nM 5´ FITC labelled 49mer
ssDNA (AGC TAC CAT GCC TGC ACG AAT TAA GCA ATT CGT AAT CAT GGT CAT
AGC T) or 5’ FITC labelled 49mer dsDNA (AGC TAC CAT GCC TGC ACG AAT TAA
GCA ATT CGT AAT CAT GGT CAT AGC T, prepared by annealing of complementary
DNA strand) at 25˚C for 10 min. Reactions were terminated by crosslinking with 0.8%
glutaraldehyde for 10 min at 25˚C and resolved in 0.8% TAE agarose gels (50 V, 50 min,
4˚C). Gels were imaged on a Typhoon FLA 9500 scanner (GE Healthcare) and quantified
using ImageJ software. The proportion of bound DNA was calculated from free ssDNA
relative to “no protein” control.
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5.5.7 Presynaptic complex assembly and disassembly assays
Single molecule ssDNA curtains were prepared and imaged by total internal reflection
fluorescence microscopy, as previously described [306, 385]. All single-molecule presynap-
tic kinetic assays were performed essentially as previously described [38, 72, 306, 363, 385,
386]. In brief, ssDNA curtains were first prepared using RPA-GFP, and presynaptic com-
plex assembly was initiated by injecting buffer solutions containing 2 µM of the indicated
recombinase and 2 mM ATP into the sample chamber at a flow rate of 1 ml/min, buffer
flow was then terminated and reactions were incubated without flow while capturing images
(90 millisecond integration) at 10 second intervals for the duration of the assembly reac-
tions. The resulting data were analyzed by integrating the RPA-GFP signal intensity over
entire ssDNA molecules, and then plotting the normalized signal intensity versus time, as
previously described [306]. Assembly rates were then extracted from the resulting graphs by
fitting the data to single exponential curves. The presynaptic complex assembly conditions
for each different recombinase were as follows: hRAD51(30 mM Tris-Acetate [pH 7.5], 1 mM
MgCl2, 5 mM CaCl2, 100 mM KCl, 1 mM ATP, 1 mM DTT, and 0.2 mg/ml BSA; 37˚C);
hDMC1 (40 mM Tris-HCl [pH 7.5], 2 mM MgCl2, 1.5 mM CaCl2, 100 mM KCl, 2.5 mM
ATP, 1 mM DTT, and 0.2 mg/ml BSA; 37˚C); ScRad51 (30 mM Tris-Acetate [pH 7.5],
20 mM Mg-Acetate, 50 mM KCl, 1 mM DTT, 2.5 mM ATP, and 0.2 mg/ml BSA; 30˚C);
ScDmc1 (40 mM Tris-HCl [pH 7.5], 2 mM MgCl2, 1.5 mM CaCl2, 100 mM KCl, 2.5 mM
ATP, 1 mM DTT, and 0.2 mg/ml BSA; 30˚C); CeRad51 (50 mM Tris-HCl [pH 7.5], 5 mM
MgCl2, 50 mM NaCl, 2 mM ATP, 1 mM DTT, and 0.2 mg/ml BSA). For all recombinase,
the stability of the presynaptic complexes was confirmed by flushing free protein from the
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sample chambers while retaining ATP in the reaction buffers (as indicated above) while
monitoring the samples at 30˚C (to emulate the conditions of the dsDNA binding assays,
see below). Filament disassembly kinetics were measured by flushing the sample chambers
with buffers (as indicated above) lacking ATP (or in the case of hRAD51, lacking both ATP
and Ca2+), while collecting images (90 millisecond integration) at 10 second intervals for the
duration of the assembly reactions, and the resulting data were analyzed similarly to the
assembly reactions.
5.5.8 Yeast Strain construction
A W303 strain, LS1009-1 (MAT α ade3::GAL-HO leu2-3,112 trp1-1 ura3-1 can1-100;
his3-11,15 ade2-1), was genetically modified at the RAD51 and MAT loci. First, the endoge-
nous Z box was replaced with the commercially produced mutated Z box segments using a
previously described method [412]. Briefly, two fragments were created by PCR: Fragment
1 consists of 100 nt upstream of Z box, the mutated 315 nt Z box, 100 nt downstream of
the Z box, 300 nt upstream of K. lactis URA3 start codon, and 550 nt downstream from the
K. lactis URA3 start codon; Fragment 2 contains100 nt downstream of the K. lactis URA3
start codon, 200 nt downstream K. lactis URA3 stop codon, 100 nt upstream of Z box,
the mutated 315 nt Z box, and 100 nt downstream of the Z box. The two fragments were
transformed into LS1009-1 and transformants were selected on SC-ura plates after growth at
30˚C for two days. Colonies were patched onto SC-ura plates and grown at 30˚C overnight.
Colony PCR was performed checking for the presence of K. lactis URA3 at the MAT locus.
Positive patches were transferred to YPD and grown for one day and then replica plated
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to 5-FOA plates to select for colonies that lost the K. lactis URA3 gene. Colonies were
patched onto YPD, grown overnight, and colony PCR of the MAT locus was performed.
PCR fragments were then digested with the following restriction enzymes: MfeI (1 in 8 and
1 in 5), BglII (1 in 7), AflII (1 in 6), SpeI (1 in 4). Clones that yielded PCR fragments with
the modified Z boxes were confirmed by DNA sequencing. The rad51 mutations were made
in the Z box variant strains using a standard “pop-in/pop-out” method “pop-in/pop-out”
method [413]. Briefly, rad51 mutants were inserted into pRS406 (URA3) plasmid using XhoI
and BamHI cut sites. Each rad51 mutant was additionally altered with silent mutations to
create unique restriction enzyme cut sites: HindIII (Rad51-DL1, DM, DL2), AfeI (M301Q,
H302K), and PstI (A298E). Plasmids were then cut with EcoRI, transformed into the Z
box variant strains, plated on SC-ura plates, and grown for 2 days at 30˚C. Colonies were
patched onto SC-ura plates and grown overnight. Patches were tested for plasmid integra-
tion by colony PCR. Positive patches were then transferred to YPD and grown overnight.
Patches were then struck onto 5-FOA plates and grown for 2 days at 30 °C. Colonies were
patched onto YPD, grown overnight, and colony PCR of the RAD51 locus was performed.
Clones that yielded PCR fragments with the modified Z boxes were identified by restriction
digestion and confirmed by DNA sequencing.
5.5.9 Plating assays
Cells were cultured overnight in YPD, and ten-fold serial dilutions of the cultures were
spotted on YPD media containing either MMS or Zeocin at the indicated concentrations.
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5.5.10 Rad54 focus formation
Cells were grown overnight in SC with supplemental adenine at 23˚C before being
pelleted, resuspended at higher densities, and immobilized on a microscope slide by mixing
with 1.4% agarose. Images were acquired on a Leica DM5500B upright microscope (Leica
Microsystems) illuminated with a 100W mercury arc lamp. A Chroma 41028 high-efficiency
filter cube was used for Rad54-YFP imaging. Images were captured with a Hamamatsu Orca
AG cooled digital CCD (charged-coupled device), and analysis of image data was performed
with Volocity software (Perkin-Elmer). We acquired 20 z-stacks spaced by 300 nm. Exposure
times were as follows: DIC images (30 milliseconds), YFP fluorescence images (5 seconds).
5.5.11 MAT switching assays
This assay was modified from previously published protocols [291]. For each strain,
colonies were grown in 2 ml of YPD overnight. Cultures were spun down at 3000 x g for 2
min, washed with 2 ml of YPL, and resuspended in 5 ml of YPL and grown for 8-10 hours.
240 ml of YPL media was inoculated at the end of the day such that the OD600 was around
0.02 and grown overnight at 30˚C. Cultures were allowed to grow until OD600 0.4 to 0.6
and 60 ml of culture was removed for DNA extraction (time point 0). 20 ml of 20% galactose
was then added to the media and cells were allowed to grow for one hour. An additional
60 ml of culture was removed for DNA extraction. The rest of the culture was spun down,
washed with 10 ml of sterile deionized water, and then resuspended in 160 ml of YPL with
2% glucose. 50, 45, 35, and 25 ml of cultures were then taken at 30, 60, 180, 300 min after
YPL-glu resuspension, respectively. DNA was extracted as described previously [414]. For
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each sample, 10 µg of DNA was digested with StyI for 12 hours at 37˚C and then incubated
for 20 min at 65˚C to inactivate StyI. Samples were loaded into a 1% agarose gel and run
in 1x TBE buffer for 2.5 hours at 160 V. DNA was fixed to GE Amersham Hybond-N+
(Cat. No. RPN303B) membrane by capillary transfer for 5 hours and UV-crosslinked (120
mJ/cm2) Membranes were equilibrated with 25ml of GE Amersham Rapid-hyb buffer (Cat.
No. RPN1636) at 65˚C for 30 min. 20 ng of SAE2 and MAT probes were labeled using
Thermo Scientific RadPrime DNA Labeling System (Cat. No. 18428011) and CTP-[￿-32P]
(PerkinElmer Cat. No. BLU508H250UC) in a 50 µl reaction. Labeled probes were denatured
at 95˚C for 5 min and immediately put on ice and diluted with 100 µl of ice cold H2O. 75
µl of diluted probe was added to the hybridization buffer and membranes were incubated
for 4 hours at 65˚C. Membranes were then washed with 2x SSC with 0.1% SDS for 15min
at 65˚C and then two more washes with 1x SSC with 0.1% SDS for 20 min each at 65˚C.
A phosphor screen was exposed to the membrane for 12 hours and imaged on GE Typhoon
FLA 9000 Imager and analyzed using ImageJ.
5.5.12 Molecular dynamics simulations
To gain insight into the mechanism by which the three lineage-specific amino acid
residues in Dmc1 might stabilize mismatched base pairs, we sought to determine locate the
position of these residues relative to the presynaptic ssDNA. A structure of the Dmc1 filament
bound with the presynaptic ssDNA in not yet available. Therefore, as an initial alternative
we replaced the corresponding residues of hRAD51 filament with the corresponding amino
acids from Dmc1, yielding an initial structure for the hRAD51 with the following three
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mutations: A240E, M243Q, and H244K. An initial structure wherein the side chains of these
amino acids were randomly oriented was generated using Pymol (https://pymol.org), and
the resulting mutant hRAD51 structure was then relaxed using all-atom molecular dynamics
(MD) simulations, which were performed using Gromacs 5.0.6 (http://www.gromacs.org).
In the simulation, the mutated structure was solvated with 27,267 water molecules in the
13.8 nm x 13.8 nm x 13.8 nm periodic boundary box. We added 186 Na+ and 158 Cl- ions
to neutralize the system and to simulate a 100 mM salt concentration. The AMBER99SB-
ILDN force fields were used for the protein and DNA molecules, while the TIP3P force
field was used for water molecules. In all the simulations, we used the particle mesh Ewald
method to calculate the electrostatic energy using a grid spacing of 0.16 Å and four-order
interpolation. The cut-off length of electrostatic and Van der Waals interaction calculation
was set to 1.0 Å. The bond lengths that include hydrogen atoms were constrained by p-
LINCS for the protein and DNA molecules and by SETTLE for the water molecules. The
initial structures were equilibrated before the start of the production simulation by 5× 104
steps of the steepest descent energy minimization and by 1 x 105 steps of MD simulations
with position restraints of the protein and DNA molecules. The first half of the equilibration
MD simulation was conducted in the NVT ensemble at T = 300 [K] and second half in the
NPT ensemble at T = 300 [K] and P = 1 [atm]. The 5 × 106 steps (10-ns) production
simulations were performed in the NPT ensemble at T = 300 [K] and at P = 1 [atm] by the
leap-frog integrator with 2-fs time step. The snapshots presented in Figure ??B and C were
obtained from the last frame of the simulations.
From the production simulations, we found that E240 in the hRAD51 A240E M243Q
H244K triple mutant makes contacts with the complementary DNA strand, which are absent
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in the simulation performed for wt hRAD51. We calculated the distances between the three
atoms in E240 (Cβ, Cδ, Cγ) and the O4’ atom in the backbone sugar, yielding distances
of 5.0 ± 0.5 (Cβ), 6.8 ± 0.7 Å (Cδ), and 5.8 ± 0.7 (Cγ). This result suggests that these
three atoms may make contact with the complementary DNA strand. For wt hRAD51, the
corresponding residue is A240. The distance between the Cβ atom in A240 and the O4’
atom in the backbone sugar is 7.9 in the structure obtained by the electron microscopy
[39]. Thus, more atoms of E240 are indicated to have contacts with the complementary
DNA strand compared to A240. This more intimate interaction is consistent with a model
where Dmc1 may stabilizes mismatches by making nonspecific contacts with the phosphate




BRCA1–BARD1 Promotes RAD51-Mediated Homologous DNA
Pairing
This chapter is adapted from work originally published as: “Sequence imperfections
and base triplet recognition by the Rad51/RecA family of recombinases,” Weixing Zhao,
Justin B. Steinfeld, Fengshan Liang, Xiaoyong Chen, David G. Maranon, Chu Jian Ma,
YoungHo Kwon, Timsi Rao, Weibin Wang, Chen Sheng, Xuemei Song, Yonhong Deng, Judit
Jimenez-Sainz, Lucy Lu, Ryan B. Jensen, Yong Xiong, Greg M. Kupfer, Claudia Wiese, Eric
C. Greene, Patrick Sung. Nature. (2017). I was responsible for all of the single molecule
experiments along with associated experimental design and data analysis.
6.1 Abstract
The tumor suppressor complex BRCA1–BARD1 functions in the repair of DNA double-
stranded breaks by homologous recombination. During this process, BRCA1–BARD1 facil-
itates the nucleolytic resection of DNA ends to generate a single-stranded template for the
recruitment of another tumor suppressor complex, BRCA2–PALB2, and the recombinase
RAD51. Here, by examining purified wild-type and mutant BRCA1–BARD1, we show that
both BRCA1 and BARD1 bind DNA and interact with RAD51, and that BRCA1–BARD1
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enhances the recombinase activity of RAD51. Mechanistically, BRCA1–BARD1 promotes
the assembly of the synaptic complex, an essential intermediate in RAD51-mediated DNA
joint formation. We provide evidence that BRCA1 and BARD1 are indispensable for RAD51
stimulation. Notably, BRCA1–BARD1 mutants with weakened RAD51 interactions show
compromised DNA joint formation and impaired mediation of homologous recombination
and DNA repair in cells. Our results identify a late role of BRCA1–BARD1 in homolo-
gous recombination, an attribute of the tumor suppressor complex that could be targeted in
cancer therapy.
6.2 Introduction
Mutations in BRCA1 (breast cancer susceptibility gene 1) are linked to familial breast
and ovarian cancers, and also to Fanconi anaemia [216, 415–418]. Since its discovery over
twenty years ago [419–421], BRCA1 has been implicated in various biological processes, in-
cluding mRNA splicing and microRNA biogenesis [422–426], DNA damage signaling, cell
cycle checkpoints [416, 427], the avoidance of replication–transcription conflicts [428, 429],
and DNA double-strand break (DSB) repair by homologous recombination [415, 418, 430–
432]. The role of BRCA1 in these processes has remained mostly undefined, largely because of
difficulties in obtaining high-quality protein preparations for biochemical analyses. BRCA1
(1,863 residues) forms a stable complex with BARD1 (BRCA1-associated RING domain
protein 1; 777 residues) [433, 434]. Depletion of BARD1 engenders DNA damage sensitiv-
ity, homologous recombination deficiency, and genome destabilization [433, 435–438]. The
ablation of BARD1 in mice leads to cancer susceptibility [437], and probable disease-causing
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mutations are found in patients with cancer [439–443].
We have investigated the multifaceted role of BRCA1–BARD1 in homologous
recombination-mediated DSB repair. During the repair process, the DSB ends are resected
to yield 3￿ single-stranded DNA tails [444]. These DNA tails become coated with replica-
tion protein A (RPA), which is subsequently displaced by the recombinase protein RAD51
to form a nucleoprotein complex termed the presynaptic filament. The presynaptic fila-
ment searches for, engages, and then invades a homologous duplex target to form a nascent
heteroduplex DNA joint, the displacement loop or D-loop. This is followed by DNA syn-
thesis and resolution of DNA intermediates to complete repair [28]. There is evidence that
BRCA1 promotes DNA end resection by acting as an antagonist of 53BP1 and regulating the
MRE11–RAD50–NBS1–CtIP resection nuclease complex, and also participates in RAD51-
mediated presynaptic filament formation with the tumor suppressors BRCA2 and PALB2
[216, 445]. To gain mechanistic insights into how BRCA1–BARD1 promotes homologous
recombination, we have developed a robust system for co-expressing BRCA1 and BARD1
in insect cells and a protocol to obtain BRCA1–BARD1 for biochemical testing. Our results
reveal novel attributes of BRCA1–BARD1 and a role for this protein complex in the DNA
strand invasion step of homologous recombination-mediated chromosome damage repair.
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6.3 Results
6.3.1 DNA Binding by BRCA1 and BARD1
BRCA1–BARD1 was expressed in insect cells and purified to near homogeneity (Fig.
6.1A-D). We used the DNA electrophoretic mobility shift assay (EMSA) to test the ability of
BRCA1–BARD1 to bind radiolabelled single-stranded DNA (ssDNA), double-stranded DNA
(dsDNA), the replication fork, the D-loop and DNA bubble (a short section of unwound DNA
that forms during biological processes such as transcription). We also performed competition
experiments in which the nucleoprotein complex of BRCA1–BARD1 and radiolabelled D-
loop was challenged with an unlabeled DNA species. The results revealed that BRCA1–
BARD1 has the highest affinity for the D-loop and DNA bubble, followed by the replication
fork, dsDNA and ssDNA (Fig. 6.1E-H, Fig. 6.2A,B and Fig. 6.3A,B).
BRCA1 is known to bind DNA [446, 447]. Using the southwestern assay, we found
that both BRCA1 and BARD1 bind the D-loop, with BARD1 showing an apparently higher
affinity for the substrate (Fig. 6.2C). Consistent with this, BRCA1–BARD11–142 (full-length
BRCA1 in complex with only the RING domain of BARD1) exhibited a lower affinity for
various DNA substrates (Fig. 6.1I,J). Together, our results show that both BRCA1 and
BARD1 contribute to the DNA-binding capability of the BRCA1–BARD1 complex. The
DNA-binding domain of BRCA1 was previously found to reside within the protein’s middle
region [446, 447] and our mapping effort has led to the isolation of the BARD1 DNA-
binding domain (Fig. 6.3C-E). Notably, the BARD1 domain exhibited similar DNA-binding
properties to the complex (Fig. 6.3F-I). Thus, BARD1 is a structure-specific DNA-binding
protein with the highest affinity for the D-loop and DNA bubble.
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Figure 6.1: Purification of BARD1-BRCA1 and mutant variants, and DNA-binding
properties of BRCA1-BARD1 and BRCA1-BARD11−142 Schematics of BRCA1 (A)
and BARD1 (B) and mutant variants of these proteins tested in this study. (C) SDS–
PAGE of purified BRCA1–BARD11−142 (lane 2), BRCA1–BARD1 (lane 3), BRCA1–BARD1AAE
(lane 4), BRCA11−500–BARD1 (lane 5), BRCA11−500–BARD11−261 (lane 6) and BRCA11−500–
BARD1∆163–261 (lane 7). Size markers were run in lane 1. (D) SDS–PAGE of purified
BRCA1–BARD1 (lane 2), BRCA1–BARD1∆123–162 (lane 3), BRCA1–BARD1K140N (lane 4) and
BRCA1￿758–1064–BARD1 (lane 5). Size markers were run in lane 1. (E)DNA binding test of
BRCA1–BARD1 with a mixture of D-loop, DNA bubble and dsDNA. (F) Quantification of data
from experiments in E. Data are means ± s.d., n = 5. (G) DNA binding test of BRCA1–BARD1
with a mixture of D-loop, dsDNA and ssDNA. (H) Quantification of data from experiments in G.
Data are means ± s.d., n = 4. (I) DNA binding test of BRCA1–BARD11−142 with a mixture of
D-loop, DNA bubble and dsDNA. (J) Quantification of the results obtained with 32 nM of protein
complexes in E and I. Data are means ± s.d., n = 3 (BRCA1–BARD11−142) or 5 (BRCA1–BARD1).
**P < 0.01.
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Figure 6.2: DNA-binding and RAD51-interaction attributes of BRCA1-BARD1. (A)
Binding of D-loop, DNA bubble (Bubble), replication fork (RF), dsDNA and ssDNA. (B) Quantifi-
cation of interaction shown in A. Data are means ± s.d., n = 3 (bubble, RF, dsDNA and ssDNA) or
5 (D-loop). (C) Southwestern analysis to test D-loop binding. Bovine serum albumin (BSA) was
the negative control. (D) Pull-down analysis for interaction of RAD51 or yRad51 with BRCA1–
BARD1. (E) Far western analysis for interaction of BRCA1 and BARD1 with RAD51. B1–B1,
BRCA1–BARD1. BSA and RAD54 were the negative and positive controls, respectively.
6.3.2 RAD51 Interaction with BRCA1-BARD1
BRCA1 has been shown to co-immunoprecipitate with RAD51 from cell extracts[432],
but it has remained unclear whether it associates with RAD51 directly. By affinity pull-
down, we found that BRCA1–BARD1 interacts with human RAD51 but has little or no
affinity for yeast Rad51 (yRad51) (Fig. 6.2D) or Escherichia coli RecA (Fig. 6.4A). We also
determined that four or five RAD51 molecules are bound by BRCA1–BARD1 (Fig. 6.4B,C).
Notably, formation of the BRCA1–BARD1–RAD51 complex was not affected by benzonase
or ethidium bromide (Fig. 6.2D and 6.4D), indicating that the association is not bridged
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Figure 6.3: DNA Binding by BARD1. (A) BRCA1–BARD1 (5 nM) was incubated with ra-
diolabelled D-loop (10 nM) and then the nucleoprotein complex was presented with an increasing
concentration of unlabelled ssDNA, dsDNA, fork, bubble or D-loop as indicated. (B) Quantification
of data from experiments in A. Data are means ± s.d., n = 2 (ssDNA) or 3 (all other substrates).
(C) DNA binding test of BRCA11−500–BARD11−261 with a mixture of D-loop, dsDNA and ss-
DNA. (D) DNA binding test of BRCA11−500–BARD1∆163–261 with a mixture of D-loop, dsDNA
and ssDNA. (E) Comparison of results obtained using 32 nM of BRCA1–BARD1 (from Fig. 6.1G)
BRCA11−500–BARD1 (from Fig. 6.15A), BRCA11–500–BARD11–261 (from C) and BRCA11–
500–BARD1￿163–261 (from D). Data are means ± s.d., n = 3 (BRCA11–500–BARD11–261 and
BRCA11–500–BARD1￿163–261) or 4 (BRCA1–BARD1 and BRCA11−500–BARD1). **P < 0.01.
(F) SDS–PAGE of purified BARD1124–270. (G) EMSA to test BARD1124–270 for binding to the D-
loop, DNA bubble (Bubble), double-stranded DNA (dsDNA) and single-stranded DNA (ssDNA).
(H) Nucleoprotein complex consisting of BARD1124–270 (16 nM) and radiolabelled D-loop (10 nM)
was challenged with an increasing concentration of unlabelled ssDNA, dsDNA, fork, DNA bubble
or D-loop as indicated. (I) Quantification of data from experiments in H. Data are means ± s.d.,
n = 3 (D-loop and ssDNA) or 4 (Bubble, RF and dsDNA).
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by nucleic acid. Surprisingly, both BRCA1 and BARD1 retained RAD51 in the far western
assay, with BARD1 showing a more robust signal (Fig. 6.2E), whereas the homologous
recombination factors RAD51D–XRCC2 and DSS1 did not bind RAD51 under the same
conditions (Fig. 6.4E). These results helped to establish that BRCA1–BARD1 associates
with RAD51 in a species-specific manner, and that both proteins in the complex participate
in this interaction.
6.3.3 BRCA1-BARD1 enhances homologous DNA pairing
Given that BRCA1–BARD1 binds DNA and interacts with RAD51 (Fig. 6.2), we
hypothesized that it would enhance either the assembly of the presynaptic filament or the
potential of the presynaptic filament to mediate DNA strand invasion, or both. We used
a DNA strand exchange assay [448, 449] (Fig. 6.5A) to test whether BRCA1–BARD1
could facilitate RAD51 presynaptic filament assembly. Although the BRCA2–DSS1 complex
promotes RAD51 presynaptic filament assembly on RPA-coated ssDNA [449, 450], BRCA1–
BARD1 does not (Fig. 6.5B,C). Moreover, unlike BRCA2–DSS1 [448, 450], BRCA1–BARD1
cannot target RAD51 to ssDNA when dsDNA is present (Fig. 6.5D-F).
Next, we conducted a D-loop assay to test whether BRCA1–BARD1 could promote
DNA strand invasion (Fig. 6.6A). Notably, BRCA1–BARD1, in amounts substoichiomet-
ric to RAD51, strongly enhanced the reaction, regardless of whether ATP (Fig. 6.5G-I)
or the non-hydrolysable analogue AMP-PNP (Fig. 6.6A-C) was used as the nucleotide co-
factor, while BRCA2–DSS1 did not stimulate strand invasion (Fig. 6.6A-C). By contrast,
BRCA1–BARD1 did not enhance the activity of yRad51 (Fig. 6.5J,K). BRCA2–DSS1 did
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Figure 6.4: The RAD51 interaction attributes of BRCA1-BARD1. (A) Affinity pull-down
to test for the interaction of RecA with BRCA1–BARD1 (B1–B1) via the Flag tag on BRCA1. The
supernatant (S), wash (W) and eluate (E) fractions were analysed by SDS–PAGE and Coomassie
blue staining. (B) Affinity pull-down with Flag-tagged BRCA1–BARD1 (66 nM) and an increasing
concentration of RAD51 (1, 2, 4 and 8 µM). The eluates from the pull-down experiment were
analysed by SDS–PAGE with Coomassie blue staining. (C) The amount of BRCA1–BARD1 and
RAD51 in lanes 2–5 of B was quantified against known quantities of these protein species, run and
stained in the same SDS polyacrylamide gel. Data are means ± s.d., n = 3. (C) Affinity pull-down
to test for the interaction of RAD51 with BRCA1–BARD1 with or without ethidium bromide (EB)
being present. (E) Far western analysis to examine RAD51D–XRCC2 (DX2), GST–DSS1 (DSS1)
and BRCA1–BARD1 for RAD51 interaction. (F) Schematic of the GST-tagged RAD51 fragments
examined (top). Results from the pull-down experiment to test for interaction of BRCA1-BARD1
with the RAD51 fragments via the GST tag on the latter (bottom). RAD51 fragments and BRCA1
were revealed by immunoblot analysis using anti-GST or anti-Flag antibodies, respectively. (G)
GST pull-down assay to test for the interaction of the RAD51-T3 fragment with BRCA1–BARD1,
BRCA11−500–BARD1 and BRCA1–BARD11−142 The RAD51 fragment, GST, BRCA1 and BARD1
were revealed by immunoblot analysis using anti-GST, anti-Flag or anti-His antibodies, respectively.
(H) GST pull-down assay to test for competition between BRCA1–BARD1 (198 nM) and BRCA2–
DSS1 (66 nM) for RAD51 (1 µM); DSS1 was GST-tagged. RAD51, BRCA1 and BRCA2 were
revealed by immunoblot analysis using antibodies specific for them.
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Figure 6.5: Lack of recombination mediator
activity in BRCA1-BARD1 and species-
specific enhancement of RAD51 recombi-
nase by BRCA1-BARD1. (A) Schematic of
the test for mediator activity of BRCA com-
plex (BRCA1–BARD1 and BRCA2–DSS1). (B)
BRCA1–BARD1 and BRCA2–DSS1 were tested
for recombination mediator activity with RPA-
coated ssDNA as substrate. (C) Quantifica-
tion of data from experiments in B. Data are
means ± s.d., n = 3. (D) Schematic of the test
for ssDNA targeting activity of BRCA com-
plex (BRCA1–BARD1 and BRCA2–DSS1). (E)
BRCA1–BARD1 was tested alongside BRCA2–
DSS1 for the ability to target RAD51 to ssDNA.
(F) Quantification of data from experiments in
E. Data are means ± s.d., n = 3. (G) Schematic
of the D-loop assay. (H) D-loop reactions were
carried out with the indicated concentration of
BRCA1–BARD1 and ATP as the nucleotide co-
factor. (I) Quantification of data from experi-
ments in H. Data are means ± s.d., n = 3. (J)
BRCA1–BARD1 and Saccharomyces cerevisiae
Rad54 (yRad54) were tested for their influence
on D-loop formation catalysed by S. cerevisiae
Rad51 (yRad51). (K) Quantification of data
from experiments in J. Data are means ± s.d.,
n = 3.
not stimulate D-loop formation by BRCA1–BARD1–RAD51 when the ssDNA substrate was
pre-incubated with RAD51 or when ssDNA and plasmid DNA were premixed (Fig. 6.7A,B).
However, with RPA-coated ssDNA, D-loop formation became more robust in the presence
of BRCA1–BARD1 and BRCA2–DSS1 than with either complex alone (Fig. 6.7C,D). To-
gether, these results reveal an unexpected role of BRCA1–BARD1 in promoting DNA joint
formation that is catalyzed by RAD51 (Fig. 6.6D).
In homologous DNA pairing, the presynaptic filament captures the duplex partner and
then assembles the synaptic complex in which the recombining DNA molecules are aligned
in homologous registry and base switching has occurred [28]. By monitoring the protection
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Figure 6.6: Enhancement of
RAD51-mediated D-loop for-
mation by BRCA1-BARD1.
(A) Assay schematic of D-loop
reactions. (B) D-loop reactions per-
formed with the BRCA1–BARD1
or BRCA2–DSS1 complex. (C)
Quantification of the reactions in
B. Data are means ± s.d., n = 3.
(D) Schematic depicting the
role of BRCA1–BARD1 in DNA
strand invasion during homologous
recombination.
of dsDNA against restriction enzyme digestion (Fig. 6.8A), we found that BRCA1–BARD1
stimulates synaptic complex formation (Fig. 6.8B,C). Next, we used our DNA curtain assay
[306, 363] to examine the pairing of homologous DNA sequences in real time (Fig. 6.8D). As
previously reported [306, 363], the RAD51 presynaptic filament was able to engage a 70-base
pair dsDNA fragment harboring 9-nucleotide homology (Fig. 6.8E). Importantly, the results
showed enhancement of DNA engagement by BRCA1–BARD1 (Fig. 6.8E). However, we
found no evidence that BRCA1–BARD1 has any effect on the binding site distributions, the
pairwise distance distributions, or the resident time (koff ) of the bound dsDNA (Fig. 6.7E
and Fig. 6.8F,G). Since BRCA1–BARD1 does not affect the koff of the aligned dsDNA, we
speculate that it acts by increasing the kon of dsDNA engagement. We note that BRCA1–
BARD1 mutants impaired for BARD1–RAD51 interaction or lacking the RAD51-interaction
domain of BRCA1 cannot promote pairing with the duplex target (see below). We also
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Figure 6.7: Interplay between
BRCA2-DSS1 and BRCA1-
BARD1. (A) D-loop reactions
performed with the indicated concen-
tration of BRCA1–BARD1 (B1–B1),
BRCA2–DSS1 (B2–D1), and order of
addition of reaction components. (B)
Quantification of data from experi-
ments in A. Data are means ± s.d.,
n = 3. NS, non-significant. (C) D-loop
reactions performed with the indicated
concentration of BRCA1–BARD1,
BRCA2–DSS1, and order of addition
of reaction components. (D) Quan-
tification of data from experiments
in C. Data are means ± s.d., n = 3.
*P < 0.05; **P < 0.01. (E) Pairwise
distance distributions for Atto565-
dsDNA bound to the RAD51–ssDNA
filaments with or without BRCA1–
BARD1. Data are means ± errors
(determined by bootstrapping). (F)
BRCA1–BARD1 (100 and 200 nM)
was tested with filaments of yRad51–
ssDNA in synaptic complex assembly
as assayed by protection against
restriction digest. (G) Number of
dsDNA oligonucleotides bound by
the RAD51–ssDNA filament without
(n = 49) and with BRCA1–BARD1
(n = 54), BRCA1–BARD1AAE
(n = 50) or BRCA11−500–BARD1
(n = 50). Data are means ± 95%
confidence intervals. **P < 0.01.
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verified that BRCA1–BARD1 does not affect the ability of presynaptic filaments harboring
yRad51 to engage dsDNA (Fig. 6.7F and Fig. 6.8).
6.3.4 Functional relevance of BARD1-RAD51 interaction
We sought to isolate RAD51-binding defective mutants of BRCA1–BARD1 for bio-
chemical and genetic testing. First, we co-expressed RAD51 with various BRCA1 fragments
in insect cells and conducted co-immunoprecipitation. Consistent with a previous study
[432], BRCA11–1527 could interact with RAD51, whereas BRCA11–1000 and BRCA11–500 were
impaired in this regard (Fig. 6.9A-C). Notably, BRCA1–BARD1 could co-precipitate much
more RAD51 than BRCA1 alone. This result, together with the far western data (Fig. 6.2E),
indicates that BARD1 harbors a major RAD51-interaction domain (Fig. 6.10A). Deletion
analysis showed that the region between residues 123 and 162 of BARD1 is indispensable
for RAD51 interaction (Fig. 6.9D-G and Fig. 6.10A,B). Moreover, a GST-tagged BARD1
fragment harboring these residues could efficiently associate with RAD51 (Fig. 6.9H), indi-
cating that it encompasses the RAD51 interaction domain. We also discovered that the core
domain of RAD51 (referred to as T3), which has been implicated in BRCA2 binding via the
BRC4 repeat of BRCA2 [451], can interact with BRCA1–BARD1 (Fig. 6.4F), but not with
BRCA1–BARD11–142 or BRCA11–500–BARD1 (Fig. 6.4G). Interestingly, BRCA1–BARD1
could compete with BRCA2–DSS1 for RAD51 association (Fig. 6.4H).
We expressed and purified the mutant BRCA1–BARD1∆123–162 complex, in which the
RAD51-interaction domain of BARD1 has been deleted. BRCA1–BARD1∆123–162 retained
normal DNA-binding activity (Fig. 6.11A,B) but was defective in RAD51 interaction (Fig.
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Figure 6.8: Promotion of synaptic complex formation by BRCA1-BARD1. (A) Schematic
of the synaptic complex assay. (B) Synaptic complex formation by the RAD51–ssDNA filament
and BRCA1–BARD1. (C) Quantification of synaptic complex formation. Data are means ± s.d.,
n = 3 (for lanes 6 and 7) or 6 (for lanes 2–5). (D) Schematic of DNA curtain assay. (E) Number of
dsDNA oligonucleotides bound by each RAD51–ssDNA or yRad51–ssDNA filament as a function of
BRCA1–BARD1 concentration. Data are means ± 95% confidence intervals, n = 49 (RAD51), 50
(RAD51 + 10 nM BRCA1–BARD1), 38 (RAD51 + 50 nM BRCA1–BARD1), 54 (RAD51 + 100 nM
BRCA1–BARD1), 51 (yRad51) or 53 (yRad51 + 100 nM BRCA1–BARD1). (F) Binding distribu-
tion for Atto565–dsDNA with or without BRCA1–BARD1. (G) Semi-log survival plot of the synap-
tic complex with and without 100 nM BRCA1–BARD1. *P < 0.05; **P < 0.01. NS, non-significant.
In F and G, data are means ± errors (determined by bootstrapping). The multiGaussian in F and
the lines in G were fitted with least squares analysis.
220
Figure 6.9: Identification of the RAD51 interaction domain in BRCA1-BARD1. (A)
Schematic of the BRCA1 deletion variants37 examined in this study. (B) Testing BRCA1 dele-
tion variants alone or in complex with BARD1 for the ability to co-immunoprecipitate RAD51
from insect cell extracts using anti-Flag resin with Benzonase treatment. The immunoprecipitates
were analyzed by western blotting with antibodies against the Flag epitope (for BRCA1), the His6
epitope (for BARD1), or RAD51, as indicated. The cell extracts (10% of total) were probed for
their RAD51 content. (C) Quantification of data from experiments in B. Data are means ± s.d.,
n = 3. *P < 0.05; **P < 0.01. (D) Summary of the RAD51 interaction ability of BARD1 trunca-
tion mutants, based on the pull-down analyses in (E) (for BRCA1–BARD1, BRCA11–500–BARD1
and BRCA11–500–BARD11–261), (F) (for BRCA11–500–BARD1, BRCA11–500–BARD11–261 and
BRCA11–500–BARD11–122), (G) (for BRCA11–500–BARD1￿123–261, BRCA11–500–BARD1∆123–162,
BRCA11–500–BARD11–261 and BRCA11–500–BARD11–162) and (H) (for BARD1123–162). In E, F
and G, the eluates from the affinity resin were analyzed by SDS–PAGE and Coomassie blue stain-
ing. In H, the interaction between RAD51 and GST–BARD1123–162 was tested by pull-down using
glutathione resin. The input and eluate fractions were analyzed by western blotting with antibodies
against GST or RAD51, as indicated.
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Figure 6.10: Relevance of the BARD1-RAD51 complex in DNA strand invasion. (A)
Domains in BRCA1–BARD1. (B) Alignment of the RAD51 interaction domain in BARD1 or-
thologues. The highlighted residues (green) were changed to AAE or N (red). The asterisks
denote BARD1 mutations found in human cancers (cBioPortal for Cancer Genomic). (C) Testing
of RAD51 interaction with wild-type or mutant BRCA1–BARD1. (D) Examination of BRCA1–
BARD1 mutants in the D-loop reaction. (E) Quantification of data from experiment in D. Data
are means ± s.d., n = 3 (BARD1∆123–162), 4 (BARD1WT and BARD1AAE) or 5 (BARD1K140N ).
P values were calculated using two-way ANOVA and multiple comparisons were corrected by the
Bonferroni method. **P < 0.01.
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6.10C) and, accordingly, failed to enhance D-loop formation (Fig. 6.10D,E) or synaptic
complex assembly (Fig. 6.11C,D). Sequence alignment of the RAD51-interaction domain
in BARD1 orthologues revealed a number of conserved amino acid residues (including the
FXDA motif; Fig. 6.10B). On the basis of this information, we generated a compound mutant
that changes the conserved residues F133 and D135 to alanine and A136 to glutamic acid (the
AAE mutant); F133 was included because other RAD51-interaction motifs [451–453], such
as BRC4 in BRCA2 [451], also harbor a functionally indispensable phenylalanine residue.
We expressed and purified the mutant BRCA1–BARD1AAE complex. Biochemical testing
revealed that, even though the mutant complex binds DNA normally (Fig. 6.11A,B), it is
impaired not only for RAD51 association (Fig. 6.10C), but also for the ability to stimulate
D-loop formation and synaptic complex assembly (Fig. 6.8G, 6.10D,E, and Fig. 6.11C,D).
Together, these results provided evidence that the BRCA1–BARD1–RAD51 complex is in-
dispensable for the enhancement of RAD51-mediated DNA strand invasion.
Cancer-associated mutations have been identified within the RAD51-interaction do-
main of BARD1. One such mutation (K140N), found in two patients with colorectal ade-
nocarcinoma or uterine corpus endometrial carcinoma, alters the conserved residue K140
(cBioPortal for Cancer Genomic) [454, 455] next to the FXDA motif (Fig. 6.10B). To deter-
mine the relevance of this mutation, we expressed and purified the BRCA1–BARD1K140N
mutant complex for testing. Although the mutation had no impact on DNA binding (Fig.
6.11A,B), it attenuated the affinity of BRCA1–BARD1 for RAD51 (Fig. 6.10C) and also
compromised the ability of the tumor suppressor complex to enhance D-loop formation and
synaptic complex assembly (Fig. 6.10D, E and Fig. 6.11C,D).
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Figure 6.11: Characterization of BRCA1-BARD1 mutants. (A) BRCA1–BARD1 (n = 3),
BRCA1–BARD1AAE (n = 3), BRCA1–BARD1∆123–162 (n = 3), and BRCA1–BARD1K140N (n = 4)
were tested for their DNA binding activity using a mixture of radiolabelled D-loop and dsDNA as
substrates. (B) Quantification of data from experiments in A. Data are means ± s.d. (C) Wild-
type and mutant variants of BRCA1–BARD1 (300 nM each) were tested for the ability to promote
synaptic complex formation. (D) Quantification of data from experiments in C. Data are means ±
s.d., n = 3. (E) Synaptic complex formation by RAD51–ssDNA filament with BRCA1–BARD1
(100 and 200 nM) and BRCA1￿758–1064–BARD1 (100 and 200 nM). (F) Quantification of data
from experiments in E. Data are means ± s.d., n = 6 (BRCA1–BARD1 with Mg2+ and ATP) or
n = 2 (all other conditions). *P < 0.05; **P < 0.01.
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6.3.5 Cellular Role of the BRCA1-BARD1-RAD51 Complex
We conducted cell-based studies to investigate the association between BRCA1–
BARD1 and RAD51 and to ascertain the importance of the BRCA1–BARD1–RAD51 com-
plex. The amount of RAD51 that co-immunoprecipitated with wild-type siRNA-resistant
BARD1 (BARD1WT res) was increased by treatment of cells with mitomycin C (MMC) (Fig.
6.12A), and the BARD1AAEres mutation impaired the DNA damage-induced association
with RAD51 (Fig. 6.12A). Cellular fractionation confirmed that the nuclear localization of
BRCA1 and BARD1 is not affected by the BARD1AAEres mutation (Fig. 6.13A).
Next, we used the direct repeat-green fluorescent protein (DR-GFP) reporter [217, 456],
which measures DSB-induced homologous recombination, and a CRISPR–Cas9-stimulated
gene-targeting assay [457, 458] to investigate whether the BARD1AAEres mutation affects ho-
mologous recombination. As expected, knockdown of endogenous BRCA1 or BARD1 using
small inhibitory RNA (siRNA) impaired homologous recombination in both systems (Fig.
6.13B-D). Notably, although the ectopic expression of BARD1WT res in BARD1-deficient
cells fully restored homologous recombination, ectopic expression of BARD1AAEres resulted
in only partial complementation (Fig. 6.12B and Fig. 6.14A,B). Moreover, in clonogenic cell
survival assays, BARD1-deficient cells expressing BARD1AAEres were markedly more sensi-
tive than cells expressing BARD1WT res to MMC and to the poly-ADP ribose polymerase
(PARP) inhibitor olaparib (Fig. 6.12D and Fig. 6.14C).
We also investigated whether the BARD1AAEres mutation would affect the DNA
damage-induced assembly of RAD51 nuclear foci. As expected, knockdown of endogenous
BRCA1 diminished RAD51 focus formation, either spontaneously or after γ-ray exposure
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Figure 6.12: Biological relevance
of the BARD1-RAD51 com-
plex. (A) Immunoprecipitation to
test BARD1WT and BARD1AAE for
RAD51 association after treatment
with MMC. Asterisk denotes a non-
specific band. (B) Schematic of the
DR-GFP reporter assay (top). Re-
sults obtained with cells expressing
BARD1WT res or BARD1AAEres upon
treatment with BARD1 siRNA or con-
trol siRNA (siCtrl) (bottom). Data
are means ± s.d., n = 3. (C) Schematic
of the CRISPR–Cas9 gene target-
ing assay (top). Results obtained
with cells expressing BARD1WT res or
BARD1AAEres upon treatment with
BARD1 siRNA or siCtrl. Data
are means ± s.d., n = 3. (D) Clono-
genic survival of cells expressing
BARD1WTres or BARD1AAEres af-
ter treatment with olaparib or MMC.
Data are means ± s.d., n = 3. EV,
empty vector. P values were calcu-
lated using two-way ANOVA and mul-
tiple comparisons were corrected by
the Bonferroni method. **P < 0.01.
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Figure 6.13: Role of BRCA1 and BARD1 in homologous recombination and RAD51
focus formation. (A) Western blot to verify the nuclear localization of endogenous BRCA1 and
ectopically expressed Flag-SBP-tagged BARD1 or the AAE mutant in HeLa cells. The cytoplasmic
(C) and nuclear (N) fractions were also analyzed for their alpha-tubulin and histone H3 contents.
(B) Western blot analysis to detect endogenous BRCA1 and BARD1 after treatment of DR-U2OS
cells with BRCA1 or BARD1 siRNA. (C) Homologous recombination frequency in DR-U2OS cells
with siRNA-mediated knockdown of BRCA1 or BARD1. Data are means ± s.d., n = 3. (D) Gene-
targeting efficiency of CRISPR–CAS9 in U2OS cells with siRNA-mediated knockdown of BRCA1
or BARD1. Data are means ± s.d., n = 3.
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Figure 6.13: (cont.) (E) Western blot analysis to detect endogenous BRCA1, BARD1 and BRCA2
after treatment of HeLa cells with siRNA against BRCA1, BARD1 or BRCA2. Alpha-tubulin
serves as loading control. (F) Representative micrographs of RAD51 foci (red) in the nuclei of
HeLa cells treated with BRCA1, BARD1, BRCA2 or control siRNA 8 h after exposure to 4 Gy γ-
rays. Blue, DAPI. (G) Quantification of RAD51 foci at various time points after exposure to 4 Gy
γ-rays or sham irradiation. The mean values ± s.e.m. of 4 (siBRCA2 and siBARD1), 6 (siBRCA1)
or 7 (siControl) independent experiments are shown. (H) Western blot analysis to detect endoge-
nous BRCA1 and 53BP1 after treatment of DR-U2OS cells with BRCA1 or TP53BP1 siRNA.
(I) Homologous recombination frequency in DR-U2OS cells with siRNA-mediated knockdown of
BRCA1 and/or TP53BP1. Data are means ± s.d., n = 3. (J) Western blot analysis to detect en-
dogenous BARD1 and 53BP1 after treatment of DR-U2OS cells with BARD1 and/or TP53BP1
siRNA. (K) Homologous recombination frequency in DR-U2OS cells with siRNA-mediated knock-
down of BARD1 or TP53BP1. Data are means ± s.d., n = 3. (L) Western blot analysis to detect
ectopically expressed and endogenous BARD1 after treatment of U2OS cells with BARD1 and/or
TP53BP1 siRNA. As the abundance of ectopically expressed Flag-SBP-tagged wild-type and mu-
tant BARD1 was lower than that of endogenous BARD1, we revealed it with anti-Flag antibodies
in western blot analysis. (M) Homologous recombination frequency in DR-U2OS cells treated with
siRNA against BARD1 and/or TP53BP1 and stably expressing BARD1WT res or BARD1AAEres.
Data are means ± s.d., n = 3. *P < 0.05; **P < 0.01; NS, non-significant.
(Fig. 6.13E-G). However, treatment with siRNA targeting BARD1 impaired RAD51 focus
formation to a lesser extent (Fig. 6.13G). In cells depleted of endogenous BARD1 and ex-
pressing BARD1WT res or BARD1AAEres, RAD51 focus formation occurred similarly, both
spontaneously and after γ-irradiation (Fig. 6.14D,E). However, as indicated by S4/S8 phos-
phorylation of RPA32, BARD1AAEres cells retained a much higher level of DNA damage
72 h after release from MMC treatment (Fig. 6.14F). These results showed that homologous
recombination-mediated repair is deficient in BARD1AAEres-expressing cells despite the fact
that RAD51 focus formation is not affected. Even though depletion of 53BP1, an inhibitor of
DNA end resection [459], partially overcame the homologous recombination defect associated
with BRCA1 deficiency (Fig. 6.13H,I), it did not suppress the homologous recombination
defect in BARD1-deficient cells (Fig. 6.13J,K). In cells lacking both BARD1 and 53BP1,
BARD1AAEres was less able than BARD1WT resto reverse the homologous recombination
deficiency (Fig. 6.13L,M). Together, our results help to establish the biological importance
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Figure 6.14: Characterizations of human cells expressing BARD1 mutants. (A) Western
blot analysis to detect ectopically expressed and endogenous BARD1 after treatment of U2OS cells
with BARD1 or control siRNA for the experiments in Fig. 6.12B. (B) Western blot analysis to
detect ectopically expressed and endogenous BARD1 after treatment of U2OS cells with BARD1
or control siRNA for the experiments in Fig. 6.12C. (C) Western blot analysis to detect ectopically
expressed and endogenous BARD1 after treatment of HeLa cells with BARD1 or control siRNA for
the experiments in Fig. 6.12D. In a–c, as the abundance of ectopically expressed Flag-SBP-tagged
wild-type and mutant BARD1 was lower than that of endogenous BARD1, we revealed it with
anti-Flag antibodies in western blot analysis. (D) Representative micrographs of RAD51 foci (red)
in the nuclei of HeLa cells expressing Flag-SBP-tagged BARD1WTres or BARD1AAEres 8 h after
exposure to 4 Gy γ-rays. Blue, DAPI. (E) Quantification of RAD51 foci at various time points
after exposure to 4 Gy γ-rays or sham irradiation. The mean values ± s.e.m. of 5 (8-h time point)
or 3 (all other time points) independent experiments are shown. NS, non-significant. (F) Western
blot to reveal pRPA32(S4/S8) (with tubulin as the loading control) at various time points (0, 24
and 72 h) after a 1-h treatment with 2 µM MMC.
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of the BRCA1–BARD1–RAD51 complex in DNA damage repair via homologous recombina-
tion and provide cellular evidence for a role of BRCA1–BARD1 in the DNA strand invasion
step of homologous recombination.
6.3.6 Cellular Role of BRCA1 in RAD51-Mediated DNA Pairing
To investigate the role of BRCA1 in RAD51-mediated reactions, we expressed and
purified BRCA11–500–BARD1, which lacks the RAD51 interaction and DNA binding domains
of BRCA1 [432, 446] and also BRCA1∆758–1064–BARD1, in which the RAD51-interaction
domain of BRCA1 has been deleted. These mutant complexes appeared to be proficient
in DNA binding (Fig. 6.15A-E) but were weakened for RAD51 interaction (Fig. 6.15F-
H). Importantly, neither mutant complex could strongly enhance RAD51-mediated D-loop
formation (Fig. 6.15I,J) or synaptic complex assembly (Fig. 6.7G and 6.11C-F). Thus,
BRCA1 is also indispensable for the functional integrity of BRCA1–BARD1 as a co-factor
of RAD51.
6.4 Discussion
Our study has revealed that BRCA1–BARD1 enhances DNA invasion in homologous
recombination by interacting directly with RAD51 (Fig. 6.16). Mechanistically, BRCA1–
BARD1 functions with the RAD51 presynaptic filament in the assembly of the synaptic
complex, a critical precursor to D-loop formation (Fig. 6.16). Both BRCA1 and BARD1 are
indispensable for this attribute. It is likely that physical association with RAD51 facilitates
dsDNA engagement by the presynaptic filament and that the specific recognition of unwound
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Figure 6.15: Characterizations of BRCA11–500-BARD1 and BRCA1∆758–1064–BARD1.
(A) BRCA11–500–BARD1 was tested for DNA binding using a mixture of radiolabelled D-loop, ds-
DNA, and ssDNA as substrates. (B) Quantification of data from experiments in A. Data are
means ± s.d., n = 4. (C) Comparison of results obtained using 32 nM BRCA1–BARD1 (from
??G) and BRCA11–500–BARD1 (from A). Data are means ± s.d., n = 3. NS, non-significant.
(D)BRCA1–BARD1 and BRCA1∆758–1064–BARD1 were tested for DNA binding using a mix-
ture of radiolabelled D-loop, bubble, and dsDNA as substrates. (R)Comparison of results ob-
tained using 16 nM BRCA1–BARD1 and BRCA1∆758–1064–BARD1. Data are means ± s.d., n = 4.
NS, non-significant. (F) Far western analysis to detect RAD51 association with BRCA11–500 and
BARD1 immobilized on nitrocellulose membrane. (G) Pull-down assay to test for the interaction
of RAD51 with BRCA11–500–BARD1, BRCA1–BARD11–142 and BRCA1–BARD1 via the Flag tag
on the BRCA1 species. The eluates from the various anti-Flag resin fractions were subjected to
immunoblot analysis with anti-Flag (for BRCA1), anti-His (for BARD1) and anti-RAD51 anti-
bodies. (H)Pull-down assay to test for the interaction between RAD51 and BRCA1–BARD1 or
BRCA1∆758–1064–BARD1 via the Flag tag on the BRCA1 species. (I) BRCA11–500–BARD1 and
BRCA1∆758–1064–BARD1 were tested along with the wild-type complex for the ability to enhance
RAD51-mediated D-loop formation. (J) Quantification of data from experiments in I. Data are
means ± s.d., n = 3 or 4. **P < 0.01..
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Figure 6.16: Role of BRCA1 and BARD1 in homologous recombination and RAD51
focus formation. (A) Western blot to verify the nuclear localization of endogenous BRCA1 and
ectopically expressed Flag-SBP-tagged BARD1 or the AAE mutant in HeLa cells. The cytoplasmic
(C) and nuclear (N) fractions were also analyzed for their alpha-tubulin and histone H3 contents.
(B) Western blot analysis to detect endogenous BRCA1 and BARD1 after treatment of DR-U2OS
cells with BRCA1 or BARD1 siRNA. (C) Homologous recombination frequency in DR-U2OS cells
with siRNA-mediated knockdown of BRCA1 or BARD1. Data are means ± s.d., n = 3. (D) Gene-
targeting efficiency of CRISPR–CAS9 in U2OS cells with siRNA-mediated knockdown of BRCA1
or BARD1. Data are means ± s.d., n = 3.
DNA by BRCA1–BARD1 enhances the formation of the nascent DNA joint in the D-loop
reaction. As we have not observed significant stimulation by BRCA1–BARD1 of DNA
strand exchange between an oligonucleotide and a short linear duplex, it remains possible
that the complex facilitates DNA homology search within a long duplex DNA target. A
model incorporating this new function and the known roles of BRCA1–BARD1 in DNA end
resection and RAD51 presynaptic filament assembly is shown in (Fig. 6.16).
The findings from our study open up a new avenue towards understanding how mu-
tations in BRCA1–BARD1 affect its DNA damage repair and tumor suppression functions.
Indeed, we have provided evidence that the cancer-associated mutation K140N in BARD1
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compromises the physical and functional interactions of BRCA1–BARD1 with RAD51. We
note that the region of BRCA1 (amino acid residues 758–1,064) that harbors the RAD51-
interaction domain [432] is frequently mutated in cancer (cBioPortal for Cancer Genomic)
[454, 455] and that deletion of this domain abolishes the activity of BRCA1–BARD1 in
RAD51-mediated DNA strand invasion. The biochemical systems established in our work
should be valuable for determining the impact of pathogenic mutations on BRCA1–BARD1
functions. Moreover, our findings may guide the development of targeted therapies for breast,
ovarian, and other cancers.
6.5 Methods
6.5.1 Construction of plasmids
A His6 affinity tag was fused to BARD1 in pFastbac-BARD1 (from J. Parvin) using
the QuikChange mutagenesis kit (Stratagene). The mammalian pS-Flag-SBP-BARD1res
expression vector was modified by removing the GFP coding sequence from the pS-Flag-
SBP-BARD1 vector (from X. Yu) and introducing silent mutations into the siRNA target
regions of BARD1using oligos 1 (5’-GAT GAT AAT ATG GCC ACA ACC AGC GGC
CGC GAC TCT AGA TC-3’) and 2 (5’-GAT CTA GAG TCG CGG CCG CTG GTT GTG
GCC ATA TTA TCA TC-3’) and oligos 3 (5’-GAA AGT CAG ATA TGT TGT GAG CAA
GGC AAG TGT CCA GAC CCA GCC TGC AAT AAA AA-3’) and 4 (5’-TTT TTA TTG
CAG GCT GGG TCT GGA CAC TTG CCT TGC TCA CAA CAT ATC TGA CTT TC-
3’), respectively. QuikChange site-directed mutagenesis was used to construct the mutant
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forms of BARD1: BARD11–122, BARD11–162, BARD11–261, BARD1∆123–162, BARD1∆123–261,
BARD1∆163–261, BARD1AAE and BARD1K140N (the sequences of the primers used are avail-
able upon request). BARD1123–162was introduced into pDEST15 for expression of the GST-
tagged form of this BARD1 fragment in E. coli. BARD1124–270 was cloned into pE-SUMO
vector (LifeSensors Inc.) for expression of the SUMO-tagged form of this BARD1 domain
in E. coli.
6.5.2 Protein purification: purification of BRCA1–BARD1 from
insect cells
pFastbac-Flag-BRCA1 (from J. Parvin) and pFastbac-His-BARD1 were introduced
into E. coli strain DH10Bac for bacmid generation. The bacmids were used to transfect
SF9 insect cells to generate recombinant baculoviruses. After amplification in SF9 cells, the
viruses were used to infect Hi5 insect cells for expression of BRCA1 and BARD1 (10 ml
BRCA1 and 10 ml BARD1 P3 viruses for 600 ml culture). After a 44-h incubation at 27 °C,
cells were harvested by centrifugation, frozen in liquid nitrogen, and stored at −80 °C. All
purification steps were carried out at 0–4 °C. To prepare extract, the frozen cell pellet (8 g,
from 600 ml culture) was thawed and suspended in 40 ml cell breakage buffer A (50 mM
Tris-HCl, pH 7.5, 500 mM KCl, 1 mM 2-mercaptoethanol, 0.5% NP-40, 5 mM MgCl2, 2 mM
ATP and the following protease inhibitors: aprotinin, chymostatin, leupeptin, and pepstatin
A at 3 µg ml−1 each, and 1 mM PMSF) for cell lysis using a Dounce homogenizer type B
pestle (30 strokes). The lysate was cleared by centrifugation at 10,000g for 15 min, and
the supernatant was incubated with 3 ml anti-Flag M2 affinity resin (Sigma) for 2 h. The
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resin was transferred to a column (1.5 × 15 cm), washed with 50 ml lysis buffer and then
with 50 ml buffer B (25 mM Tris-HCl, pH 7.5, 300 mM KCl, 10% glycerol, 0.5 mM EDTA,
0.01% Igepal CA-630, 1 mM 2-mercaptoethanol, 5 mM MgCl2 and 2 mM ATP), before the
bound proteins were eluted four times with 2 ml buffer B containing the single Flag peptide
(200 µg ml−1). The eluates were combined and mixed with 32 ml buffer C (25 mM Tris-
HCl, pH 7.5, 10% glycerol, 0.5 mM EDTA, 0.01% Igepal CA-630, 1 mM 2-mercaptoethanol)
before being further fractionated in a 1 ml HiTrap SP Sepharose HP column (GE Healthcare)
using a 12 ml gradient of 75–500 mM KCl in buffer C. The pooled BRCA1–BARD1 fractions
(250–350 mM KCl) were further fractionated in a gel filtration column of Superose 6 10/300
GL (GE Healthcare), which was developed with 24 ml buffer C containing 300 mM KCl.
The peak fractions were pooled, divided into 10-￿l portions, frozen in liquid nitrogen, and
stored at −80 °C. The mutant forms of BRCA1–BARD1 were expressed and purified using
the same procedures. The yield of highly purified BRCA1–BARD1 from 600 ml insect cell
culture ranged from 150 to 300 ￿g with a final concentration of 300–500 µg ml−1.
Protein purification: purification of BARD1123–162 and BARD1124–270 from E. coli The
GST–BARD11–162 expression plasmid pDEST15–BARD11–162 or the BARD1124–270 expres-
sion plasmid pET-SUMO-BARD1124–270 was introduced into E. coli Rosetta (DE3) cells.
An overnight culture derived from a single colony in 50 ml LB medium grown at 37 °C was
used to inoculate 2 l fresh LB medium. IPTG was added to 0.4 mM when the cell density
had reached OD600 = 0.8, and cells were harvested after a 16-h incubation at 16 °C. All the
subsequent steps were carried out at 0–4 °C. The cell pellet (8 g) was suspended in 50 ml
buffer D (20 mM KH2PO4, pH 7.5, 10% glycerol, 0.5 mM EDTA, 0.01% Igepal CA-630,
1 mM 2-mercaptoethanol and 300 mM KCl) containing the protease inhibitors (aprotinin,
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chymostatin, leupeptin, and pepstatin A at 3 ￿g ml−1 each, and 1 mM PMSF) and cell
lysate was prepared by sonication. After centrifugation (100,000g for 90 min), the clarified
lysate was incubated with 2 ml Glutathione Sepharose 4 Fast Flow resin (GE Healthcare;
for GST-BARD1123–162) or Ni-NTA resin (GE healthcare; for BARD1124–270) for 2 h. The
affinity resin was transferred to a glass column (1.5 × 15 cm) and washed with 20 ml buffer
D before being eluted three times with 3 ml of 20 mM glutathione or 150 mM imidazole
in buffer D. For BARD1124–270, the His6-SUMO tag was cleaved by the Ulp1 protease by
overnight incubation at 4 °C. The eluates were pooled and concentrated in a Centricon-10K
concentrator (Amicon) to 0.5 ml before being further fractionated in a Superdex 200 10/300
GL column (GE Healthcare) with 24 ml of buffer C containing 300 mM KCl. The peak
fractions were pooled, concentrated to ∼ 100 µl as above, divided into 5 ￿l portions, frozen
in liquid nitrogen, and stored at −80 °C.
6.5.3 Protein purification: other recombination proteins
BRCA2–DSS1, RAD51, RPA and yeast Rad51 were purified to near homogeneity using
our previously described procedures [185, 409, 449].
6.5.4 DNA substrates and DNA binding assay
D-loop, DNA bubble, replication fork and double-stranded DNA were assembled from
oligonucleotides 5/6/7, oligonucleotides 5/6, oligonucleotides 8/9/10/11 and oligonucleotides
12/13, respectively; the asterisk identifies the oligonucleotide that was 32P-labelled at its
5￿ end in each substrate. The single-stranded DNA substrate was 5￿ 32P-labelled oligonu-
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cleotide 12. These DNA substrates (10 nM each) were incubated with wild-type or the
specified mutant form of BRCA1–BARD1 at 37 °C in 10 µl buffer E (25 mM Tris-HCl, pH
7.5, 90 mM KCl, 1 mM DTT, and 100 µg ml−1 bovine serum albumin (BSA)) for 10 min.
After the addition of loading buffer (50% glycerol, 20 mM Tris-HCl, pH 7.4, 0.5 mM EDTA,
0.05% Orange G), the reaction mixtures were resolved by 6% native polyacrylamide gel elec-
trophoresis in TAE buffer (30 mM Tris-acetate, pH 7.4 and 0.5 mM EDTA) at 4 °C. The gels
were dried, and DNA species were visualized by autoradiography and quantified using the
Personal Molecular Imager and Quantity One software (Bio-Rad). Since the nucleoprotein
complexes formed by BRCA–1-BARD1 do not always migrate as well-defined species, we
quantified DNA binding by measuring the disappearance of the DNA substrate.
Oligo 5: 5’-CAT TGC ATA TTT AAA ACA TGT TGG AA GGC TCG ATG CAT
GCT GAT AGC CTA CTA GTG CT G CTG GCT TTC AAA TGA CCT CTT ATC AAG
TGA C-3’
Oligo 6: 5’-GTC ACT TGA TAA GAG GTC ATT TGA ATT CAT GGC TTA GAG
CTT AAT TGC TGA ATC TGG T CT GGG ATC CAA CAT GTT TTA AAT ATG CAA
TG-3’
Oligo 7: 5’-CTG CTA CGA TGC TAG TCG TAG CTC GGC AGT CGT AGC AGG
TTC CCA GCA CCA GAT TCA GC A ATT AAG CTC TAA GCC ATG AA-3’
Oligo 8: 5’-GAC GCT GCC GAA TTC TAC CAG TGC CTT GCT AGG ACA TCT
TTG CCC ACC TGC AGG TTC ACC C-3’
Oligo 9: 5’-GGA CAT CTT TGC CCA CCT GCA GGT TCA CCC-3’
Oligo 10: 5’-TGG GTG AAC CTG CAG GTG GGC AAA GAT GTC C-3’
Oligo 11: 5’-GGG TGA ACC TGC AGG TGG GCA AAG ATG TCC CAG CAA
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GGC ACT GGT AGA ATT CGG CAG CGT C-3’
Oligo 12: 5’-TTA TAT CCT TTA CTT TGA ATT CTA TGT TTA ACC TTT TAC
TTA TTT TGT ATT AGC CGG ATC CTT ATT TCA ATT ATG TTC AT-3’
Oligo 13: 5’-ATG AAC ATA ATT GAA ATA AGG ATC CGG CTA ATA CAA AAT
AAG TAA AAG GTT AAA CAT AGA ATT CAA AGT AAA GGA TAT AA-3’
6.5.5 Affinity pull-down
RAD51, yRad51 or RecA (5 µM) was incubated with 0.5 ￿M Flag–BRCA1–BARD1 or
3 ￿M GST–BARD1123–162 at 4 °C for 30 min in 30 µl buffer F (25 mM Tris-HCl pH 7.5, 10%
glycerol, 0.5 mM EDTA, 0.05% Igepal CA-630, 1 mM 2-mercaptoethanol, 150 mM KCl).
Then the reaction mixture was mixed with 12 µl anti-Flag M2 affinity resin or Glutathione
Sepharose 4 Fast Flow resin at 4 °C for 30 min to capture protein complexes through the
Flag tag on BRCA1 or the GST tag on BARD1, respectively. After the resin was washed
three times with 200 ￿l buffer F, bound proteins were eluted with 20 ￿l 2% SDS at 37 °C for
5 min. The supernatant (S), last wash (W) and SDS eluate (E), 8 ￿l each, were analyzed by
SDS–PAGE and Coomassie blue staining.
6.5.6 Southwestern analysis
BRCA1–BARD1 was resolved in a 7.5% SDS–PAGE gel and transferred onto a nitro-
cellulose membrane (Bio-Rad) at 4 °C in transfer buffer (25 mM Tris-HCl, 192 mM glycine,
pH 8.3, 20% methanol). After being soaked in buffer G (25 mM Tris-HCl, pH 7.5, 2 mg
ml−1 BSA, 1 mM DTT, 0.1% Triton X-100, 10% glycerol and 100 mM KCl) at 4 °C for 20 h,
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the membrane was rinsed twice with buffer H (25 mM Tris-HCl, pH 7.5, 200 µg ml−1 BSA,
90 mM KCl, 4 mM MgCl2 and 1 mM DTT) and then incubated in 10 ml buffer H containing
32P-labelled D-loop DNA (2 nM) at 25 °C for 1 h. The membrane was washed four times
with 10 ml buffer H before analysis by phosphorimaging.
6.5.7 Far western analysis
After SDS–PAGE, BRCA1 and BARD1 were transferred onto a nitrocellulose mem-
brane, as described for the southwestern analysis. The membrane was soaked in buffer
I (10 mM KH2PO4 at pH 7.4, 150 mM KCl, 15 mg ml−1 BSA, 2 mM 2-mercaptoethanol,
0.05% Tween 20) at 25 °C for 2 h and then incubated with 5 µg ml−1 RAD51 in buffer I at
25 °C for 2 h. Then, the membrane was washed with 10 ml buffer I three times, incubated
with anti-RAD51–HRP antibodies (Abcam, ab195548) for 1 h in buffer I, washed again with
10 ml buffer I three times, and developed with the Super Signal Substrate Kit (Pierce).
6.5.8 Homologous DNA pairing assay
The homologous DNA pairing assay was conducted as described [448, 449]. The reac-
tion was assembled in buffer J (25 mM Tris-HCl, pH 7.5, 60 mM KCl, 1 mM DTT and 100 ￿g
ml−1 BSA) containing 1 mM ATP and 2 mM MgCl2 in a final volume of 12.5 µl. For media-
tor activity, the 150-mer oligonucleotide 14 (6 µM nucleotides) was first incubated with RPA
(600 nM) at 37 °C for 5 min, and then RAD51 (2 µM) with or without the indicated concen-
tration of BRCA1–BARD1 or BRCA2–DSS1 was incorporated into the reaction. Following
a 5-min incubation at 37 °C, 32P-labelled homologous dsDNA (40 bp; oligos 15 (5’-TAA
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TAC AAA ATA AGT AAA TGA ATA AAC AGA GAA AAT AAA G-3’) and 16 (5’-CTT
TAT TTT CTC TGT TTA TTC ATT TAC TTA TTT TGT ATT A-3’); 1.6 µM base pairs)
and 4 mM spermidine hydrochloride were added. For testing of ssDNA targeting activity,
RAD51 was incubated with the mixture of ssDNA, 32P-labelled dsDNA and spermidine
hydrochloride with and without BRCA1–BARD1 or BRCA2–DSS1 for 30 min. The reaction
was terminated by adding an equal volume of 1% SDS containing 1 mg ml−1 proteinase K.
Following a 5-min incubation at 37 °C °C, the deproteinized reaction mixtures were resolved
in an 8% non-denaturing polyacrylamide gel in TAE buffer. The gel was dried onto 3MM
CHR cellulose chromatography papers (GE Healthcare), and DNA species were visualized
by autoradiography and quantified, as above.
6.5.9 D-loop assay
The D-loop assay was conducted as described [453, 460]. In brief, the 32P-labelled
90-mer oligonucleotide 17 (5’-AAA TCA ATC TAA AGT ATA TAT GAG TAA ACT TGG
TCT GAC AGT TAC CA A TGC TTA ATC AGT GAG GCA CCT ATC TCA GCG
ATC TGT CTA TTT-3’; 2.4 ￿M nucleotides) was incubated with RAD51 (1 ￿M) at 37 °C
for 5 min in buffer J containing 1 mM MgCl2 and 2 mM ATP or AMP-PNP. Following the
incorporation of the indicated concentration of BRCA1–BARD1 and a 5-min incubation at
37 °C, the D-loop reaction was initiated by adding pBluescript SK replicative form I DNA
(37 ￿M base pairs) and was incubated at 37 °C for 7 min. The molar ratio of the 90-mer to
pBluescript plasmid in the reactions was 2.1 to 1. The reaction was terminated by adding
an equal volume of 1% SDS containing 1 mg ml−1 proteinase K and a 5-min incubation at
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37 °C. The deproteinized reaction mixtures were resolved by electrophoresis in a 1% agarose
gel, which was dried onto Hybond-N membrane (GE Healthcare). Phosphorimaging analysis
was used to visualize and quantify the radiolabelled DNA species.
6.5.10 Synaptic complex assay
The synaptic complex assay was conducted at 37 °C as described5,6. In brief, RAD51
(4 ￿M) was incubated with the 60-mer oligonucleotide 18 (12 ￿M nucleotide; 5’-AAT GTT
GAA TAC TCA TAC TCT TCC TTT TTC AAT ATT ATT GAA GCA TTT ATC AGG
GTT ATT-3’), which is homologous to the SspI restriction site in the target pUC19 dsDNA,
in 8 ￿l buffer K (35 mM Tris-HCl, pH 7.5, 50 mM KCl, 2 mM ATP, 2 mM MgCl2, 100 ￿g ml−1
BSA, and 1 mM DTT) for 5 min. After adding the indicated amounts of BRCA1–BARD1 in
1 ￿l volume, the reaction mixture was incubated for 5 min. Then, linear pUC19 plasmid DNA
(85 ￿M nucleotides) was added in 1 ￿l, followed by a 5-min incubation and treatment with 2.5
units of SspI for 10 min. The reaction mixtures were resolved by agarose gel electrophoresis
in TAE buffer, and DNA species were stained with ethidium bromide. The heterologous
oligonucleotide 19 (5’-CAG AAT CAG GGG ATA ACG CAG GAA AGA ACA TGT GAG
CAA AAG GCC AGC AAA AGG CCA GGA-3’) was used as a control.
6.5.11 DNA curtain imaging analysis
RAD51 filaments were assembled on ssDNA curtains, and the dsDNA-binding proper-
ties of the resulting RAD51–ssDNA filaments were measured as described39,40. To deter-
mine the number of dsDNA-binding events, BRCA1–BARD1 was diluted from a 1.5 ￿M stock
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with buffer K (30 mM Tris–acetate pH 7.5, 1 mM MgCl2, 5 mM CaCl2, 100 mM KCl, 2 mM
ATP, 1 mM DTT, and 0.2 mg ml−1 BSA) to concentrations ranging from 10 to 100 nM,
introduced into the flow cell chamber, and incubated for 10 min at 37 °C. After washing
with 1 ml buffer K (at 1 ml min−1), 2.16 nM Atto565-labelled dsDNA (70 bp) with 9 nt of
homology (oligos 20 (5’-Atto565-CCG GAG GCC TTA GGC CTT AGG CCT TAG GCC
TTC AGC TGT TAG CCT TAG CTA GCT AGC TAG CTA GCT AGC T-3’; the under-
lined sequence is homologous to the ssDNA substrate) and 21 (5’-AGC TAG CTA GCT
AGC TAG CTA GCT AAG GCT AAC AGC TGA AGG CCT AAG GCC TAA GGC CTA
AGG CCT CCG G-3’) to the RAD51–ssDNA filaments was introduced into the chamber,
followed by a 10-min incubation at 37 °C. Then, the cell was washed with 0.5 ml buffer K
(at 1 ml min−1) and three images were taken. The length of each of the RAD51–ssDNA
filaments and the number of labeled dsDNA molecules bound were recorded and normalized
to a length of 50 pixels ( 40 kb). The weighted average and standard deviation based on
the length of each filament were calculated. Confidence intervals of 95% are represented as
error bars. For survival probabilities, experiments were conducted without or with 100 nM
BRCA1–BARD1 and 100 ms exposures were recorded every 30 s over 90 min. Dwell times
of 180 molecules were determined for each experiment by kymograph and survival proba-
bilities were plotted on a semi-log plot. Error bars represent 70% confidence as measured by
bootstrap analysis, a close approximation of one standard deviation from the mean.
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6.5.12 Cell culture and transfection
U2OS and HeLa cells from ATCC were grown in Dulbecco’s modified Eagles
medium (DMEM) supplemented with 10% fetal bovine serum (Sigma), 100 ￿g ml−1
streptomycin, and 100 U ml−1 penicillin (Sigma). The cells were tested for my-
coplasma contamination by Bionique testing labs (http://www.bionique.com/). Con-
trol siRNA (UAGCCGGUAGACUUAGGUCUG), BARD1 siRNA (AAGAGUAAAGCU-
UCAGUGCAA), BRCA1 siRNA (AAGCUCCUCUCACUCUUCAGU) and BRCA2 siRNA
(UUGGAGGAAUAUCGUA GGUAA) oligonucleotides were purchased from Qiagen.
TP53BP1 siRNA (s14313) was purchased from Ambion-Thermo Fisher Scientific. Trans-
fection of siRNA, pS-Flag-SBP-BARD1resand pCMV-I-SceI-3×NLS was carried out using
Lipofectamine 2000 (Invitrogen) according to the manufacturer’s instructions. To generate
stable HeLa and U2OS cell lines expressing Flag–SBP–BARD1 or its mutants, cells were
transfected with their respective plasmids (pS-Flag–SBP–BARD1WTres, pS-Flag–SBP–
BARD1AAEres, and pS-Flag–SBP–BARD1K140Nres) and individual clones were selected
with 800 ￿g ml−1G418.
6.5.13 Co-immunoprecipitation analysis
HeLa cells grown on 15-cm cell culture dishes were treated with or without 1 ￿M MMC
overnight before collection. Following a wash with PBS, cells were scraped off and transferred
to Eppendorf tubes. Whole cell lysate was prepared by adding 1 ml lysis buffer (300 mM
NaCl, 1.0% Triton X-100, 5 mM EDTA, 2 mM NaVO4, 2 mM Na4O7P2, 0.02% NaN3, and
50 mM Tris-HCl, pH7.4) with protease inhibitors (Roche Complete Protease Inhibitor Cock-
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tail Tablet) to cell pellets. Following a 12-s sonication, the cell extract was cleared by
centrifugation at 18,400g for 15 min at 4 °C. The supernatant fraction (2 mg protein in to-
tal) was incubated with DNase I (20 U) for 15 min at room temperature and 15 min at
37 °C. Then, 50 ￿l anti-Flag resin (Sigma) or anti-mouse IgG resin (Santa Cruz) was added,
followed by a 12 h incubation at 4 °C overnight. After the resin was washed four times with
lysis buffer, bound proteins were eluted with 100 ￿l SDS gel loading buffer (50 mM Tris-
HCl pH 6.8, 2% SDS, 0.1% bromophenol blue, 10% glycerol, 10% 2-mercaptoethanol) and
100 ￿l of the eluates were subjected to western blot analysis with anti-Flag and anti-RAD51
antibodies.
6.5.14 Immunoblot analysis
Protein was extracted from cells collected two days after transfection with the indicated
siRNAs using NETN buffer (20 mM Tris-HCl pH 8, 420 mM NaCl, 1 mM EDTA, 0.5% Igepal
CA-630, 1 mM DTT, and Roche Protease Inhibitor Cocktail) and 8 freeze–thaw cycles. Blots
(20–50 ￿g total protein) were probed with the following antibodies: BARD1 (Bethyl, A300-
263A; Santa Cruz Biotech, Sc11438), BRCA1 (Abcam, ab16780), 53BP1 (Abcam, ab36823),
Flag M2-HRP (Sigma, A8592), Phospho RPA32 S4/S8 (Bethyl, A300-245A), BRCA2 (EMD
Millipore, OP95-100UG), RAD51 (Santa Cruz Biotech, sc-8349), Actin (Abcam, ab3280),
Tubulin (Santa Cruz Biotech, sc-53030), HA.11 (16B12) (Covance, MMS-101P), or GST-
HRP (NEB, E2624S) according to the instructions provided by the manufacturers. If needed,
the blots were incubated with HRP-conjugated secondary antibodies (Pierce 31450 for rabbit
anti-mouse IgG-HRP; Sigma A6154 for goat anti-rabbit IgG-HRP; Santa Cruz Biotech Sc-
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2032 for goat anti-rat IgG-HRP) before visualization of protein signals using the ECL kit
(Thermo Scientific Pierce).
6.5.15 DR-GFP reporter assay
The DR-U2OS cell line containing a single integrated copy of the DR-GFP reporter
was used [217, 456]. Exponentially growing cells were seeded in 6-well plates at 2 × 105 cells
per well before transfection with 2 ￿l siRNA (20 ￿M) and 5 ￿l Lipofectamine 2000 (Invitro-
gen). One day after siRNA transfection, cells were transfected with 2 ￿g I-SceI expression
vector (pCBASce) and 5 ￿l Lipofectamine 2000. Homologous recombination proficiency was
determined by counting the fraction of GFP-positive cells using a BD FACScalibur S 72 h
after I-SceI transfection. The results were derived from between three and five transfections
of at least three independent experiments.
6.5.16 CRISPR–Cas9-induced gene targeting assay
The assay was conducted as described [458]. U2OS cells were seeded in 6-well plates at
2 × 105 cells per well before transfection with 2 ￿l siRNA (20 ￿M) and 5 ￿l Lipofectamine 2000
(Invitrogen). One day after siRNA transfection, cells were co-transfected with 1.6 ￿g sgRNA
plasmid pX330-LMNA1 (from G. Dellaire) and 0.4 ￿g donor template pCR2.1-CloverLamin
(from G. Dellaire) and 5 ￿l Lipofectamine 2000 (Invitrogen). Gene targeting efficiency was
determined by counting the per cent of Clover-positive cells using a BD FACScalibur S
72 h after plasmid co-transfection. The results were derived from between three and five
transfections of at least three independent experiments.
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6.5.17 Immunofluorescence microscopy and image analysis
HeLa cells in exponential growth were transfected on two consecutive days in Opti-
MEM medium using RNAiMAX (Invitrogen) with 20 nM BARD1 or control siRNA, as rec-
ommended by the manufacturer. Exposure to ￿-rays was performed using a 137Cs ￿-irradiator
(J.L. Shepherd, model 81-14) and a dose rate of 1.05 Gy min−1. Immunohistochemistry was
performed as previously described [461], except that cells were fixed in 4% paraformalde-
hyde at room temperature for 10 min and permeabilized in 0.4% Triton X-100 in PBS for
5 min. Rabbit anti-RAD51 (H-92; Santa Cruz Biotechnology; 1:2,000) and goat anti-rabbit
AlexaFluor-488 secondary antibodies (Invitrogen; 1:750) were used. For image capture of
RAD51 foci, Z-stack section images consisting of 20 stacks (0.2-￿m intervals) from 100 to 150
nuclei per sample were taken using a 63× oil objective and a Zeiss Axio-Imager.Z2 micro-
scope equipped with Zen Blue software (Carl Zeiss Microscopy). For computational analyses
of foci, Z-stacks were collapsed down to the maximum intensity projections, and a combina-
tion of ImageJ (http://rsb.info.nih.gov/ij/) and Cell Profiler (http://www.cellprofiler.org/)
software programs was used with the following custom program settings for image process-
ing: minimum object size = 3; maximum object size = 35; despeckle ratio = 0.3; rolling ball
size = 5. A custom-built pipeline for automated cell (80–300 pixel units) and foci counting
with settings for shape (0.5) and dimensions (5 pixels diameter) was employed. The thresh-
old for foci detection was determined based on sham-irradiated samples, and nuclei with >5
foci per nucleus were counted positive. Group allocation and outcome assessment were done
in a fully blinded manner.
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6.5.18 Clonogenic survival assay
HeLa cells were transiently transfected with siRNA as described above. After 48 h,
cells were seeded into 6-well plates at 50–32,000 cells per well, and treated with 0, 5, 10
and 20 nM MMC (Sigma) or 0, 0.5, 1 and 2 ￿M Olaparib (Selleckchem) in regular growth
medium for 14 days. Cells were fixed with 10% methanol and 10% acetic acid, and stained
with 1% crystal violet in methanol before colonies were counted. Clonogenic survival was
determined for a given concentration of cells that were plated by dividing the number of
colonies on each treated plate by the number of colonies on the untreated plate, taking the
plating efficiency of untreated cells into account.
6.5.19 Preparation of cytoplasmic and nuclear extracts
The Dignam method for the preparation of cytoplasmic and nuclear extracts was fol-
lowed [462]. In brief, 109 cells were washed with PBS and Dignam buffer A (10 mM Hepes
pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT and 0.5 mM PMSF), collected by centrifu-
gation, and lysed in two packed cell volumes of Dignam buffer A using a Dounce homogenizer
(50 strokes) with the type A pestle. After centrifugation, the supernatant containing cyto-
plasmic proteins was saved for analysis. The pelleted nuclei were resuspended and lysed in
3 ml Dignam buffer C (20 mM Hepes pH 7.9, 1.5 mM MgCl2, 420 mM NaCl, 0.2 mM EDTA,
0.5 mM DTT, 25% glycerol, and 0.5 mM PMSF) using a Dounce homogenizer (80 strokes)
with the type B pestle. Debris was removed by centrifugation to yield the nuclear extract
fraction. The cytoplasmic and nuclear fractions, 20 ￿g each, were analysed by immunoblot-
ting for their content of BRCA1, Flag–SBP–BARD1, tubulin and histone H3.
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6.5.20 Statistics and reproducibility
The statistical analysis was performed using Prism 7 (GraphPad Software, Inc.;
http://www.graphpad.com/quickcalcs/ttest1.cfm) on the data from at least three indepen-
dent experiments, as specified. Unless stated otherwise, statistical significance was assessed
by two-tailed unpaired Student’s t-test. *P ￿ 0.05 and **P ￿ 0.01 were considered significant.
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Discussion and Future Perspectives
A mixture of curiosity and logical rigor has allowed humanity to ask and answer ques-
tions about how collections of colliding molecules bond, break, and interact in unfathomably
complex ways to coalesce into the miraculous life forms that exists on this planet today. This
relentless pursuit of knowledge has led to the branching of many fields including molecular
genetics, biochemistry, structural biology, and single-molecule biophysics. Over the course
of this work, we have seen the power of combining these various scientific techniques to an-
swer a question of why organisms evolved seemingly redundant proteins. We arrived at this
question because evolution is a brutally efficient force that rarely leaves room for the unnec-
essary consumption of limited resources. These concluding remarks will seek to demonstrate
how this work has begun to answer the question why eukaryotes evolved two recombinases
for mitotic and meiotic recombination and on the future work that can bring us further
answers.
Summary
In the first chapter, we explored the novel technique high-throughput single-molecule
DNA curtains developed in the Eric Greene Lab which has allowed us to answer questions in
the field of homologous recombination that have otherwise been unsolved. The basic premise
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of single-molecule biophysics is that the macroscale metabolic and catabolic pathways that
govern the lifecycle of an organism are made up of countless individual molecules that move
and interact in seemingly infinite ways but in total, result in the workings of the cell. By
only looking at the summation of the molecules, we miss the finer details that can lie in the
subpopulations of molecular behaviors. Exploring these subpopulations can provide greater
mechanistic understanding in how these pathways work.
Although chapter one features an analogy to explain this concept of subpopulations, I
often provide individuals trying understand the power of single-molecule biophysics with the
everyday event of traffic. On a typical Friday afternoon, millions of commuters leave work
within a range of a couple hours, producing the phenomena of rush hour. This unstable
equilibrium of moderate to heavy congestion generally allows cars to move a decent pace,
however, small perturbations, such as a long weekend motivating a subpopulation of people
looking to get away can quickly lead to complete standstills on that same road and in that
same time window. A subpopulation of savvy commuters, knowing that a long weekend is
approaching might try to leave work earlier and thus expanding the rush hour window all
simply by the influence of another subpopulation. Thus, we will use single-molecule research
to explore the inner workings and subpopulations of behaviors that govern homologous
recombination towards our better mechanistic understanding of the pathway.
In chapter two, we use single-molecule DNA curtains to understand shared principles
in how recombinases across life sample partially homologous DNA molecules towards under-
standing how recombinases are so efficiently able to search the entire genome for their desired
target. A set of universal principles emerged showing that all members of the RecA/Rad51
family of recombinases required at least 8 nt of homology in order to stably bind dsDNA
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and that increases in binding stability occurred in 3 nt steps. Since it was previously known
that recombinase bind to 3-nt, this 8 nt benchmark hints at how recombinases might com-
municate with adjacent recombinase molecules to create a cooperative energetic barrier to
sampling every possible homologous triplet in the genome. By setting this lower bound to 8
nt, the number of possible substrates across the genome for a presynaptic filament to search
greatly reduces this search. The 3 nt stepping points to the way in which recombinases
bind nucleotide triplets in a very unique way. Each triplet is held in a B-form-like DNA
structure with large stretches in between, creating an asymmetric or recombinase-stretched
(RS)-DNA. The exact reason why it might be advantageous for recombinases to bind DNA
in this manner for the homology search and eventual homologous pairing is still a topic of
exploration. However, by using this triplet stepping behavior, we were able to show the first
significant biophysical or biochemical difference between Dmc1 and Rad51. Specifically,
Dmc1 appears to be more tolerant of mismatches in internal triplets along the captured
dsDNA, whereas RecA and Rad51 could not. This could potentially explaining by eukary-
otes evolved two recombinases. Since, Dmc1’s role during meiotic recombination is to form
crossover events with heterologous homologs, it might beneficial for Dmc1 to be tolerant of
mismatches.
In chapter three, we test the limits of Dmc1’s tolerance to dsDNA imperfections towards
understanding how Dmc1 mediates this novel behavior. We found that although Dmc1 was
intolerant of insertions in triplets, it was still able to tolerate multiple mismatches within
a triplet as long as there were flanking non-mismatched triplets on each side. In addition,
Dmc1 was able to stabilize DNA with abasic sites suggesting a potential role in interacting
with the phosphate backbone. However, if this is the case, it is most likely not through non-
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bridging oxygen atoms on the DNA backbone since it was still able to stabilize a mismatched
triplet with a methylphosphonate backbone.
In chapter four, we combine structure alignments with principles of structure/function
to find lineage-specific amino acids in Dmc1 loops, L1 and L2, that differ from those Rad51’s
loops and due to their three-dimensional proximity to the presynaptic and captured DNA,
potentially mediate Dmc1’s mismatch stabilization behavior. By using basic cloning, pu-
rification and bulk biochemistry techniques, we then made chimeras and tested their basic
function to show that most chimeras retained the DNA-dependent ATPase and strand ex-
change activities that define recombinases. We then used the same single-molecule technique
discussed in chapters 1 through 3 to show that, in fact, we can create a Dmc1 mutant with
Rad51-like amino acids in L1 that can no longer tolerate mismatches and a Rad51 mutant
with Dmc1-like amino acids in L1 that is able to tolerate mismatches. We pair down these
mutations to determine the minimal amount of amino acids necessary for producing this ef-
fect and found that three in particular are most critical. We then venture into the world of in
vivo yeast genetics to see how this mismatch tolerance could affect mitotic recombination by
introducing mismatches in the homology target of MAT-type switching, the Z box, and see
whether mutant Rad51’s with Dmc1-like amino acids in L1 MAT-type switch with greater
efficiency than WT. Although the full loop swap mutants were somewhat deficient both in
vitro and in vivo, the Rad51 M301Q point mutant proved to more efficient than WT once the
Z box had at least mismatches every 1 in 5 bps. This might not seem biologically relevant
since homologs will certainly not diverge by as much as 80%. In addition, one of the reasons
we needed to introduce so many mutations is that we found that Rad51 is inherently very
tolerant of mismatches in vivo and work from other labs have found the same [378]. Thus, in
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order to capture any discernible difference between mutant Rad51 and WT, we needed WT
begin to struggle with the mutated templates we were providing. Again, from a bulk average
perspective, this subtle difference between mutant and WT seems irrelevant. But what we
argue, is that this subtle difference we’ve now seen in vitro and in vivo might represent a
huge effect over the course of generations. Small differences in a single 3-hour repair process
could snowball into massive differences when talking on evolutionary scales. For example,
the primordial yeast with only primordial Rad51 might have been able to sporulate with
91.4% efficiency while another yeast had an extra Rad51 copy in its genome with a single
mutation in L1 that allowed 91.7% sporulation efficiency. Over the course of millions of
generations, that has huge implications in evolutionary fitness.
Finally, in chapter 5, we find that the protein expressed by tumor suppressor gene,
BRCA1, when in combination with BARD1 is capable of aiding RAD51 in dsDNA capture
without affecting the stability of the captured DNA on the filament. This research helps
us to draw the link between those with BRCA1 mutations and why they might be more
susceptible to cancer. This is an excellent example of how basic science research can aid
in our understanding of disease, while simultaneously, the ardent pursuit in understanding
this particular gene was because of the disease is produces. The fact that BRCA1 mutations
specifically lead to cancer in the third-decade of light, shows how slight defects in a proteins
Rad51 mediating activity could lead to RAD51 repairing DNA in a slightly less efficient
manner, leading to more effects on genomic integrity.
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Future Work
There are many avenues for this research moving forward. One potential avenue is
using the method we demonstrated worked for L1 and use bioinformatics, primary structure
alignment, and known tertiary and quaternary structure information to explore other lineage-
specific amino acids that might be responsible for differences in how Rad51 and Dmc1
interact with mediators and anti-recombinases. For example, there may be particular amino
acids or groups of amino acids that make Dmc1 resistance to binding Hed1 or Srs2 stripping
Dmc1 from the presynaptic filaments. Using the addition of the in vivo assay developed,
this information can go from the microscope to the agar plate towards understanding the
impact such mutations might have on HR and cell function in general.
In terms of my primary findings with L1 and L2, I had findings that showed Dmc1 had
significantly higher affinity for labeled dsDNA than Rad51 and L2 appeared to be responsible
for this behavior. One issue is effect was not conserved between yeast and humans, however,
one could explore why that is the case or try to pair down the amino acids that are most
critical for this effect as done with L1 and mismatch stabilization. Since the Rad51 with
a Dmc1-like L2 was extremely deficient in vivo, finding the minimal mutations necessary
could allow for understanding how greater dsDNA capture by Dmc1 might be important
for meiotic recombinase. Additionally, the analogous L1 point mutations could be made
in Dmc1 and see whether mismatch intolerance persists once those three amino acids are
mutated. Additionally, in vivo yeast genetics can be done with Dmc1, looking at meiotic
recombination as well as in vivo work in mice and C. elegans, looking at the effect of these
mutations in Rad51 and Dmc1 in multicellular organisms with longer lifespans.
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Finally, the recent intersection between DSBR and neurology is a nascent field and
quite fascinating. Looking at the relationship between DNA tensions as a regulator for
transcription could be an excellent question for DNA curtains to answer. Overall, the of
the main themes of this is work is that by combining, techniques across fields and using all
available clues from both medicine and the lab bench, significant progress can be made in
understanding the world and the organisms that occupy it.
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